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ABSTRACT
GpdQ is a phosphohydrolase from Enterobacter aerogenes whose rare 
ability to hydrolyse simple diesters of phosphoric acid like dimethyl 
phosphate and diethyl phosphate first caught the attention and interest of 
researchers in the 1970s. When GpdQ was characterised further in more 
recent times, it was found to have an exceptionally broad substrate 
repertoire. The enzyme has primarily phosphodiesterase activity -  capable 
of hydrolysing a wide range of phosphodiesters including 
glycerophosphodiesters that are believed to be its natural substrates. 
Additionally, GpdQ has low phosphomonoesterase, phosphotriesterase and 
phosphonate monoesterase activities.
In this study, the promiscuity of GpdQ was exploited and we set out to 
improve the enzyme’s activity on one of the non-physiological 
phosphodiesters, bis (p-nitrophenyl) phosphate. Directed evolution was the 
main strategy used to achieve this goal. After the first four rounds of 
evolution, the hexameric quaternary structure of the catalytically improved 
GpdQ mutants was found to have broken down and high activity was 
associated with the dimer. Rational design was then employed to identify 
mutations that would promote dissociation and form a stable GpdQ dimer. 
These rationally-designed mutants were included for gene shuffling from 
the fifth round of directed evolution onwards. At the end of this study, eight 
full rounds of evolution were completed. Three GpdQ dimers displaying 
~500-fold &cat/Km improvement were successfully engineered.
In the course of this work, mutagenesis studies of GpdQ active site residues 
were also performed. In collaboration with fellow GpdQ investigators in the 
University of Queensland, the non-identical binding affinities of the two 
metal-coordinating sites was successfully characterised, providing more 
insight into the catalytic mechanism of the enzyme. Finally, future research
directions are also proposed in order to further characterise the substrate 
specificity of the mutants with improved bpNPP activity from this study.
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CHAPTER ONE: INTRODUCTION AND LITERATURE REVIEW
This dissertation is about directed evolution, rational design and mechanistic 
studies of a phosphohydrolase enzyme from Enterobacter aerogenes. The 
enzyme in question is GpdQ, which has very high levels of activity with 
phosphodiesters and low levels of activity with other types of phosphate 
esters.
This chapter presents introductions and overviews of:
1.1 Properties and limitations of enzymes: the long-term aims of this 
work.
1.2 Organophosphate compounds that are substrates of GpdQ.
1.3 An introduction to GpdQ -  its origin, isolation and cloning, catalytic 
properties.
1.4 The structure of GpdQ.
1.5 Rv0805, a 3 \5 ’-cyclic nucleotide phosphodiesterase from 
Mycobacterium tuberculosis that has the closest sequence and 
structural similarity to GpdQ.
1.6 Protein engineering strategies used in this study, namely directed 
evolution and rational design. This section also explains how 
rational design complements directed evolution in engineering 
enzymes.
1.7 The overview of this thesis.
1.1 ENZYMES
Enzymes are biological catalysts -  they are usually proteins. There are 
numerous reviews and biochemical texts that give detailed description of the 
properties of these molecules and a detailed coverage will not be provided 
here. For our purposes it is sufficient to say that enzymes are molecules that 
catalyse or increase the rate of chemical reactions so that life is possible. 
The ability of enzymes to accelerate reactions has not escaped the attention
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of chemists and applications for enzymes are increasingly being found in 
industrial and academic settings. However, their properties impose practical 
limits upon their use. There are a few obvious examples. For instance, 
enzymes are not stable over wide temperature ranges. Most enzymes from 
enteric bacteria work at the optimum temperature of 37°C and suffer from 
denaturation at high temperatures. More importantly, not all reactions of 
industrial importance are found in nature and an appropriate enzyme to 
catalyse a reaction may not exist naturally. If we could design or evolve 
enzymes for particular applications then these molecules would provide an 
efficient and clean way to carry out chemical conversions. This thesis is 
concerned with the process by which the substrate specificity of an enzyme 
can be altered. The field of directed evolution is still rapidly developing and 
much work needs to be done in understanding how to evolve enzymes and 
understanding the molecular consequences of this evolution. For reasons 
outlined later, I chose to work with an enzyme that had a very broad 
specificity and set out to increase its activity towards a relatively poor 
substrate. Specifically I was interested in enhancing the ability of GpdQ to 
degrade non-physiological substrates -  simple phosphate esters. This study 
was intended to be the fist step in evolving GpdQ to degrade a variety of 
phosphate esters. It was also intended to provide some understanding how 
the enzymes could possibly be redesigned to catalyse new hydrolysis 
reactions.
In summary, the aim of my work was to first evolve an enzyme and 
secondly to try and understand how improvements in activity came about. 
To achieve this second aim we need to have some knowledge of the enzyme 
structure and in particular the enzyme active site. Would attempts to change 
the substrate specificity of an enzyme merely change residues in the active 
site or would the changes be more widespread? If the changes were 
widespread ie. not restricted to the active site then we would like to know 
what effect these changes had on the active site -  how did the changes
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enhance activity? These are the types of questions that we would like to 
address with the results from the directed evolution studies.
The structure of a protein is traditionally described on four levels -  primary 
(the amino acid sequence of a protein), the secondary structure (a-helices 
and ß-sheets), tertiary structure (subunit or chain structure -  the 
arrangement of secondary structure elements) and quaternary structure (the 
arrangement of a number of subunits to give a functional enzyme molecule 
complex) [1]. Much has been written about protein structure and little needs 
to be added here. However, it is worth mentioning that protein subunits 
(tertiary structure) are often divided into domains -  discrete portions of 
proteins made up of compact globular folds that are thought to be important 
in protein folding, function and evolution. Protein chains larger than -200 
residues usually fold into such globular clusters [1, 2]. Similar domains are 
often found in a variety of proteins. For example, the ot/ß hydrolase fold is 
an ideal fold for forming hydrolytic enzymes [3]. Similarly, the structure of 
the catalytic domain of GpdQ has been found in a variety of 
phosphohydrolases and it is worth looking at this structure looking at it in 
some detail before analysing the results of directed evolution. We do this in 
section 1.4 of this introductory chapter.
1.1.1 Enzyme active sites
The active site of an enzyme is where catalysis takes place [4] and it is 
usually a cleft that is surrounded by residues whose protruding side chains 
form the surface of the site and interact directly with ligand molecules 
(substrate, product or co-factor). The shape, structure and chemical 
properties of the active site allow the recognition of the substrate molecule, 
thus giving enzymes the specificity or selectivity (stereo-specificity and/or 
geometric specificity) [1]. A protein engineer would like to understand how 
the specificity can be altered -  what residues can be altered and which 
residues need to be conserved to maintain catalysis. In the case of GpdQ, it
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was known that it had a low level of activity to a wide range of substrates -  
would evolution alter residues on the periphery of the active site so or would 
resides in the centre of the active site be altered? These are the type of 
questions that we would like to address in this thesis.
The active sites of most enzymes are usually contained within a single 
domain, but in many enzymes the active site at the interface between two 
domains so that changes in enzyme activity may also involve changes in the 
oligomeric structure of the enzyme [5, 6]. The catalytic properties of an 
enzyme may depend upon the structure of its active site as well as the 
manner in which the subunits are arranged.
There are two models that describe enzyme specificity: the lock-and-key 
model and the induced fit model. In the lock-and-key model, Emil Fischer 
likened the active site of an enzyme to a lock and the substrate molecule to a 
key: their shapes are rigid, geometrically complementary and fit exactly into 
each other [7], This model is an adequate description of many enzymes. In 
particular hydrolytic enzymes usually have active sites that conform to the 
lock and key model and usually obey Michaelis-Menten kinetics. GpdQ was 
expected to conform to this model.
Highly regulated enzymes or enzymes that need to exclude water from the 
active site usually do not conform to this model. Instead, the behaviour of 
these enzymes can be explained by the induced fit model proposed by 
Koshland. In this model, the active site of an enzyme is flexible and 
undergoes modifications upon substrate binding and is finally moulded to 
the shape of the substrate molecule to catalyse a reaction [8]. Enzymes that 
undergo induced fit are usually highly regulated and do not exhibit 
Michaelis-Menten kinetics -  they are often described as cooperative 
enzymes. Figure 1.1 shows the Michaelis-Menten plots for three forms of 
cooperativity in enzyme kinetics -  positive, negative and no cooperativity. 
Non-cooperative enzymes give a hyperbolic Michaelis-Menten plot.
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Michaelis-Menten plots of positively cooperative enzymes are sigmoidal in 
shape while negatively cooperative ones are ‘biphasic’, where the velocity 
continues to increase at high substrate concentrations.
A
10 • • • • •
ubstrate concentration
0 0.5 t 1.5 2 2.5 5
•  Positive cooperativity 
- No cooperativity
♦  Negative cooperativity
50
Figure 1.1: Michaelis-Menten plots of cooperative/non-cooperative enzymes.
Michaelis-Menten plots of three enzymatic behaviours that exhibit positive, negative 
and no cooperativity respectively. The three curves at low substrate concentrations 
(circled in A) are magnified in B.
During the course of this study, deviations from Michaelis-Menten kinetics 
were observed in some GpdQ mutants and attempts were made to 
understand the molecular basis of this behaviour. The Hill equation, a 
common method to describe cooperativity was used to analyse these non- 
Michaelis-Menten kinetics, as will be described in Chapters 2 and 3.
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1.1.2 Metalloenzymes
GpdQ contains two metal ions as co-factors and is a metalloenzyme. This 
class of enzymes is very common; more than one third of all known 
enzymes require metal ions for enzyme activity. A database dedicated to 
metalloproteins was set up in recent years to offer scientists information 
about the geometrical parameters of metal-binding sites in protein structures 
available from the Protein Data Bank (http://metallo.scripps.edu/) [9].
Residues that coordinate the metal ions are known as ligands. Amino acids 
that regularly act as metal ligands are cysteine, histidine, aspartic and 
glutamic acids as well as their amides, and tyrosine. The functional groups 
of these residues form a shell of hydrophilic atomic groups of oxygen, 
nitrogen and sulfur atoms, where metal ions can bind comfortably [10]. 
Metals that are commonly found in hydrolytic enzymes like GpdQ are 
transition metals like Co2+, Zn2+, Fe2f, Fe3f, Mn2+; alkaline earth metal ions 
like Mg2t that have a tendency to bind less tightly [1]. A review of the 
coordination chemistry relevant to metalloenzymes is available [11].
Metal ions can have at least two functions in hydrolytic reactions. They can 
act as Lewis acids and activate nucleophiles for attacking chemical bonds in 
the substrate [1]. Metal ions are also known to participate in catalysis by 
interacting with the substrate (binding) and ensuring that it is oriented 
correctly for catalysis [12].
Metalloenzymes are generally thought of as binding their metal with high 
affinity. Indeed this is frequently the case. In fact some proteins have 
demonstrated the need for metal binding to occur prior to their folding, thus 
playing a structural role. There are also examples of metal ions controlling 
conformational changes to the active site [13-15]. However, metal ions do 
not always bind tightly to an enzyme and they do not always bind prior to 
the substrate. For example, metals are essential for DNA polymerase
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activity, but the metals are not bound tightly to the protein in the absence of 
the DNA substrate [16, 17]. Clearly, the affinity of an enzyme for metals is 
important for its function and how this affinity can be modulated is of 
considerable interest to the protein engineer. In the case of GpdQ I have 
tried to understand how the binding affinities of the metal ions can be 
modulated by mutating metal ligating residues and measuring changes in 
activity.
1.2 ORGANOPHOSPHATE COMPOUNDS
1.2.1 The chemistry of organophosphate compounds
Organophosphate compounds (OPs) of relevance to this thesis are esters of 
phosphoric acid (H3PO4). The term also applies loosely to sulfur analogues 
of phosphoric acid as well as phosphonic acids. Phosphoric acid is triprotic, 
meaning it contains three potential protons to donate. Therefore, phosphoric 
acid can be esterified from one to three stages, forming a monoester, diester 
or triester, respectively. Structures of the main classes of organophosphates 
are shown below.
Hydrolysis Hydrolysis Hydrolysis
X
I
HO----- P------OH
OH
Phosphoric acid 
(source of P;, 
inorganic phosphate)
X
HO----- P------OH
o r *
Phosphomonoester
X
Phosphodiester
X
R'O-------P------OR'"
1 r '
Phosphotriester
Phosphonic acid Phosphonomonoester Phosphonodiester
Figure 1.2: Chemical structures of the common classes of OPs.
X can be oxygen or sulfur while R, R’ and R” are alkyl, alkenyl, alkynyl, aryl and 
even phenol groups.
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1.2.2 Organophosphate compounds and their uses
Phosphotriesters
Organophosphate triesters are synthetic and do not occur naturally in the 
environment. They are used extensively in the production of insecticides 
and chemical warfare agents. In both applications, OP triesters act as potent 
nerve agents by inhibiting acetylcholinesterase (AChE) and ultimately 
causing death. AChE is a serine esterase that catalyses the hydrolysis of the 
neurotransmitter acetylcholine into choline and acetic acid [1, 18, 19]. 
Figure 1.3 shows examples of OP triesters that are commonly used in 
pesticides and chemical warfare agents.
Mulathion
R = Et, X = O: Paraoxon (EPO)
R = Et, X = S: Parathion (EPS)
R = Me, X = O: Methyl paraoxon (MPO)
R = Me, X = S: Methyl parathion (MPS)
VX
Figure 1.3: Examples of phosphotriesters.
Examples of phosphotriesters that are commonly used on pesticides (A) and 
chemical warfare agents (B).
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Phosphodiesters andphosphomonoesters
While phosphotriesters are not naturally occurring compounds, diesters and 
monoesters are abundant in nature and have play important biochemical 
roles, including in genetic materials like DNA and RNA (Figure 1.4), 
enzyme co-factors like ADP, intracellular energy transfer (ATP) and as 
intermediates in biochemical reaction pathways [19]. Phosphodiesterases 
that specifically react upon the phosphodiester bonds in DNA are known as 
nucleases.
N Adenine triphosphate (dATP)
Cytosine
l triphosphate (dCTP)
Phosphodiester
bond
Phosphodiester 0 -----P
bond
O
Figure 1.4: The phosphodiester bonds in DNA.
The phosphodiesters that are of interest in this study are those from the 
direct breakdown of triesters or have the same leaving group as the triesters, 
for example dimethyl phosphate (DMP), diethyl phosphate (DEP) and bis 
(p-nitrophenyl) phosphate (bpNPP) (Figure 1.5).
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o o
H3C----- P------CH3 Dimethyl
phosphate
Ch3Ch2----- P------CH2CH3 Diethyl
phosphate
O
0 ©
O
O
►------ o ------
o
©
Figure 1.5: Examples of phosphodiesters.
Chemical structures of the ionised forms of dimethyl phosphate, diethyl phosphate 
and bis (p-nitrophenyl) phosphate.
1.2.3 The toxicity of organophosphate triesters
As discussed earlier, the popularity and commercial success of OP triesters 
are mainly due to their inherent ability to deactivate AChE. Unfortunately, 
the toxicity of OP triesters extends beyond the targeted organisms to pose 
serious threats to the environment, ecology and health [18-20]. As a result, 
many scientific research groups have set out to develop methods to degrade 
or to remove OP triesters from the environment.
Although the use of OP triesters as pesticides and nerve agents has a history 
of less than a century, some bacteria have evolved enzymes that are capable 
of hydrolysing a wide range of these compounds. These phosphotriesterases 
(PTEs) include the identical organophosphate hydrolases from
Flavobacterium sp. [21] and Pseudomonas diminuta [22],
organophosphorus acid anhydrase (OPAA) from Altermonas sp. [23] and 
OpdA from Agrobacterium radiobacter P230 [24]. OpdA and OPH have 
-90% sequence identity but the former has additional polypeptide chain 20 
amino acids in length at the C-terminus and there are three other amino acid 
differences located in the substrate binding pocket [25, 26]. In the Ollis
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laboratory, the C-terminus extension was deleted from the opdA gene so 
that the expressed enzyme would have an increased similarity to OPH [27].
All these PTEs, due to their individual substrate specificities, catalyse the 
hydrolysis of different phosphotriesters with various efficiencies. For 
instance, OpdA activities with triesters like methyl derivatives of paraoxon 
and parathion are nearly diffusion limited whereas its methyl chloropyrifos 
activity is relatively low [28]. Various research groups, including the Ollis 
laboratory, have set out to engineer their respective PTEs towards higher 
activity with poor substrates, since PTEs provide a promising OP 
detoxification and bioremediation technology that is both efficient and safe 
[29-32].
1.3 GpdQ - A NOVEL GLYCEROPHOSPHODIESTER 
PHOSPHODIESTERASE FROM ENTEROBACTER AEROGENES
This section 1.3 is a summary of previous work on GpdQ, including the 
isolation, purification, cloning of the gpdQ gene and characterisation of the 
enzyme activity.
1.3.1 Growth of Escherichia coli co-expressing OpdA and GpdQ using 
paraoxon as the sole phosphorus source
In 2003, Dr Sean Yu-McLoughlin created an Escherichia coli system that 
was capable of utilising dimethyl paraoxon (MPO), a phosphotriester, as the 
sole phosphorus source. The E. coli system would go through the following 
proposed catabolic pathway (Figure 1.6) for the breakdown of MPO to 
phosphate, P j  [32].
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©
° P dA Dimethyl GpdQ Methyl _____  p. . .
Methyl paraoxon -------------------------- ►  phosphate phosphate ^  ' P
Phosphotriesterase Phosphodiesterase Phosphatase
Figure 1.6: The proposed catabolic pathway for the breakdown of methyl 
paraoxon (MPO).
This rationally designed pathway was for the mineralisation of MPO in an E. coli that 
co-expresses recombinant OpdA and GpdQ. Phosphatases such as alkaline 
phosphatase are naturally expressed by E. coli.
E. coli transformed with the recombinant opdK gene would express the PTE 
to readily degrade MPO. However, it had been previously reported that E. 
coli was unable to use dimethyl phosphate (DMP), the hydrolysis product of 
MPO, as its sole phosphorus source [33]. Therefore, a phosphodiesterase 
from an external source that is capable of hydrolysing DMP was sought.
Enterobacter aerogenes was reported to be able to survive on DMP as its 
sole phosphorus source [34]. Gerlt and co-workers had isolated and 
characterised the phosphohydrolase that was responsible for DMP 
hydrolysis [35, 36]. The enzyme was found to be hexameric with a subunit 
molecular weight of 29 kDa. The phosphohydrolase was also found to be 
capable of hydrolysing a range of monoesters and diesters of phosphoric 
acid.
Yu-McLoughlin et al. isolated the gene for this enzyme from the 
chromosome of a strain of E. aerogenes obtained from a wallaby. The 
genomic DNA was isolated and digested into fragments sized between 2 and 
10 kb with the restriction endonuclease Sau3Al. The DNA fragments were 
then cloned into plasmids. The library of E. aerogenes genomic DNA
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fragments was used to transform DHlOß E. coli cells that were then selected 
on minimal medium supplemented with 0.1 dimethyl phosphate (DMP) as 
the sole phosphorus source. A single colony of E. coli grew significantly 
larger than the rest. The plasmid was isolated and characterised as described 
in the next section. This new plasmid was later used to transform fresh 
DHlOß E. coli cells that already bore the opdA gene. These cells were then 
tested positive for growth on medium with dimethyl paraoxon (MPO) as the 
sole phosphorus source. The ability of the cells to grow on MPO as its sole 
phosphorus source would signify the success of the catabolic pathway 
outlined in Figure 1.7, where the breakdown of methyl paraoxon (MPO) 
occurred in three catalysed hydrolysis steps. OpdA catalysed the hydrolysis 
of MPO to DMP that then served as a substrate for GpdQ to be hydrolysed 
to release methyl phosphate, a monoester. E. coli readily expressed 
phosphomonoesterases with the likes of alkaline phosphatase (encoded by 
the phoA gene) [37] that would hydrolyse methyl phosphate to phosphate, 
that could be directly utilised by the bacteria as an energy source.
1.3.2 Characteristics and properties of GpdQ
The phosphohydrolase gene was isolated as part o f a putative operon 
The plasmid from the single E. coli colony that grew using DMP as the sole 
phosphorus source was isolated and studied. The presence of a 5.6-kb 
fragment was revealed and its sequence was determined. BLAST analysis of 
the sequence indicated that the fragment was partially homologous to 
glycerol-3-phosphate (G3P) uptake (ugp) operon of E. coli (Figure 1.7) [32]. 
The ugp operon contained four genes (A, B, C and E) that code for an ABC 
transporter that utilises the energy of adenosine triphosphate (ATP) 
hydrolysis to transport molecules across the cell wall [38, 39]. The E. 
aerogenes DNA fragment could be divided into the promoter region and 
five putative open reading frames (ORFs) four of which were homologous 
to proteins in the ugp operon of E. coli as indicated in the figure below 
(Figure 1.7). Additionally, a nucleotide sequence upstream of the putative E.
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aerogenes ugp operon has a 78% sequence match to the E. coli phosphate 
box, which is where the transcription activator PhoB binds when phosphate 
is limited [32, 40, 41].
I K f\ K
I  OR1-3 \ OR.F2 ORF3 \
, /
ORF4
)
ORF5
V
'1 /  V
A. aerogenes 5.ft kb DNA trapir.cn:
K _ J n l\ I
L
p-
I
UfZP B ) »HP* ugpt . ugpC J
y i'v V A
V  V  V V  V
A. coii uf(p operon
Figure 1.7: Comparison of the 5.6-kb DNA fragment isolated from E. aerogenes 
and the E. coli ugp operon.
ORFs in the E. aerogenes DNA fragment and their respective homologous genes in 
the E. coli ugp operon are shaded in the same colours, eg. ORF1 and ugpA are 
shaded in purple. P indicates the promoter region of each operon while PB indicates 
phosphate box. ORF3 is the 825-bp long gpdQ gene.
The remaining gene in the ugp operon codes for UgpQ, a 
glycerophosphodiesterase (GDPD) that had a high level of sequence 
similarity to GlpQ, a periplasmic GDPD whose sequence and structure is 
known [42-44]. GlpQ was one of more than 10 bacterial GDPD proteins 
whose structures were to be found in the Protein Data Bank 
(http://www.rcsb.org/pdb/). The GDPDs from Thermotoga maritima [45], 
Agrobacterium tumefaciens [46] and Thermoanaerobacter tengcongensis 
[47] and a homolog of GlpQ found in Borrelia hermsii [48] all adopt a 
central (oc/ß)8 barrel tertiary fold with the conserved sequence motif 
HR(X)nEXD(X)nH(X)nEXK that coordinates metals in the active site. The 
structure of UgpQ, the cytosolic GDPD in E. coli has not been solved but 
multiple sequence alignments with other GDPDs predict the protein to 
assume a similar TIM barrel structure [49]. An example of a GDPD- 
catalysed hydrolytic breakdown of glycerophosphodiesters that typically 
yields glycerol-3-phosphate (G3P) and an alcohol is shown in Figure 1.8.
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* R can be ethanolamine, choline, glycerol or glycerophosphoglycerol.
.rn-glycemphosphoethanolamine (GPE) Ethanolamine
Figure 1.8: Glycerophosphodiesters and their hydrolysis.
(A) The general chemical structure of glycerophosphodiesters; (B) Hydrolysis of s/> 
glycerophosphoethanolamine (GPE) catalysed by GDPDs.
ORF3 of the E. aerogenes DNA fragment had 825 base pairs and encoded a 
30.8-kDa protein that was designated GpdQ. No sequence similarity was 
detected between GpdQ and UgpQ. Instead, it was found to exhibit 
sequence similarity to a wide range of phosphatases, including 5’ 
nucleotidase from E. coli, Ser/Thr protein phosphatase 1 from rabbit, kidney 
bean purple acid phosphatase and rat protein acid phosphatase. These 
phosphatases are functionally diverse yet have similar structures. They fold 
into what is called an oc/ß sandwich motif that contains a binuclear metal 
centre in their active site. Multiple alignment of the amino acid sequences of 
GpdQ and four examples of these dimetallophosphatases reveal the 
conserved sequence motif of DXH(X)nGD(X)nGNHD/E(X)nH(X)nHXH, 
where residues that coordinate the two metal ions have been underlined [32, 
50]. The binuclear metal center at the active sites of these enzymes is 
capable of coordinating a wide range of divalent metal ions including Mn2+, 
Co2f' Ni2+, Zn2+, and also Fe3 at the site with higher metal binding affinity. 
Subsequent over-expression of the GpdQ protein showed, as expected, 
activities with phosphodiester and phosphomonoester substrates such as sn-
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glycerophosphoethanolamine (GPE), DMP, bis (p-nitrophenyl) phosphate 
(b/?NPP) and p-nitrophenyl phosphate (pNPP). Additionally, the protein 
exhibited very low activity with paraoxon, a phosphotriester.
GpdQ, a highly promiscuous enzyme
GpdQ is a catalytically promiscuous enzyme with an exceptionally broad 
substrate specificity. All other known GDPDs generally show activity with 
a range of GPDs [45-49]. With GpdQ, the enzyme’s substrate repertoire is 
more extensive than the majority of GDPDs. GpdQ has primarily 
phosphodiesterase activity, capable of hydrolysing the phosphodiester bonds 
in simple alkyl phosphodiesters like dimethyl phosphate (DMP) and diethyl 
phosphate (DEP), other model phosphodiester substrates like bis (p- 
nitrophenyl) phosphate (bpNPP) and O-ethyl (p-nitrophenyl) phosphate (O- 
Et-pNPP). Additionally, GpdQ shows low activity towards 
phosphomonoesters, phosphotriesters, phosphonate monoesters and notably, 
an analogue of EA 2192, a highly toxic and stable hydrolysis product of the 
nerve agent VX [32, 51, 52].
1.4 THE STRUCTURE OF GpdQ
Three crystal structures of native GpdQ have been deposited in the Protein 
Data Bank (http://www.rcsb.org/pdb/). Jackson et al. first solved the 
structure in 2006 (PDB accession codes 2DXL and 2DXN) at 2.9 Ä and 3.0 
Ä respectively [53]. Another structure of a higher resolution (1.9 Ä) was 
obtained from this study with the PDB code 3D03 [52]. Structural resolution 
analysis confirmed the a/ß sandwich tertiary fold.
1.4.1 Overall quaternary structure
Native GpdQ is homo-hexamer that is made up of six monomers of ~30.8 
kDa each. The structure of GpdQ was initially determined with crystals
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belonging to the P2i3 space group. The GpdQ molecule was found to have 
D3 (dihedral hexamer) symmetry like aspartate carbamoyl transferase.
The quaternary organisation of GpdQ can be described as a trimer of 
dimers:
i. Two subunits are related by a two-fold axis and are linked by strong 
interactions including an inter-chain disulfide bond, to form a dimer 
(Figure 1.9). The GpdQ dimer has a C2 symmetry.
ii. Three dimers form a hexamer. The hexamer is held together by weak 
interactions.
Figure 1.9: The GpdQ dimer.
The GpdQ displays a C2 symmetry. Here, the catalytic domains are 
coloured in blue, the dimerisation domains in red, the cap domains in 
yellow, the Co metal ions in pink.
19
CHAPTER ONE
Figure 1.10: The GpdQ hexamer.
Ribbon diagrams showing the D3 symmetry of the GpdQ hexamer as viewed from 
the 3-fold axis (A) and the perpendicular 2-fold axis (B). Different colours are used 
to highlight the six chains that form the hexamer. In (B), metal ions (black spheres) 
are displayed to highlight the location of the active sites in the GpdQ hexamer.
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Protein oligomerisation
It is widely believed that protein oligomerisation happens as a result of the 
evolutionary process. The importance of protein oligomerisation is 
evidenced by its prevalence in nature [54-56]. It has been proposed that 
protein oligomerisation plays many roles that include foremostly, the 
functionality of a protein. Oligomerisation enables allosteric regulation 
involving cooperativity between subunits, a complete active catalytic site 
between subunits, or binding of substrate/product/effector at an additional 
regulatory site that exists between subunits. Oligomerisation also 
contributes to conformational and thermal stability, thus making the protein 
less susceptible to degradation. The reduced surface area also protects the 
protein from degradation and is thought to enhance the diffusion of 
substrates to the enzyme active site. Additionally, the increased complexity 
of an oligomer allows a more efficient control over the accessibility and 
specificity of the active site [54-57].
On the molecular level, oligomerisation reduces translation errors by 
providing an extra proofreading step in rejecting defective subunits. 
Moreover, association of homo-oligomers provides a compact and efficient 
way for large proteins to be encoded, thus minimising the genome size. In 
other words, only a small genetic or DNA space is required to encode small 
protein subunits which will later self-assemble to form a large protein 
complex [54-57].
Oligomerisation results in the burial of surface area of each protein 
monomer. For example in GpdQ, the surface area of a monomer (12886.6 
Ä2) is reduced by -23% in a dimer and -32% in a hexamer, respectively. 
These values were calculated using the software AREAIMOL in the CCP4 
Program Suite using a 1.4-Ä probe that was about the size of a water 
molecule. This method was based on the formula devised by Lee and 
Richards [58],
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Dissociation o f protein oligomers
Protein oligomers are also known to dissociate, along with a concomitant 
change in enzyme activity. The process is often reversible; therefore these 
enzymes are able to re-associate to form the oligomer, as influenced by 
regulatory effectors [57]. Dissociation could lead to both positive and 
negative changes towards toward the enzyme activity, depending on 
individual enzymes.
It has also been shown that dilution has an effect on the specific activities of 
purine nucleoside phosphorylase with 50 pM inosine and 50 mM phosphate, 
respectively [59]. It is also likely for enzyme concentration to shift the 
equilibrium of the associated/dissociated enzyme mixture.
Despite the numerous advantages that oligomeric proteins have over their 
individual subunits, monomers also have a few functional niches. Many 
transfer and transport proteins like Cytochrome c are small and they diffuse 
rapidly to their sites of action within the cell. Small proteins are also more 
stable at low concentrations. Furthermore, unwanted oligomerisation of 
proteins can result in the formation of pathogenic aggregates [54, 55, 60].
Advances in protein engineering have enabled enzymes with stable 
quaternary structures to dissociate [61, 62], including GpdQ in this thesis. A 
brief review on protein engineering is given in section 1.6 of this chapter.
1.4.2 Structural domains in a GpdQ monomer
Jackson et at. divided the 274-residue GpdQ monomer into the following 
three domains [53] (Figures 1.11 and 1.12):
i. Catalytic (residues 1-195)
ii. Dimerisation (residues 196-255)
iii. Cap (residues 256-274)
These domain definitions are consistent with SCOP classifications [63].
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Figure 1.11: The GpdQ monomer.
Ribbon representation of a GpdQ monomer, with the three domains in different 
colours for clarity reasons. Numbers 1 and 2 indicate the pair of two-stranded anti-
parallel ß-sheets in the dimerisation domain while 3 shows the third shorter strand.
Crystal structures showed that the catalytic domain exhibited ot/ß or aßßa 
sandwich fold that had been predicted earlier through the amino acid 
sequence analysis of GpdQ. This means GpdQ is a structurally novel GDPD 
[53]. Other bacterial GDPDs that have been previously characterised are 
either dimeric or monomeric [45, 47, 64, 65], with the exception of the 
GDPD from A. tumafaciens, which is a hexamer. However, each chain in 
the hexamer adopts the classical TIM barrel fold [46].
The other two additional domains, namely the dimerisation domain and the 
cap domain, contribute to the quaternary structure and the D3 symmetry of 
the hexameric enzyme.
1.4.3 The conserved catalytic domain, active site and binuclear metal 
center
The catalytic domain exhibits the conserved oc/'ß sandwich structural motif; 
the active site and the binuclear metal center of the enzyme lie within this 
domain. Apart from the tertiary structure of the catalytic domain, the active
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site residues of this superfamily of oc/ß sandwich phosphohydrolases are 
also conserved, including GpdQ and kidney bean purple acid phosphatase 
[66]. Additionally, two phosphodiesterases, whose structures have been 
solved, are known to adopt this oc/ß sandwich and the active residues are 
conserved too. The two proteins are the Rv0805 Class I I I  3’,5’-cyclic 
nucleotide phosphodiesterase from Mycobacterium tuberculosis [67] and the 
and the MJ0936 phosphodiesterase from Methanococcus jannaschii [68]. 
The binuclear metal center at the active sites of these enzymes is capable of 
coordinating a wide range of divalent metal ions including Mn2t, Co2+’Ni2t, 
Zn2< and also Fe3' at the site with a higher metal binding affinity.
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Figure 1.12: The active sites of oc/ß sandwich dimetallo-phosphohydrolases.
Simplified diagrams showing ligand coordination geometries at the active sites of 
GpdQ, Rv0805, MJ0936 phosphodiesterases and kidney bean protein acid 
phosphatase.
The three phosphodiesterases, GpdQ, Rv0805 and MJ0936 consist of the 
same metal ion ligands: an aspartate and two histidines at the oc-site; an 
asparagine and two histidines as the ß-site as well as another aspartate 
residue acting as the bridging ligand for the two metal ions. The active site 
of kidney bean purple acid phosphatase differs in one residue: instead of 
two histidines at the oc-site it has a tyrosine, which connects to the Fe3+ ion 
via a charge transfer, thus giving the enzyme the characteristic purple colour
24
CHAPTER ONE
[66]. The active sites of other related phosphatases like the Ser/Thr protein 
phosphatase from bacteriophage X and 5’-nucleotidase from E. coli also 
vary slightly [69, 70].
Figure 1.13 shows the active site architecture of GpdQ.
Figure 1.13: The active site of GpdQ.
It has been shown that the active site of GpdQ was able to coordinate Mn2\  
Co2+, Zn2+, Cd2+ and Fe2+ [51-53, 71-73], The bpNPP activities of GpdQ 
reconstituted with the first four metals have been characterized. The order of 
activities is Mn2+ > Cd2+> Co2* > Zn2+.
Non-identical metal binding sites
It is common for metalloenzymes that bind more than one metal ion to have 
binding sites that are distinguished by differences in their affinities for the 
metal ions [74]. In many members of the a/ß sandwich binuclear 
hydrolases, including PAPs, and E. coli 5’-nucleotidase [75-79], the affinity 
of the a-site (thus so-called) is always greater than that of the ß-site. 
However, for the bacteriophage X Ser/Thr protein phosphatase, the affinities 
of the two sites are reversed as the a-site lacks one ligand, that is the C- 
terminal histidine [80, 81].
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While analysing the structure of GpdQ, Jackson et al. observed full and 
partial metal occupancies at the a- and ß-sites respectively [53]. This 
observation will be discussed in more detail in Chapter 3. The observation 
agreed well with the ligand coordination geometries at the GpdQ active site: 
although both a- and ß-metal ions are coordinated by two histidine ligands 
each and jointly, the bridging D50 ligand, the a-metal has another strong 
acidic ligand in aspartate (D8) whereas the ß-metal is additionally 
coordinated by an asparagine residue (N80) (Figure 1.13).
The different metal binding affinities of the a- and ß-sites play a pivotal 
role in the catalytic mechanism of binuclear metallohydrolases. In PAPs for 
instance, it has been proposed that the loose-binding metal ion is responsible 
for substrate binding [77, 82, 83] while the nucleophile has been shown to 
bind to the tight binding trivalent one [84, 85].
1.4.4 The dimerisation domain
The dimerisation domain of GpdQ consists of a pair of two-stranded, anti- 
parellel ß-sheets and a third shorter strand between them. The shorter strand 
is not directly involved in the dimeric interface between two GpdQ subunits. 
(Figure 1.11) [53]. This domain is made up of approximately 60 residues 
(residues 196-255) and a significant number of them are large aromatic 
residues like trytophan, tyrosine and phenylalanine, which are favoured in 
ß-sheet secondary structures as well as other non-polar residues like 
methionine and valine [86]. The predominance of these non-polar residues 
creates a hydrophobic core within the dimeric interface (Figure 1.14).
Each GpdQ subunit most likely folds into a globular subunit and the 
protein-protein interface is formed by very specific interactions (eg. 
hydrogen and hydrophobic) between many residues on the surface of the 
domain. This is evidenced by exclusion of water at the interface (Figure 
1.14) and in the figure showing the electrostatic potential of the GpdQ
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Figure 1.14: The dimerisation domain of GpdQ.
A diagram of the dimerisation domain of GpdQ, highlighting the lack of water 
molecules (pink dots) in the hydrophobic core of the interface (centre) and the 
predominance of non-polar and aromatic amino acids in the domain. The dimeric 
interface results in 1667 A2 of the total surface area of each chain [53].
monomer (Figure 1.15). Specific interacting residues are typically 
complementary in shape and chemical properties (Figures 1.14 and 1.16).
Figure 1.15: Electrostatic potential mapped to the molecular surface of the 
GpdQ monomer.
Red indicates negatively charged surface; blue, positively charged; white 
uncharged. The arrow points to the hydrophobic core of the dimer interface.
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Figure 1.16: The GpdQ dimer and the intertwining dimerisation domains.
A diagram of a GpdQ dimer demonstrating how the ß-strands donated from the 
dimerisation domain of each monomer (in blue) form a barrel at the interface. 
Catalytic and cap domains are in pink and green respectively.
1.4.5 The cap domain
The cap domain of GpdQ is made up of the last 19 (256-274) residues of the 
C-terminus. This domain is a relatively small piece of peptide with a short 
ß-sheet followed by a short oc-helix. Despite its size, the cap domain plays 
important structural roles in GpdQ and is also possibly involved in the 
catalytic mechanism of the enzyme.
Formation o f the GpdQ dimer through 3D domain swapping 
Domain swapping is a common structural phenomenon in protein dimers. 
This mechanism is defined by the replacement of one portion or domain of a 
protein subunit by the same domain from another identical chain [87, 88]. In 
general, exchanged domains can vary from a single ß-strand to a globular, 
tertiary structural domain that may cause a sizable burial area in the ‘closed’ 
interface [87, 89].
Domain swapping in GpdQ is formed through C-terminal the cap domain. 
Domain swapping via C-terminal extensions has been reported in proteins
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like the bovine pancreatic ribonuclease (RNAse A), human alpha-crystallins 
and the capsid of the HIV-1 virus [90-93].
This cap structure in GpdQ extends from the dimerisation domain and sits 
above the active site of the other dimerising chain. The stability of this 
domain is strengthened by an inter-chain disulfide bond (between C54 of 
one monomer and C269 of the other monomer) (Figure 1.16). 
Intramolecular disulfide bonds play an important role in regulating protein 
activity, as well as maintaining the stability and folding of the tertiary 
structure [94]. Intermolecular disulfide bonds, on the other hand, usually 
take part in the quaternary structure of a protein, by stabilising the assembly 
of subunits to fonn an oligomer [95-97].
Chain A Chain B
Figure 1.17: The domain swapping mechanism by the cap domain and the 
inter-chain disulfide bond.
The cap domains are highlighted in yellow while the disulfide bond is in green.
Apart from the inter-chain disulfide bridge, there are also symmetric 
interactions between N53 and R56 of one chain with S268, the backbone 
oxygen of P270 of another chain within the same dimeric unit (Figure 1.17).
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Figure 1.18: Inter-chain interactions by the cap domain of GpdQ.
Diagram showing the three inter-chain bonds contributed by the cap domain of 
GpdQ towards the formation of the dimer.
Formation o f the GpdQ hexamer
In the GpdQ hexamer, the cap domains of all the six chains are located at 
the interfaces between one GpdQ dimer and another (Figure 1.18). The 
hexamer is held together weakly with electrostatic interactions, hydrogen 
bonds and an inter-chain hydrophobic patch that is explained in detail in 
Chapter 5.
Figure 1.19: The GpdQ hexamer with the cap domains highlighted.
The cap domains of all the six subunits in red colour to highlight their locations at the 
interface between the three dimeric units. The interaction between the three dimeric 
units results in the burial of 1131 Ä2 of the total surface area of each chain [53].
Controlling access into the active site
A cap domain structure is also present in several other phosphohydrolases 
from both the TIM barrel GDPD and (oc/ß) sandwich dimetallo- 
phosphoesterase superfamilies of enzymes. This domain, which is additional
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to the structurally conserved catalytic domain (primary domain), is often 
smaller and located near the active site. Examples of enzymes with this fold 
include the GDPD from Thermotoga maritima [45] (Figure 1.19), 
periplasmic 5’-nucleotidase from Escherichia coli [70] and Mrel 1 nuclease 
from Pyrococcus furiosus [98].
Cap secondary aoma*"
Catalytic dom ain with 
TIM oairel fold
Figure 1.19: The cap domain in a TIM barrel GDPD.
A diagram of the GDPD from T. maritima (PDB accession code 101Z), with the cap 
domain coloured in red.
The cap domains of GpdQ (Figure 1.16) and the GDPD from T. maritima 
shown in Figure 1.19 are both located at the entrance to the active site. It is 
widely proposed that these domains have evolved to constrain the 
accessibility of the active site in order to enhance the substrate specificity of 
the enzymes [45, 70, 98]. In particular the complexity of the cap domain 
seemingly correlates with the size and other chemical properties of the 
physiological substrate.
The cap sub-domain in GpdQ also differs from the other enzyme examples 
in several other ways. Foremostly in GpdQ, the structure is a small peptide 
(a short ß-strand followed by one turn of a-helix) made up of approximately 
the last 20 residues of the C-terminus. In the enzymes shown in Figure 1.19, 
their cap domains are much larger and they form small globular domains. 
The cap domain in the GDPD from Thermotoga maritima consists of ~50 
residues.
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Interestingly, a cap domain is not found in the Rv0805 3’,5’-cyclic 
nucleotide phosphodiesterase from Mycobacterium tuberculosis [67] and the 
MJ0936 phosphodiesterase from Methanococcus janaaschii [68]. These two 
phosphodiesterases have been shown previously in section 1.4.3 to be 
structurally related to GpdQ. The homology exists only between the 
catalytic domains, where (a/ß) sandwich fold and all the active residues are 
conserved.
I. 5 Rv0805 - A 3 \5 ’-CYCLIC NUCLEOTIDE
PHOSPHODIESTERASE FROM MYCOBACTERIUM
TUBERCULOSIS
3’,5’-cyclic nucleotide phosphodiesterases (PDEs) catalyse the hydrolysis of 
the phosphodiester bond of second messenger cAMP to yield the 
biologically inert 5’-AMP, as a form of homeostatic regulation of signal 
transduction. Previously, this superfamily of enzymes was divided by their 
amino acid sequences and tertiary structure into two major classes of I and
II. A third class was reported by Richter and the catalytic domain of this 
PDE class III of enzymes closely resembles that of dimetallophosphatases 
like purple acid phosphatase and calcineurin [99]. Examples of PDEs class 
III enzymes have been found in E. coli (CpdA) [100], Vibrio fischeri [101] 
and Mycobacterium tuberculosis (Rv0805) [66, 102],
A search on the DALI server [103] nominated the PDE from M. 
tuberculosis, Rv0805, as the enzyme with the highest sequence similarity to 
GpdQ. Sequence alignment of Rv0805 [104] and GpdQ using the BLOSUM 
comparison matrix of the ClustalW multiple alignment program 
(http://www.ebi.ac.uk/Tools/clustalw) shows approximately 22% similarity 
(Figure 1.20). All the seven residues coordinating the metal ions are 
conserved. Superimposition of the X-ray structures of these two enzymes 
confirmed that the catalytic domains are homologous (Figure 1.21). It 
should be noted that only the proteolytic fragment of the first 278 out of a
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total of 318 residues of Rv0805 were crystallised. Therefore, it cannot be 
ascertained if the cap domain is present in the complete protein.
RV0805 MHRLRAAEHPRPDYVLLHISDTHLIGGDRRLYGAVDADDRLGELLEQLNQSGLRPDAIVF
GpdQ ------------ MLLAHISDTHFRSRGEKLYGFIDVNAANADWSQLNALRERPDAVW
• * *★** + *•  ^  ^t # * *★ I *. z •••••*** ★★★★•★t
Rv0805 TGDLADKGEPAAYRKLRGLVEPFAAQLGAELVWVMGNHDDRAELRKFLLDEAPSMAPLDR
GpdQ SGDIVNCGRPEEYQVARQILG----SLNYPLYLIPGNHDDKALFLEYLQPLCPQLGSDAN
•**••• * ,*  *• * •• ^ ^  ★ • ★★★★★•★ • • • ★ ★ •
Rv0805 — VCMIDG— LRIIVLDTSVPGHHHGEIRASQLGWLAEELATPAPDGTILALHHPPIPS-
GpdQ NMRCAVDDFATRLLFIDSSRAGTSKGWLTDETISWLEAQLFEGGDKPATIFMHHPPLPLG
★ *•'•!*'* (* •★ • t • # ** •* t ' • • •★★★★•★
RvO 8 0 5 VLDMAVTVELRDQAALGRVLRGTDVRAILAGHLHYSTNATFVGIPVSVASATCYTQDLTV
GpdQ NAQMDPIACENGHRLLALVERFPSLTRIFCGHNHSLT------------- MTQYRQALIS
• ★ t »•! * • * * • • ■  *; t ** * * I * * * Hr
Rv0805 AAGGTRGRDGAQGCNLVHVYPDTWHSVIPLGGGETVGTFVSPGQARRKIAESGIFIEPS
GpdQ TLPGT------------------- VHQVPYCHEDTRPYYDLSPASCLMHRQVGEQWVSYQ
. ** 2  * * (*  ^ !**••• * ( • • • •
Rv0805 RRDSLFKHPPMVLTSSAPRSPVD
GpdQ HSLAHYAGPWLYDENISCPTEER
Figure 1.21: Amino acid sequence alignment of Rv0805 and GpdQ.
The two large insertions (1, 2) in GpdQ are part of the extensive dimerisation 
domain.
Figure 1.22: Structural alignment of Rv0805 and GpdQ.
Structural superimposition of Rv0805 (red) and GpdQ (blue) monomers (RMSD = 
2.298,179 to 179 atoms).
Throughout this thesis, kinetic and structural comparisons are often drawn 
between GpdQ site-specific mutants and their equivalents in Rv0805.
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1.6 PROTEIN ENGINEERING STRATEGIES
This study is largely concerned with modifying the activity of an enzyme. 
As a concept, this is fairly easy to understand, but the tools for this work 
have only been available for a few years and as a consequence our 
understanding of how to proceed with this type of study is growing rapidly. 
This type of “protein engineering” offers the potential of being able to 
convert our knowledge of proteins into products for industry and medicine. 
It is worth spending some time going over the need for this type of work 
and the recent history that led to the current activity.
1.6.1 Protein engineering
History and background
Enzymes undergo biological evolution, a very slow process that takes place 
over times scales of several million years, with mutation, selection, 
recombination and drifts as the driving forces. It has been suggested that 
during the course of this enormous length of time that the resultant enzymes 
should be near perfect -  in fact they are probably ideally suited to the 
requirements of the host organism. However, this does not mean that 
enzymes are ideally suited for industrial applications. For example, an 
enzyme that operates in a pathway may be regulated so that it only functions 
under a specific set of conditions -  these conditions may not be appropriate 
for laboratory or industrial applications. Furthermore, nature can generate a 
particular level of enzyme activity by increasing (or decreasing) the amount 
of enzyme produced whereas in the laboratory efficient enzymes are 
desired. Nature can also adjust the level of enzyme activity by changing the 
stability of the enzyme. One could find other examples of enzymes that are 
ideally suited to the cellular environment, but that are not ideally suited to 
the needs of researchers. Even if an enzyme is available to catalyse a 
reaction, a great deal of work may be required to optimise it activity for 
practical applications.
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A time line for the development of techniques useful for protein engineering
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Figure 1.23: Time line for the development of techniques in DNA research and 
molecular biology that are useful for protein engineering.
It can be seen that by the mid-1980s, a great deal had been learnt about
proteins -  the structures of numerous proteins and their functions were 
known. However, the ability to modify proteins was limited and the idea of 
generating new proteins was not a practical objective. Chemical 
modification could be used to alter some types of residues and proteases 
could be used to cleave proteins, but in both cases the processes were not 
specific and usually resulted in a considerable loss of protein. Around this 
time, rapid advances in molecular biology, especially in DNA sequencing 
and recombinant DNA technology started to offer some hope that proteins 
could be modified in a specific way. Such a development was logical, 
considering the irreversible process of how DNA transcribes into RNA that 
later translates into proteins, as stated in the central dogma of molecular 
biology [105].
Initially the developments in molecular biology led to studies that were 
aimed at understanding how proteins functioned -  residues were mutated 
site specifically and changes in activity were monitored. Eventually the idea
is given in Figure 1.22.
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emerged of modifying proteins in a useful way and the term “protein 
engineering” was coined [106, 107]. Some of the first studies were directed 
at improving the stability of enzymes used in laundry detergent, but as the 
tools have improved the objectives of the practitioners have also become 
more ambitious.
The tw’o main strategies
Two general strategies for protein engineering have emerged: rational 
design or redesign and directed evolution (directed molecular evolution).
1.6.2 Rational design
The rational approach to protein engineering requires a thorough knowledge 
of protein structure and a good understanding of how sequence, structure 
and function are related. One examines the structure with a view of 
rationally changing some property of the protein and then uses site-directed 
mutagenesis to make changes.
Site-directed mutagenesis is a technique that introduces a mutation at a 
defined site of a DNA molecule. This technique was developed in the late 
1970s [108]. Site-directed mutagenesis is also commonly known as site- 
specific mutagenesis and oligonucleotide-directed mutagenesis. PCR-based 
site-directed mutagenesis protocols are the most commonly used method. 
The sequence of the DNA needs to be known so that oligonucleotide pairs 
bearing the desired mutation can be designed [109, 110]. Detailed 
procedures in site-directed mutagenesis are presented in Chapter 2. 
Stratagene developed several QuikChange™ Site-Directed Mutagenesis 
systems that allow not only single but multiple mutations to be created 
simultaneously. Some of these kits even facilitate frame-shift mutations 
such as insertion and deletion [111].
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In this study, site-directed mutagenesis was used for two purposes. The first 
was to generate active site mutants where residues at the active site of GpdQ 
were substituted by other amino acids (Chapter 3). The effects of the 
mutations were then tested in order to better understand the roles of these 
residues and the catalytic mechanism. Secondly, site-directed mutagenesis 
was used to rationally design GpdQ mutants to develop a stable dimer 
(Chapter 5).
Although rational approaches to protein engineering have yielded some 
impressive results, they pale into insignificance when compared with the 
results achieved by natural selection over the course of evolutionary time. 
The tools used by nature to evolve protein, have till recent times been much 
more powerful than those available to protein engineers. Directed evolution 
seeks to use tools that mimic natural evolution for the purpose of evolving 
proteins for human purposes.
1.6.3 Directed evolution
Directed evolution or in vitro evolution is a strategy that mimics natural 
evolution and has the aim of developing enzymes on the laboratory 
timescale of months, with desirable properties that are not normally found 
or not optimal in nature. The main advantage directed evolution has over 
rational design is that the approach requires no prior understanding of the 
enzyme structure and mechanism. Random mutagenesis in directed 
evolution leads to the discovery of other valuable and beneficial mutations 
which otherwise will not be identified via rational design, since with 
rational design, the focus is often primarily on the active site [112-119].
Over the recent years, the application of directed evolution has successfully 
engineered enzymes with properties such as altered substrate specificities, 
which includes expanded substrate repertoires and improved weak 
promiscuous activities [28, 120-124], antibiotic resistance [125], improved
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protein solubility [126], improved protein expression [127] organic solvent 
resistance [128], thermal stability [129] and enantioselectivity [130].
Directed evolution is usually comprised of sequential rounds of two 
processes: generating diversity (through mutagenesis and/or recombination) 
and screening/selection. Figure 1.23 illustrates the general concept of 
directed evolution studies. A complete cycle of generating diversity and 
screening/selection is usually called one round of evolution, with the best 
variants selected commonly referred to as first, second or third generation 
mutants.
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Figure 1.24: A schematic representation of directed evolution studies.
Directed evolution consists two independent areas of technology: generating 
diversity (creation of a library of genetic variants) and screening/selection of variants 
for desired properties.
Generating diversity
The invention of the polymerase chain reaction (PCR) in 1984 was followed 
by the development of error-prone PCR (epPCR) five years later. epPCR is 
a straightforward method for library construction, where the amplified full- 
length genes of an enzyme are subject to random mutagenesis [131-137].
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Specific methods of introducing mutations to the amplified genes will be 
discussed in Chapter 4. The generated library of mutants is then screened or 
selected for the desired function. Each mutant must be assayed.
For subsequent rounds of evolution, the best variants selected or screened 
from the previous generations are subject to in vitro sexual recombination. 
The two main techniques in recombining genes are Stemmer’s DNA 
shuffling [138-140] and Zhao’s staggered extension process (StEP) [137, 
141-143]. In this study, StEP was used and the concept of this technique is 
discussed in Chapter 2.
Screening/selection
Finding a suitable method to screen or select a library of mutants is often a 
challenging process. In selection, the target enzyme property is essential for 
survival and the mutant carrying the desired function can be easily 
distinguished from the background of reactions of all other mutants, eg. 
antibiotic resistance. Selection methods are generally less laborious and 
allow larger libraries to be evaluated. However, the target feature sometimes 
cannot be easily linked to cell survival. A screen is more versatile than 
selection, involving a direct measurement of enzymatic activity. The 
throughput is usually lower for a screen than it is for a selection [144].
1.6.4 A semi-rational approach to enzyme engineering -  combining 
rational design and directed evolution
As pointed out earlier, rational design relies on structural knowledge of a 
protein and molecular modelling to predict desired amino acid changes. 
These changes are introduced into the gene of the protein by methods such 
as site-directed mutagenesis. Another disadvantage of rational design is that 
it can practically test only a small number of modifications [134].
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Random mutagenesis, on the other hand, is the most vital step in generating 
diversity in directed evolution. However, random mutagenesis is biased and 
has limitations due to factors like transition bias and codon degeneracy.
Directed evolution is the only possible enzyme engineering method when 
the structure and the mechanism of the enzyme are not available. When the 
crystal structure of the enzyme has been solved, like GpdQ, rational design 
will present itself as a quick and intelligent approach to improve the 
enzyme. Rational design and directed evolution are not mutually exclusive; 
they can potentially complement each other. Whilst rational design can offer 
speed and precision, directed evolution may enable novel non-intuitive 
solutions to be found. Researchers will often apply both strategies to 
achieve optimal results [145]. Both approaches have been used in this study 
to modify GpdQ’s activity towards a non-physiological phosphodiester 
substrate, bis (p-nitrophenyl) phosphate.
1.7 OVERVIEW OF THESIS
Based on the findings obtained from previous studies on GpdQ, especially 
the exceptionally broad substrate specificity of the enzyme, its structure, 
active site and the non-identical binding affinities at the binuclear metal 
center, this research project set out to achieve the following objectives:
i. To characterise the active site residues in order to achieve a better 
understanding of their roles and the catalytic mechanism of GpdQ. 
As part of this aim, the binding affinities of the two metal sites were 
also studied.
ii. To improve GpdQ’s weak and promiscuous activities with poor, 
non-physiological substrates using directed evolution and rational 
design. Initially, priority was given to phosphodiester substrates like 
dimethyl phosphate and diethyl phosphate as well as 
phosphotriesters like methyl paraoxon and ethyl paraoxon. 
Enhanced catalytic activities with these substrates would have more
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relevant bioremediation and industrial applications. We aimed to 
further develop Dr Sean Yu-McLoughlin’s agar plate based growth 
assay (section 1.2.1, Chapter 1) as a method to preliminarily screen 
GpdQ mutant libraries with these four phosphate ester compounds. 
On the other hand, we were able to easily screen GpdQ’s activity 
with bis (p-nitrophenyl) phosphate (bpNPP) due to reasons that it is 
a good and chromogenic substrate. GpdQ was then eventually 
evolved towards enhanced activity with this phosphodiester 
substrate. Several mutants were also designed to complement 
directed evolution in developing catalytically efficient GpdQ 
enzymes. At the end of this project, eight full rounds of directed 
evolution of GpdQ had been completed.
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CHAPTER TWO: EXPERIMENTAL PROCEDURES
2.1 INTRODUCTION
This chapter discusses all the techniques relevant to all the experimental 
work performed in preparation of this dissertation, including molecular 
biology, protein expression and purification, enzyme kinetic analysis, 
protein crystallisation, equations and computer software programs.
Equipment, chemicals and reagents
Whenever required, especially for molecular biology work, all glassware 
instruments, microtubes, micropipette tips, growth media, buffers and 
solutions were sterilised by autoclaving. Distilled water used in this study 
(mQHiO) was purified with a Milli-Q Reagent System. A complete list of 
suppliers and manufacturers of equipment, kits, chemicals and reagents is 
attached in Appendix A. Recipes of culture media, buffers and other 
reagents used in this study are given in Appendix B.
2.2 STRAINS AND VECTORS
2.2.1 Escherichia coli strains DH5a and DHlOß
Library efficiency electro-competent Escherichia coli DH5a cells were used 
throughout this project for general cloning and protein expression 
procedures. Directed evolution studies in this project involved the 
generation of genetic libraries. For this reason DH5a cells were the E. coli 
strain of choice, as these cells are known for their high transformation 
efficiency, relatively simple preparation, usage and storage. Competent cells 
were prepared from cell stock that was originally purchased from 
Invitrogen, handled and stored as described [1] with minor modifications.
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All glassware instruments, microtubes, centrifuge tubes, pipette tips, 
mQfhO, 10% (v/v) glycerol and YENB medium were sterilised prior to the 
preparation of any electro-competent cells to ensure their purity. The culture 
flasks and measuring cylinders used in making electro-competent cells were 
also set aside from other glassware in the laboratory and washed separately 
to reduce chances of contamination with salt as high ionic conductivity 
greatly reduces electroporation efficiency [1,2].
A tube of DH5a cell stock was taken out of -80°C and thawed on ice for 
about 10 minutes to minimise ‘heat shock’ towards the cells [3]. Using a 
flame sterilised inoculation loop, an inoculum was retrieved from the 
thawed cell culture and streaked onto an LB plate. The plate was then 
incubated at 37°C overnight (approximately 16 hours).
The following day, 5 mL of YENB medium was inoculated with a single 
colony of DH5a cells from the LB plate and incubated in a 37°C shaker 
(-200 rpm).
On the third day, the 5 mL overnight culture of DH5a cells was transferred 
into a 2 L baffled flask containing 1 L of YENB medium. The culture was 
grown in a 37°C shaker (-200 rpm) and the optical density of the culture at 
595 nm (OD595) was checked regularly with a cell density meter until it 
reached 0.6-0.8. It typically took about 4 hours to reach this density. The 
culture was placed on ice immediately to stop cell growth. All subsequent 
steps were carried out at 4°C.
After it had been cooled down to 4°C, the cells were harvested by 
centrifugation at 4,000 x g for 10 minutes with an SLA-3000 fixed angled 
rotor in two 500 mL centrifuge bottles. The cell pellet was resuspended with 
200 mL mQLLO by gently shaking or pipetting (no vortexing) to wash the 
remaining medium off the cells. Centrifugation at 4,000 x g for 10 minutes 
was performed again as before. This time, the cell pellet was resuspended
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with 50 mL 10% glycerol and subjected to a third round of centrifugation. 
The cells were then suspended with 10% glycerol to a final volume of 1.5-2 
mL and dispensed into 50 pL aliquots which were then immersed in liquid 
nitrogen for rapid freezing. The cell aliquots were stored at -80°C 
immediately for future laboratory use.
The DH 10ß cells used in setting up control experiments during in vivo agar 
plate-based growth assay screenings had been transformed by Dr Sean Yu- 
McLoughlin with a 5.6-kb DNA fragment containing the Enterobacter 
aerogenes ugp operon. Dr Yu-McLoughlin opted for DHlOß cells [4] as 
these cells were designed for the uptake of large DNA inserts [5].
2.2.2 Vector pCY76
The gpdQ full-length gene (825 bp) was cloned into the Nde 1 (5’ terminus) 
and EcoR\ (3’ terminus) sites of vector pCY76 by Dr Jian-Wei Liu. The last 
three nucleotides of the Nde I restriction site, CATATG, encode methionine, 
the start codon of the GpdQ protein.
The vector pCY76 {par , bla , T7(|)10t,rf, lac PO+) was constructed by Dr 
Cy Jeffries [6]. The physical map of pCY76 is shown in Figure 2.1. A full 
nucleotide sequence of the plasmid is supplied in Appendix C.
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pCY76
2 9 1 9  bp
ori: Origin of replication
lac  PO: Promoter and operator of the lac operon 
T7<t>10"r: $10 translational initiation region from T7 phage 
RBS: Ribosome binding site 
MCS: Multiple cloning site
p a r : Partition element that maintains plasmid segregational stability (especially high-copy-number 
plasmids) through many generations without antibiotic selection 
bla: Expresses ß-lactamase that is responsible for the resistance of the plasmid towards ß-lactam 
antibiotics like ampicillin
Figure 2.1: The physical map of pCY76 vector.
pCY76 was engineered as a simple, high-copy-number cloning vector that 
also offers a constitutive protein expression system under the control of the 
lac promoter. The segregational stability of the vector was enhanced by the 
insertion of the partition function {par). The lac promoter was somewhat 
‘leaky’, allowing protein expression without IPTG induction due to its 
ability to interact with both glucose and lactose. However, constitutive 
expression has certain advantages over other expression systems which use 
heat or IPTG induction as it avoids any cellular shock and stress. To reduce 
the deleterious effects of the /crc-controlled, constitutive expression system 
of pCY76, a strong ribosome binding site (RBS) and a (j)10 translational 
initiation region from T7 phage (as used for Studier’s T7 pET vectors) were 
included upstream of the multiple cloning site during design of the plasmid 
[6-9].
GpdQ expressed satisfactorily with pCY76 (Figure 2.16).
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2.3 MUTATIONAL ANALYSIS AND RATIONAL DESIGN OF GpdQ 
USING SITE-DIRECTED MUTAGENESIS
The site-directed mutagenesis (SDM) technique of introducing amino acid 
changes to GpdQ was used in this study for two purposes:
i. To explore the role of active site residues (Chapter 3).
ii. To disrupt the oligomeric structure of GpdQ (Chapter 5).
Figure 2.2 presents a summary of the methodologies used in this study in 
producing site-directed mutants.
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Figure 2.2: The process of making a site-directed mutant.
A flow-chart illustrating how a site-directed mutant was made in this study.
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2.3.1 Design of primers
An online software program provided by Stratagene 
(http://www.stratagene.com/sdmdesigner/default.aspx) was used to design 
primers for site-directed mutagenesis. Primer pairs were typically 100% 
complementary to each other; carried the mutation of interest, and were of 
25-45 bases in length with a melting temperature (Tm) > 78°C. The 
calculation of Tm is based on a formula given by Stratagene:
Tm = 81.5 + (%GC) -  (675/N) - %mismatch (Equation 2.1)
Where,
■ N is the length of the oligonucleotide primer in bases
■ Values for %GC and %mismatch should be whole numbers
A glossary of all the mutagenic primer pairs used in this research is given in 
Appendix D. Sequencing/PC R grade primers were ordered from 
Geneworks.
2.3.2 Site-directed mutagenesis polymerase chain reaction (SDM-PCR)
Site-directed mutagenesis polymerase chain reaction (SDM-PCR) was used 
to introduce point mutations in the wild-type gpdQ gene (or other mutant). 
Two models of thermocyclers were available in the laboratory: an iCyclerK 
(Bio-Rad) and a GeneAmp* PCR System 9700 (Applied Biosystems). As 
both models were equipped with a hot-top assembly, PCR reactions did not 
have to be overlaid with mineral oil.
SDM-PCR reactions were set up in 200 pL clear PCR microtubes with:
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Template pCY76-gpdQ 0.5 pi (20-30 ng)
(Purified with Qiagen Miniprep kit, about 50 ng/jul)
Forward primer (25 pM) 
Reverse primer (25 pM) 
dNTP (40 mM)
10X Native Plus buffer 
Pfu DNA polymerase 
mQH20
1.0 pi
1.0 pi
1.0 pi
5.0 pi
1.0 pi 
40.5 pi
Total volume 50.0 pi
*PCR reaction mixtures were given a 3-second quick spin in the 
microcentrifuge before they were put into the thermal cycler.
The SDM-PCR reaction mixtures were initially subject to the standard 
protocol recommended by Stratagene: Pre-denaturation at 95°C for 30 
seconds, followed by 18 cycles of 30-second denaturation at 95°C, 1-minute 
annealing at 55°C and 10 minutes of extension at 68°C.
Optimisation o f SDM-PCR
Towards the later part of this project, site-directed mutagenesis experiments 
were challenged by the increasingly prevalent phenomenon of primer 
dimerisation. Other users of QuikChange™ Site-Directed Mutagenesis kits 
have previously reported similar problems [10, 11], which highlighted one 
major shortcoming of this protocol that requires 100% complementary 
primer pairs to be 25-45 bases in length to reach a melting temperature (Tm) 
> 78°C, so that primer self-pairing can be minimised.
The primer dimerisation phenomenon encountered in this study would 
typically create amplification products that have additional ~25 base pairs, 
which was a repetition of the full-length primer sequence, (Figures 2.3).
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W261R
mutation
s h i f t s :  cR n S cllc  m mW261R CpdQ
Consensus TCACCTACCA CCACTCCCTC CCCCACTACC CCCCCCCCNC
100*
Conservation TTTTM1imiiiimiim
n \ ^ \  cun:® m ? , m mW261R CpdQ
Consensus CCTCTACCAC CAAAACATCA CTTCCCCACC CTCTACCACG
100*
Conservation
1080
782
1120
806
lllllilB IIH I HIIIBBI III! IIBBTS nnnnmnnm
W261R 
CpdQ
Consensus AAAACATCAC TTCTCCAACC CAACACCCCT AATAACCAAT
100%
Conservation i i H i i i i i i i n
1,180
______________ ______________ I
W261R
C p d Q -------------------- --------------------  ----------------- -----------------
Consensus TCGCATCCCA TGCATCGATA GATCCCGGGT CCCTCGCC
100* ---------------------------------------------------------------------------------------------------------------------------------------------------------------------
Conservation
1198
825
n m i iB iH i i
Figure 2.3: DNA sequence alignment of the W261R mutant and wild-type 
GpdQ.
The red arrow indicates the length of the primer, which contains the desired W261R 
mutation. The blue arrow shows the duplicated primer, which causes the insertion of 
29 extra base pairs into the amplified PCR product.
From the DNA sequence alignment of W261R mutant and wild-type GpdQ 
in Figure 2.3, it appeared that the primer molecules self-paired among 
themselves before the dimers annealed to the template DNA to start 
amplification, as depicted in Figure 2.4. This was surprising, considering the 
fact that Pfu DNA polymerase possesses the 3’ to 5’ exonuclease 
proofreading activity, which works to correct nucleotide misincorporation.
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Figure 2.4: Primer dimerisation.
A diagram illustrating primer dimerisation during SDM-PCR in this study.
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Alteration to cycling parameters
To overcome the primer dimerisation phenomenon, 1.5 pL of 100% DMSO 
(Sigma) was added into the PCR reactions and the final volume of the 
reactions was adjusted accordingly. DMSO is known to enhance PCR 
amplification by increasing the yield and specificity especially in GC-rich 
templates, as well as to inhibit the formation of secondary structures in the 
template DNA and primers [12]. Kureishi et al. recommended pre-boiling 
the primers especially those with a high GC content [13] but in this study, 
pre-boiled primers failed to yield any PCR product.
Cycling parameters were also altered to a program that yielded more 
amplification products, reduced primer self-pairing and was more time- 
efficient:
Pre-denaturation: 95°C 30 s
Denaturation'. 95°C 30 s
Annealing: 55°C 30 s
Extension'. 68°C 8 min
4°C oc
25 cycles
Partially overlapping primer pairs
Partially overlapping primer pairs eliminated the primer dimerisation 
problem for mutant W261R. These primer pairs complemented each other at 
the 5’-terminus, with the targeted mutation lying among the overlapping 
region. The partial overlapping also widened the melting temperature (Tm) 
gap between primer-to-template annealing and primer-to-primer self-
annealing, so the Tm > 78°C as proposed by Stratagene was no longer a strict 
requirement. This gave increased flexibility during primer design [10].
The W261R reverse primer was re-designed to give partial instead of full 
complementariness of the new primer pair (Figure 2.5). This strategy 
successfully abolished the primer dimerisation problem altogether.
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Figure 2.5: Partially complementary W261R forward (W261R-f) and reverse 
(W261R-r) primers.
The red arrow indicates the location of the point mutation.
2.3.3 Agarose gel electrophoresis and gel purification
The success of SDM-PCR was checked by running 2 pi of the reaction 
mixture on an 1.0% (w/v) agarose gel electrophoresis prepared in the SB 
buffer system. Ethidium bromide was added to the heat-dissolved gel 
solution prior to pouring to a final concentration of 0.5 pg/mL. The 
electrophoresis was always run for 30 minutes at 150 V, 300 mA. 6X 
loading dye was added to every DNA sample before it was injected into the 
wells of the agarose gel. The DNA was then visualised in the ultra-violet 
light transilluminator at a wavelength of 312 nm and photographed with the 
camera attached to the UVIpro transilluminator system. A photograph of a 
typical gel is shown in Figure 2.6.
1 kb DNA ladder
3.0 kb
2.0 kb
1.5 kb
1.0 kb
0.5 kb
Figure 2.6: SDM-PCR product visualisation with agarose gel electrophoresis.
1 kb DNA ladder was purchased from New England Biolabs (NEB). 4 pL of a 
25ng/jj L dilution of the marker was used. PCR amplication products of the correct 
size (-3.7 kb) are indicated by arrow A; non-specific amplication products are 
indicated by arrows B and C while arrow D shows primer dimers.
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After the success of PCR amplification was confirmed, the remaining 48 pL 
of each SDM-PCR reaction was subject to agarose gel electrophoresis. This 
time, the gel was illuminated with an UV lamp at 365 nm and the desired 
DNA bands (~ 3.7 kb in size) were excised. The exposure time of the gel to 
the weak UV light was kept as short as possible to minimise damage to the 
DNA. The DNA was then purified with the QiaquickK Gel Extraction Kit 
according to the protocol supplied by the manufacturer. The QG buffer from 
the kit contains guanidine thiocyanate, a chaotropic agent that helped to 
solubilise agarose at 50°C and to create a suitable pH (< pH 7.5) for the 
adsorption of DNA to the QIAquick silica membrane. The final DNA 
elution volume was 30 pL.
The additional step of gel purifying PCR products was to ensure that only 
amplification products of the correct size were selected and to prepare them 
for a more efficient subsequent Dpn\ digestion.
2.3.4 Dpn\ digestion of template DNA
At the end of SDM-PCRs, the reactions would contain a mixture of 
amplification products and a small amount of template DNA. The template 
DNA was methylated as it was acquired via E. coli cloning. To eliminate the 
template DNA, Dpn\ was added to the PCR reactions as the endonuclease 
specifically recognises and degrades methylated and hemi-methylated DNA 
cloned from E. coli. Although Stratagene recommends the addition of 1 pi 
of Dpn\ directly into unpurified PCR products without the aid of any buffer, 
incomplete digestion that resulted in a high background has been reported in 
the literature [10]. Any undigested template would have competed with the 
mutant plasmids to transform competent cells. The Dpn\ digestion mixture 
was set up as follows:
DNA from gel purification 30.0 pi
10X NEB buffer 4 3.5 pi
Dpn\ 1.5 pi
Total volume 35.0 pi
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The 1.5 pi Dpn\ was not added into the reaction all at once but 0.5 jul of the 
restriction enzyme was added hourly for three hours. Therefore, the PCR 
products were treated with Dpn\ at 37°C for three hours, after which the 
enzyme was inactivated at 80°C for 20 minutes.
2.3.5 Transformation
DH5a cells that were prepared as described in 2.2.1 were thawed on ice for 
10 minutes. Electroporation cuvettes with a gap width 0.2 cm were also 
chilled on ice. 1 pi of the Dpn\ treated PCR products was added into thawed 
50 pi DH5cx cell aliquots and mixed thoroughly by gently flicking the 
Eppendorf tube and pipetting several times. The cells were then transferred 
directly to the bottom of the chilled cuvettes between the two aluminium 
electrodes. The cuvettes were incubated on ice again for at least 1 minute. 
Shortly before electroporation, the cuvettes were tapped against the bench a 
few times to make sure that the cells were all at the bottom and the moisture 
on the walls was removed by wiping. The cells were then transformed with 
a Bio-Rad MicroPulser™ at 2.49 kV for > 4.0 milli-seconds.
Transformed DH5a cells were immediately removed from the electrodes by 
resuspensing them with 1 mL YENB medium and transferred into a 10 mL 
sterile pushed cap tube. The recovery culture was then incubated for at least 
three hours at 37°C to allow ample time for ampicillin resistance to be 
developed. After that, 100 pi of the culture was spread onto LB plates 
supplemented with 50 pg/mL ampicillin and incubated overnight at 37°C.
Electroporation cuvettes were rinsed with mQfEO several times, filled with 
70% ethanol and incubated at room temperature for an hour, washed again 
with mQLEO thoroughly then dried in a 70°C oven for reuse.
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2.3.6 Single-colony mini-cultures and plasmid isolation
Four single colonies from each LBA plate were picked to each inoculate 5 
mL of LBA medium and grown in a 37°C shaker overnight. The next day, 
the plasmid DNA in the LBA cultures was isolated and purified with the 
Qiaprep" Miniprep Kit by following the instructions in the handbook 
provided by the kit. The procedure consisted of three main steps. Firstly, 
bacterial cells were lysed briefly with a sodium hydroxide-containing buffer 
then the lysate was subsequently neutralised and cleared via centrifugation 
and pipette aspiration. The plasmid DNA (pDNA) sample that was retained 
on the QIAprep silical membrane was then purified. In the final step, pDNA 
was eluted with 30 pi of elution buffer (EB).
2.3.7 DNA verification
Double digestion with NdeI and EcoRl was used to verify the presence of 
the gene obtained from each single colony grown and purified with 
Qiaprep" Miniprep Kit. The digestion reaction was set up as below:
Template pDNA 1.0 pi
10X NEB buffer 4 1.0 pi
Nde I 0.2 pi
EcoRl 0.2 pi
mQFbO 7.6 pi
Total volume 10.0 pi
Digestion reactions were incubated at 37°C for 2 hours and then analysed 
via agarose gel electrophoresis (Figure 2.7).
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Figure 2.7: Agarose gel presentation of 5 gpdQ-pCY76 samples digested with 
Nde\ and Ecofll.
2.3.8 DNA quantitation, PCR sequencing and ethanol precipitation of 
DNA
DNA quantitation
The concentration of plasmid DNA of each sample was measured using a 
NanoDropK ND-1000 spectrophotometer. Alternatively, the DNA 
concentration was roughly estimated by comparing the intensity of DNA 
bands of the samples to the 3.0 kb band of the marker (25 ng/pl).
PCR sequencing
pDNA samples that had been verified to have the gpdQ gene incorporated
by restriction enzyme analysis were sequenced. Sequencing reactions
consisted of the following:
Template pDNA ~300 ng
Forward primer 4pCY76 (3.2 pM) 1.0 pi
or
Reverse primer M l3 (3.2 pM)
5X sequencing buffer 4.0 pi
BigDye terminator v3.1 1.0 pi
mQFEO To top up to 20.0 pi
Total volume 20.0 pi
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Oligonucleotide sequences of primers 4pCY76 and M13 are given in 
Appendix C. BigDye terminator v3.1 was purchased from Biomolecular 
Resource Facility (BRF) of John Curtin School of Medical Research 
(JSCMR) in the Australian National University (ANU) who also supplied 
the 5X sequencing buffer.
Cycling conditions were: (i) 94°C for 5 min, (ii) 96°C for 10 s, (iii) 50°C for 
5 s, (iv) 60°C for 4 min, where steps (ii) to (iv) were repeated 30 times, then 
held at 4°C until ethanol precipitation.
Ethanol precipitation
Sequencing products were transferred to 1.5 mL Eppendorf microtubes that 
were clearly labelled on the lids. An ethanol/sodium acetate solution was 
prepared by combining the following: 3.0 pL of 3M sodium acetate (pH 
4.6), 62.5 pi of 95% ethanol and 14.5 pL of 1T1QH2O for each sequencing 
sample. 80 pi of the EtOH/NaOAc solution was added to the 20 pi of every 
reaction mix. The tubes were closed, vortexed briefly and left to incubate at 
room temperature for 15 minutes so that extension products could be 
precipitated. The tubes were then spun at maximum speed (16,000 x g) for 
20 minutes with a benchtop microcentrifuge. All microtubes were aligned in 
the same orientation in the centrifuge to ensure the invisible pellet was 
deposited in the same place within each tube. After that, the supernatant was 
aspirated very carefully by pipetting away from and without disturbing the 
pellet (precipitated extension products) which most of the time was invisible 
to the naked eye. 250 pi of 70% EtOH was added to the pellet and mixed 
briefly. The microtubes were spun again at maximum speed for 5 minutes in 
the same orientation as before. All supernatant was then removed carefully 
and samples were dried in a chemical fume hood for 1 hour or overnight in a 
drawer before they were sent to BRF (Biomolecular Resource Facility) for 
direct sequencing. It was important to minimise the exposure of the samples 
to light, as BigDye terminator is sensitive to light.
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pDNA samples whose mutation(s) had been confirmed by sequencing 
results were stored at -20°C for future use. DNA sequences were analysed 
using the CLC Sequence Viewer 6 software.
2.3.9 Site-saturation mutagenesis
GpdQ residues C54, Y221 and G259 were subject to randomisation through 
site-saturation mutagenesis (SSM) [10, 14]. Degenerate primers containing 
the complete combination of 64 codons at the mutation points are designed 
to generate the SSM libraries. The oligonucleotide sequences are given in 
Appendix D.
SSM-PCR reactions were prepared and run as described in sections 2.3.2 to 
2.3.5. Ten colonies were sequenced to examine the randomness of the point 
mutations.
300 single colonies were picked manually from the LBA plates and grown 
individually in the wells of 96-well round bottom culture plates for kinetic 
analysis. Screening procedures are detailed in 2.4.2.2.
Difficulties were experienced during site-saturation mutagenesis studies 
including primer dimerisation and lack of PCR product yield despite 
numerous attempts to optimise PCR conditions and to redesign primers. 
Primer design was challenging especially for C54 and G259 as both residues 
are located in regions that were extremely high in GC content. Site 
saturation mutagenesis experiments were not pursued any further eventually.
2.4 DIRECTED EVOLUTION
Discussion of experimental procedures used in directed evolution will be 
sub-divided into two independent steps: (i) genetic library creation, and (ii) 
developing methods to screen libraries for improved variants. Figure 2.8
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summarises in the form of a flow chart, the process of making a GpdQ 
genetic library in this study.
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Figure 2.8: The process of creating a library of gpdO mutants.
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2.4.1 Genetic library creation
2.4.1.1A Preparation of gene insert
A.l Error-prone polymerase chain reaction (epPCR)
The overall philosophy of the epPCR technique is to introduce random 
mutations in a gene of interest. To achieve this, epPCR practitioners use the 
following strategies to deliberately compromise the fidelity of the 
amplification process:
i. An increased M gCf concentration. Mg“ is an essential cofactor for 
Taq DNA polymerase to function properly. 1.5 mM of the metal is 
usually enough for a standard PCR. By increasing the concentration 
of Mg2' up to 7 mM in epPCR, the formation of non-complementary 
pairs is stabilised. The pH is also increased, which possibly has an 
effect on the polymerase.
ii. An increased and unbalanced concentration o f dNTPs. Biased dNTP 
concentrations promote misincorporation of base pairs. dNTPs of 
about 200 pM each are recommended for a normal PCR. In epPCR, 
the concentrations of dCTP and dTTP are increased to 1 mM each.
iii. Addition o f M nCf to diminish the template specificity of the 
polymerase.
iv. The use o f Taq polymerase and the increased amount o f the enzyme. 
Taq polymerase is known for its relatively low replication fidelity as 
it lacks 3’-5’ exonuclease proofreading activity. Therefore, Taq 
polymerase is ideal for mutagenic PCRs and its amount is increased 
to 5 U to promote chain extensions beyond points of mismatch.
v. Prolonged PCR extension time in each reaction cycle encourages 
chain extension past mismatched positions.
vi. An increased number o f reaction cycles to enhance the overall error 
rate of the PCR [15-19].
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In a pilot study, several libraries were generated with different 
concentrations of Mn“ ranging from 0.05-0.5 mM. It was decided that the 
library created with 0.2 mM Mn2' during the epPCR step was best suited for 
this project as the library was of a good size and of a desirable level of 
mutagenesis or diversity (Table 2.1), while retaining the protein function. A 
higher amount of Mn2' used in epPCR greatly reduced the library size. 
Based on this study, two libraries generated with two different 
concentrations of 0.2 mM and 0.4 mM Mn ,were selected for more detailed 
analysis. The high mutation rate also resulted in variants carrying multiple 
mutations and many of them were therefore inactive (Table 2.2).
[M n*+] (m M ) 0.05 0.1 0.2 0.5
L ibrary size 1 x 10° 4 x 104 2 x 104 6 x 10J
E rror rate
(am ino  acid changes per gene)
0-1 1-2 3 -5 5 -9
Table 2.1: A comparison of size and error rate among four different libraries 
generated in this study with different concentrations of Mn2+.
10 clones from each library were sequenced. As the concentration of Mn2+ 
increases, a trade-off between the optimal library size and the error rate can be 
seen.
Library A 
(0.2 mM Mn2*)
Library B 
(0.4 mM Mn2*)
3.19 0.85 1.54 0.72
M ean o f 
average 
rate 
va lues 
= 1.56; 
S tandard  
devia tion  
= 1.66
0.78 0.76 0.53 0.85
M ean o f 
ave rage  
rate 
va lues 
= 0.92; 
S tandard  
de v ia tion  
= 0 .80
1.58 4.49 0.77 1.21 0.66 0.78 0.85 0.58
0.46 0.96 1.11 0.76 0.77 0.65 0.62 0.62
0.51 1.33 0.97 1.02 0.69 0.52 4.00 0.81
0.52 1.01 4.48 0.78 0.80 0.90 0.79 0.47
0.67 0.68 0.46 7.28 2.85 0.48 0.50 0.83
Table 2.2: Comparing the mean average specific activities of 24 mutants from 
each of Libraries A and B.
Libraries A and B from Table 4.2 were created with different concentrations
94 -
of Mn“ : 0.2 mM and 0.4 mM respectively. 24 variants were randomly
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picked as a stochastic representation of each library to be assayed for 1.0 
mM b/?NPP hydrolysis activity with a 96-well plate spectrophotometer. The 
average reaction rates were measured. The values given in the table are 
average rates relative to that of the wild-type GpdQ, ie. A value of 4.00 
means the average rate of the particular mutant is 4 times higher than that of 
the native enzyme. The mean average activity of a mutant from Library A 
was ~1.7 times higher than that of Library B, thus supporting the fact that a 
high error rate employed during epPCR correlates to less active mutants.
The epPCR recipe and program were developed based on published 
procedures [16-18]. The following materials were combined in a 200 pL 
PCR reaction tube:
Template DNA (gene within vector) 0.5 pi
(Purified with Qiagen Miniprep kit, about 50 ng/pL)
Forward primer SY-F (50 pM) 0.5 pi
Reverse primer SY-R (50 pM) 0.5 pi
dNTP (40 mM, 10 mM each dNTP) 1.0 pi
10X Mg2+ free PCR buffer 5.0 pi
MgCh solution (50 mM) 5.0 pi
mQFLO Top up to 50 pL final volume
MnCb solution (5 mM) 0.5 to 5.0 pi
Taq DNA polymerase 1.0 pi
Total volume 50.0 pi
Notes:
• MnCb was added into the reaction mixture just before Taq 
polymerase as MnCb may cause the PCR buffer to precipitate.
• Final concentration of primers given above was 0.5 pM. The 
concentration could be doubled if PCR yield was low.
• Primers contained NdeI (SY-F) and EcoRl (SY-R) cloning sites as 
well as sufficient nucleotide bases flanking them for specificity and 
recognition by the restriction enzymes.
• Final concentrations of MnCb in PCR reactions were between 0.05 
and 0.5 mM.
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• The amplified product PCR product was the size of the gene insert 
and was therefore smaller than the template pDNA.
PCR parameters were as follows:
94 °C 2 min
45 °C 30 sec
72 °C 2 min
94 °C 30 sec
45 °C 2 min
72 °C 5 min
4 °C oc
30 to 40 
cycles
A.2 Purification of PCR products
The PCR yield was examined with a 1.0% agarose gel electrophoresis with 
2 pL of the reaction mix (Figure 2.9).
1 kb DNA 
ladder
3.0 kb
2.0 kb
1.5 kb 
1.0 kb
0.5 kb
Lane
Figure 2.9: An agarose gel showing epPCR amplification products.
Lane 1 is 1 kb DNA ladder; lanes 2-4 show the -0.825 kb amplification products 
from three different epPCR reaction samples.
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After the PCR yield was checked, the remaining 48 pi of the reaction mix 
was loaded into a new agarose gel for a second electrophoresis run. The gel 
was viewed under the weak UV lamp and the amplification products (~ 
0.825 kb in size) were excised. The DNA was then purified with the 
Qiaquick* Gel Extraction Kit as described previously. The final elution 
volume was 50 pi.
Purifying PCR products with a gel extraction kit took longer than it would 
with a Qiaquick PCR Purification Kit. However, the former had an 
advantage in that PCR products of the correct size could be separated 
physically (by excising the band from the agarose gel) from other non-
specific products that might be found and the wild-type parental DNA itself. 
Therefore Dpn\ digestion of DNA template was not required.
Notes:
• Up to 4 PCR reactions were combined into one gel purification 
sample when the PCR yield was very low.
• TBE buffer system for agarose gel electrophoresis was preferred 
and used instead of the SB system in directed evolution to offer 
better a resolution of DNA.
A.3 Digestion with restriction enzymes
Double digestion reactions with NdeI and EcoR\ were comprised of the 
following:
Purified PCR product 50.0 pi
10X NEB Buffer 4 10.0 pi
1T1QH2O 36.0 pi
Ndel 2.0 pi
EcoRl 2.0 pi
Total 100.0 pi
Samples were incubated in a 37°C water bath for 4 hours after a 3-second 
quick spin in the microcentrifuge.
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The treatment of epPCR amplification products produced DNA fragments 
that could be ligated into the expression plasmid pCY76. DNA 
fragmentation of restriction endonucleases (REs) or digestion was the most 
vital step in ensuring the creation of a genetic library of high stringency. 
During the course of this research there was difficulty encountered in the 
Ollis laboratory in producing large mutant libraries. Several measures that 
were being undertaken to make the digestion work as efficiently as possible. 
For example, in view of the short half-life of NdeI, fresh REs were added to 
the reaction every hour for 4 hours in 0.5 pL portions so that there was a 
continual fresh supply of enzymes to cleave the DNA. The following 
strategies were used to avoid star activity.
i. Use of excessive REs was avoided to circumvent the adverse 
consequences of star activity (relaxed or altered specificity in REs). 
The amount of REs in each reaction as given above (40 U for each 
RE) was already in excess.
ii. Digestion samples were spun regularly for 3 seconds throughout 
the entire reaction process to clear the vapor formed on the lids 
which would increase the glycerol concentration of the reaction 
mixtures, leading to severe star activity.
iii. A greater reaction volume (100 pL instead of 50 pL) was used in 
order to reduce water vapor during incubation [20].
iv. Digestions were run for 4 hours that was long enough to ensure a 
complete digestion, yet short enough to avoid star activity.
Digestion was terminated by heat inactivation of the REs at 65°C for 10 
minutes.
Subsequent steps in library generation are discussed in sections 2.4.2 to 
2.4.5.
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2.4.1.IB Preparation of cloning vector
B.l Preparation of Nde\ and EcoRl cloning sites
Intact or uncut pCY76 plasmids were isolated from E. coli DH5a single 
colonies with a Qiagen Miniprep Kit where the DNA was eluted with 50 pi 
EB. To set up double digestion with Nde\ and EcoRl, each DNA miniprep 
was divided into two aliquots. The aim was to ensure a more complete 
digestion by the REs by lowering the amount of DNA in each reaction, as 
pCY76 is a high-copy-number plasmid. pCY76 vector and gpdQ gene insert 
digestion samples (as in 2.4.1.A. 1) were prepared simultaneously.
pCY76 vector 25.0 pi
10X Buffer 4 10.0 pi
mQH20 59.0 pi
Nde I 3.0 pi
EcoRl 3.0 pi
Total 100.0 pi
Digestion samples were incubated in a 37 °C water bath for 4 hours. 0.75 pi 
of NdeI and 0.75 pi of EcoRl were added to the reactions every hour for 4 
hours. The procedure was repeated until the total final volumes of Ndel and 
EcoRl reached 3.0 pL each. The reaction tubes were quick spun every time 
after new enzymes were added.
B.2 Dephosphorylation of vector DNA
The pCY76 vector DNA was dephosphorylated with calf intestinal alkaline
phosphatase (C1P) to prevent self-circularisation of the linear DNA. This
step was performed immediately after the 4-hour digestion. Vector DNA
samples were incubated at 37 °C for another 1 hour.
Vector digestion mixture ~ 100.0 pL
CIP 1.0-1.5 pL
Total -100.0 pL
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All enzymes in the reaction mixes were inactivated at 65°C for 10 minutes.
2.4.1.2 Gel purification of vector and insert DNA
Vector and insert digestion reactions were run on a 1% agarose gel with 1.0 
pg/pl ethidium bromide in the TBE buffer system. For other purposes, the 
amount of ethidium bromide added in agarose solutions was 0.5 pg/pl. The 
concentration of the stain was increased for easy viewing under the mild UV 
lamp. EtBr is not detrimental to DNA and may even protect it from UV 
damage [21].
Care was being taken during gel excision to maintain the fidelity of the 
mutant library. After electrophoresis was completed, the gel was not placed 
directly under the mild UV lamp but just close enough to see the DNA 
marker clearly. 10 pi of the marker was used instead of 4 pi for other 
routine electrophoresis runs, to ensure clear visibility of all the bands in the 
ladder. A razor was used to mark on the gel where DNA vector and insert 
bands should be, respectively (by referring to the marker). To confirm that 
the gel was cut at the right spot, it could be exposed UV light for a short 
time [22-24].
The gene insert fragments were purified with the Qiagen Gel Extraction Kit 
as described in 2.3.3. The columns were incubated for 5 minutes at room 
temperature.
After adding PE buffer before they were centrifuged. In the final step, DNA 
was eluted with 30 pL EB.
2.4.1.3 DNA quantitation
The concentration of the insert DNA and the vector DNA (prepared 
separately) was measured with the NanoDrop spectrophotometer (Figure
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2.10) . If all previous steps were performed carefully, there should be about 
90% recovery of the DNA produced by epPCR. Agarose gel electrophoresis 
was run to verify the values obtained from the spectrophotometer (Figure
2 . 11)  .
Figure 2.10: DNA UV spectrum measurement graphs.
DNA UV spectrum measurement graphs of pCY76 cloning vector (A) and gpdQ 
gene insert (B).
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Lane
1: gpdQ gene insert 
2: 1 kb DNA ladder 
3: Cut and linearised 
pCY76 vector
Lane 1 2 3
Figure 2.11: A 1.0% agarose gel showing gpdQ insert and cut pCY76 plasmid 
just before ligation.
2.4.1.4 Ligation
Purified gpdQ inserts were cloned in the digested pCY76expression vector. 
Ligation reactions were prepared according to a molar ratio of 3:1 (Insert:
vector.
DNA Size Molar ratio DNA amount in ligation
pCY76 ~2.9 kb 1 100 ng
gpdQ 0.825 kb 3 100 x 3 = ~85 ng 
(2.9/0.825)
pCY76 vector Adjust accordingly
gpdQ gene insert Adjust accordingly
10X T4 ligase buffer 5.0 pi
mQLLO Top up to 50 pi
T4 DNA ligase 1.0 pi
Total 50.0 pi
Ligation mixtures were quick spun before they were incubated overnight at 
16°C.
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2.4.1.5 Quantitative and qualitative analyses of libraries
T4 ligase was not subject to heat inactivation. 2.5 |L il of the ligation mix was 
used to transform DH5a cells directly without any prior purification step. 
The salt content in the ligation reaction reduces transformation efficiency 
and therefore was diluted with 5 pL mQLLO. The DNA-bacterial cell 
mixture was blended well by gentle flicking and pipetting to avoid ‘arcing’ 
during electroporation. The transfonned cells were immediately 
resuspended with 1 mL YENB medium and put into a 37 °C air incubator 
for 3 hours. 100 pi of the recovery culture was spread onto two LBA plates 
(50 pi each plate) and incubated overnight at 37°C. 100 pi of 100% glycerol 
was added to the remaining 900 pi of the culture. The culture was vortexed, 
frozen in liquid nitrogen and stored at -80°C.
2.4.1.5A Qualitative analysis
A qualitative analysis of the generated library had two underlying 
objectives:
i. To determine the intergrity of the library, ie. Quantitating the number 
of transformants that carry an empty plasmid and the number of 
transformants that do not carry any plasmid.
ii. To ascertain the rate of mutation.
Colony PCR and double digestion were the two methods used to determine 
the integrity of the library. In both these statistical approaches, a sizable 
amount of single colonies was randomly picked from the LBA plates.
Colony PCR
Colony PCR reactions consisted of the following:
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Single DH5a colony
SY-F forward primer (25 pM) 1.0 pi
SY-R reverse primer (25 pM) 1.0 pi
dNTP (40 mM) 1.0 pi
10X PCR buffer with Mg2+ 5.0 pi
mQH20  41.0 pi
Taq DNA polymerase 1.0 pi
Total volume 50.0 pi
Colony PCR parameters were:
94 °C 2 min
45 °C 30 sec
72 °C 2 min
uoO
N 30 sec
uoin^i- 2 min
72 °C 5 min
4 °C oc
30 cycles
Colony PCR reactions were then analysed on a 1.0% agarose-EtBr gel 
(Figure 2.12).
Figure 2.12:16 colony PCR reactions in an agarose gel presentation.
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DNA verification and sequencing
Incorporation of the plasmid was checked by restriction enzyme digestion 
and sequencing. About ten transfonnants were randomly selected from the 
LBA plates (from 2.4.5) to inoculate 5 mL LBA medium. Cultures were 
grown overnight for plasmid isolation the following day. The purified 
pDNA samples were digested with NdeI and EcoRl to check for the 
presence of gene inserts. Digestion reactions were prepared, run and 
analysed as described in 2.3.6 and 2.3.7.
The ten variants were also sequenced to determine the mutation rate.
2.4.1.5B Quantitative analysis of library size
The size of the library was estimated by counting the number of colonies on 
the two LBA plates, deriving the mean average and subtracting the 
background. The libraries generated during this study using epPCR and 
StEP were always between 104 and 105 colony-forming units in size.
2.4.1.6 Creating future libraries (second generation libraries and 
onward) using Staggered Extension Process (StEP)
StEP is an in vitro DNA recombination method first introduced in the late 
1990s. It is technically and conceptually simpler than the other older, 
conventional approach -  DNA shuffling. DNA shuffling requires substantial 
quantities of parental DNA to be digested with DNasel to create a pool of 
small fragments that are then reassembled into full-length genes by two 
different thermocycling reactions (PCR without primers followed by PCR 
with primers) [25-27].
StEP uses extremely short extension times to induce template switching 
(Figure 2.13).
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Figure 2.13: A diagram to illustrate the simplified concept of StEP.
In each cycle, the growing fragments or incomplete extension products undergo 
‘template switching’ by annealing to different templates and further extend to 
become full-length, recombined genes.
In this study, the best mutants from each round of screening were shuffled 
using the staggered extension process PCR (StEP) method. The StEP 
reaction contained 0.5 ng template DNA (a equimolar mixture of selected 
variants), 1 pM of each of the forward (SY-F) and reverse (SY-R) primers, 
1.25 mM of dNTP, 1.5 mM MgCl2, 3% DMSO and 0.1 U Taq DNA 
polymerase. DMSO was added to improve the product yield and to reduce 
the smear in the background, as seen when StEP reactions were analysed on 
agarose gels.
Four different protocols of StEP were used throughout this study (StEP-A, 
B, C and D). Initially (second to fourth generation libraries), StEP-A 
reactions were run at 94°C for 2 minutes (pre-denaturation), 80 cycles of 
45°C (10 seconds), 72°C (10 seconds) and 94°C (10 seconds), followed by 
45°C for 2 minutes and a final extension at 72°C for 5 minutes. This 
program was used to create libraries up to the fourth generation. Libraries
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generated with this process were small in size and had low recombination 
efficiency.
Cycling conditions were then optimised, based on Zhao’s journals [28-30] 
and empirical trials. A new protocol StEP-B was introduced to produce 
libraries from the fifth generation to the seventh. The StEP-B protocol was 
developed as a two-step cycle (lacking a distinct 72°C elongation step) to 
minimise extension time to ensure shuffling efficiency:
94°C 2 min
94°C
55°C
30 sec 
5 sec 80 cycles
72°C 5 min
4°C oo
Polymerisation and recombination would take place during the extremely 
short ramp time (55°C to 94°C) of the thermocycler. Tag polymerase is one 
of the quickest DNA polymerases, leading to shorter annealing/extension 
times that are better for recombination efficiency. Therefore, whenever 
StEP-PCR reactions were run, the BioRad iCycler* was used as it was the 
faster thermocycler of the two models available in the laboratory.
DNA sequencing results of the best mutants from the seventh round of 
directed evolution of GpdQ indicated that, even with a 5-second annealing 
step at 55°C, StEP-B could not recombine mutations that were as close as 
30 nucleotides (10 residues in the translated protein), eg. G259R and 
C269A. Hence, to generate libraries for the eighth round of evolution, we 
experimented with 3-second (StEP-C) and 1-second (StEP-D) annealing 
times. Table 2.3 shows the difference in activities between the two libraries 
when 24 variants from each were assayed for 1.0 mM b/?NPP hydrolysis.
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Library StEP-C  
(3-second annealing)
Library StEP-D  
(1-second annealing)
1.00 0.93 0.88 0.56
Mode 
= 6.95
3.35 1.16 9.84 1.81
Mode 
= 9.843.19 1.02 3.61 1.78 1.65 1.41 0.77 0.66
5.59 0.69 2.83 2.13 1.01 0.65 2.94 3.85
4.37 4.40 1.31 2.84 1.06 5.17 5.28 8.23
6.12 6.95 0.94 0.79 8.55 0.99 9.15 3.26
6.86 1.03 0.56 6.41 8.33 1.56 1.77 2.93
Table 2.3: Comparing the relative average activities of 24 mutants from each 
of Libraries StEP-C and StEP-D.
The highest relative activity detected among 24 variants from Library StEP- 
C was 6.95 pmol 'min compared to 9.84 pm ol1 min''from Library StEP- 
D. Although this was a marginal difference between the two values, we 
could still infer that the recombination efficiency was improved with a 
shorter annealing/extension step and this could possibly lead to the 
discovery of more potent variants with new combinations of mutations 
during screening. DNA sequencing analysis of a variant from Library StEP- 
D showed that mutations G259R and C269A were successfully recombined
(Figure 2.14).
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Figure 2.14: DNA sequence alignment of an eighth round variant from Library 
StEP-D against wild-type GpdQ, showing mutations G259R and C269A.
Nucleotides 775-777 and 805-807 encode for G259 and C269 respectively in the 
wild-type; whereas nucleotides 1111-1113 and 1141-1143 in the GpdQ variant 
encode for R259 and A269 respectively.
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Hence, the library produced from the StEP-D protocol was used for 
subsequent eighth round screening. The size of Library StEP-D (3 x 104) 
was significantly smaller than that of Library StEP-C (1 x 105). However, 
this should not be immediately regarded as a disadvantage of using a shorter 
annealing/extension step, as it was possible that Library StEP-C contained 
numerous copies of the same small set of poorly recombined mutants. 
Moreover, the in vitro method used to screen the libraries severely limits the 
number of clones that can be practically examined due to its laboriousness.
The remaining cloning procedures were the same as for the first generation 
library. The whole process of preparing a library of gpdQ mutants is 
summarised in Figure 2.8.
2.4.2 Developing methods to screen libraries for improved variants
In vivo screening is quick and less laborious compared to in vitro random 
screening, enabling a library as large as 106 to be screened. Two in vivo agar 
plate-based methods for the preliminary screening of GpdQ mutant libraries 
were tested with little success. GpdQ mutant libraries were eventually 
subject to in vitro random screening in the 96-well microtiter plate format.
2.4.2.1 In vivo agar plate-based screenings with phosphotriester and 
phosphodiesters
McLoughlin ’s growth assay method with phosphodiesters dimethyl 
phosphate (DMP) and diethyl phosphate (DEP)
A growth-based strategy for screening OpdA mutants with improved MPO 
activity was devised by Dr Sean Yu-McLoughlin during his PhD 
candidature in the Ollis laboratory [4, 31]. A catabolic pathway was 
designed within E. coli cells that co-expressed a phosphotriesterase (OpdA), 
phosphodiesterase (GpdQ) and alkaline phosphatase that would enable the 
bacteria to utilise triesters as the sole phosphorus source.
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For the purpose of screening GpdQ mutant libraries in this project, 
McLoughlin’s plate assay screening was modified slightly. DH5a E. coli 
cells that were transformed with recombinant GpdQ mutants expressed only 
the phosphohydrolase and not the other transporter proteins of the putative 
Enterobacter aerogenes ugp opcron (Figure 1.7). The E. coli transformants 
were grown on modified M9 or potassium morpholinopropane sulfonate 
(MOPS) [32] minimal medium agar plates containing 50 pg/mL ampicillin 
and 1 mM DMP or DEP as the sole phosphorus source. There was no cell 
growth after 2 days of incubation at 37°C, suggesting that the there was not 
sufficient phosphate from the catalytic breakdown of the alkyl diesters to 
support growth.
Cho ’s top agar assay method with phosphotriester methyl paraoxon (MPO) 
Cho and colleagues developed a solid phase top agar assay based on the 
formation of p-nitrophenol for rapid preliminary screening of potential OPH 
variants with enhanced methyl parathion (MPS) activity [33]. Single 
colonies of transformed DH5a cells were spread onto M9 minimal medium 
plates supplemented with 0.1% Casamino acids and 50 pg/mL ampicillin 
and 1 mM MnCf to promote growth and GpdQ activity. The minimal 
medium was used as it would not increase the background colour. After a 
48-hour incubation at 37°C, 5 mL of 0.7% agarose containing 50 mM 
CHES buffer (pH 9.0) and 1 mM methyl paraoxon (solubilised in 10% 
methanol) was laid over the colonies on the plates. The agarose-substrate 
solution was pre-boiled and cooled to 55°C before it was poured over the 
colonies.
Colonies were selected based on the intensity of the yellow colour from the 
hydrolysed product p-nitrophenol, where any clones that appeared to have a 
larger yellow halo than the wild-type GpdQ would be selected for 
rescreening using a 96-well plate reader. However, after five hours of 
incubation at room temperature, no formation of p-nitrophenol product 
could be observed.
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2.4.2.2 In vitro random screening with bis (p-nitrophenyl) phosphate
After the in vivo screening experiments were unsuccessful, the GpdQ 
mutant library was screened in vitro with substrate bpNPP. Instead of 
growing the library on LBA selection plates overnight and manually 
inoculating LBA liquid medium with single colonies, a less laborious 
method that was first developed by Dr Bradley Stevenson in our laboratory 
was used [34, 35]. The mutant library was grown in liquid media and 
screened in 96-well plates. The 1 mL YENB recovery culture (with 10% 
glycerol) from section 2.4.1.5 was diluted with LBA medium and the 
dilution was dispensed into 96-well round bottom microtiter plates to an 
average density of 2 cells per well. 200 pL of the diluted library was 
pipetted into each well. This method assumes that the enhanced activity of a 
mutant clone can be detected even when it is grown with other clones in the 
same well. It also assumes that the cells do not aggregate and divide during 
dispensation and are evenly distributed in the library, the initial number of 
viable cells placed in each well will obey the Poisson distribution:
P(r) = e'^w! (Equation 2.2)
r\
Where P(r) is the probability of a well having r number of cells when the 
mean number of cells per well is p. If p = 2 and r = 0, then P(r) would be 
0.135, meaning the expected number of sterile wells in each plate (no cell 
growth) when all the wells contain an average of 2 cells is approximately 13 
(0.135 X 96 wells).
The 96-well plates were grown in a 37°C shaker overnight. The next day, 
the number of sterile wells was counted to confirm the actual mean number 
of cells in each well. 20 pL of the 200 pL culture in each well was aliquoted 
into 96-well flat bottom assay plates, lysed with a solution containing IX 
BugBuster and 0.5 mM MnCf (final metal concentration in the assay 
reaction), and assayed with b/?NPP in 50 mM CHES pH 9.0. Production of
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p-nitrophenol from the catalytic hydrolysis of bpNPP was measured 
spectrophotometrically in a 96-well plate reader at 405 nm, room 
temperature for up to 10 minutes. With this in vitro screening method, only 
about 104 cells could be screened in each round within a reasonable period 
of one week.
The culture from wells displaying enhanced activity was streaked on LBA 
plates and incubated overnight at 37°C. Four single colonies from each 
streaking was then picked to each inoculate 200 pL fresh LBA medium and 
grown overnight at 37°C. Secondary screening of the single-colony cultures 
was conducted using exactly the same methodology described above for 
preliminary screening, with the wild-type as the control. The activity 
observed here was typically higher than during preliminary screening as 
there was no more competition among the different variants within the same 
well.
5 pL of each of the fittest mutants from every round was used to inoculate 5 
mL LBA medium. The cultures were grown overnight in a 37°C shaker. The 
plasmid DNA was isolated, analysed via an agarose gel electrophoresis after 
Ndel/EcoRl digestion and sequenced. Up to 12 of the best mutants that 
carried different combinations of mutations were subject to recombination 
using the StEP as described in 2.4.1.6. It has been shown that an efficient 
pooling strategy greatly enhances the screening throughput and the number 
of active variants being identified [36]
For the first four rounds, GpdQ was evolved with bpNPP using two 
strategies separately: towards higher affinity with low b/?NPP concentrations 
and higher catalytic affinity with high bpNPP concentrations. With the first 
three rounds of high affinity evolution, the libraries were screened with 1 
mM, 0.5 mM and 0.25 mM b/?NPP respectively. From the fifth round 
onwards, GpdQ libraries were screened with a standard bpNPP
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concentration of 1 mM. An example of kinetic progress curves from
secondary screening is shown in Figure 2.15.
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Figure 2.15: An example of a secondary screening during the sixth round of 
directed evolution.
The two wells A1 and B1 contain wild-type GpdQ. The numbers that were 
handwritten denote how times the average activity of a particular mutant is higher 
than that of the wild type. For example, mutant AC1 in well A3 displays average 
activities that are 5.03 and 2.86 higher than those of the wild-type at bpNPP 
concentrations of 1 mM and 0.1 mM respectively.
2.5 PROTEIN EXPRESSION AND PURIFICATION
2.5.1 Protein expression
pCY76-gpdQ plasmid DNA samples, purified from the Qiapreps Miniprep 
Kit, were diluted 50 times with mQH20. 1 pL of the diluted pDNA was used 
to transform DH5a cells, which were recovered with 1 mL YENB medium 
immediately after electroporation. 20 pL of the recovery culture was 
streaked onto an LBA plate that was then incubated at 37°C overnight. The 
following day, 2 single colonies were picked to inoculate 5 mL of TBA 
(Terrific Broth-ampicillin) medium in a culture flask. It was very important
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to use single colonies from a fresh transformation to ensure optimal protein 
expression.
The 5 mL starter culture was grown in a 37°C shaker for 5-8 hours (differing 
growth rates due to mutations), until the OD595 reached about 0.20. 500 mL 
TBA medium in a 1 L baffled culture flask was then inoculated with the 
starter culture and grown at 37°C overnight for 16 hours. Cells were then 
harvested by centrifugation with an SLA-3000 rotor at 4,000 x g for 15 
minutes. A 500 mL culture would typically yield 4-5 g of E. coli cells. Cells 
were stored at -80°C.
With the leaky nature of /ac-controlled constitutive expression, it was 
sometimes difficult to express recombinant proteins at high levels. pCY76 is 
a high copy number plasmid whose replication takes place in a relaxed 
fashion [6]. If the starter culture entered the log phase, it was very possible 
that the cells would divide vigorously without the correct segregation of 
plasmids to the daughter cells [37], although the par locus was included in 
the pCY76 vector to circumvent this negative phenomenon. This could 
potentially pose a threat to the expression of GpdQ. For this reason, the 
starter culture was not incubated overnight because it was important to arrest 
the cells at the lag phase during their growth. A starter culture of cell density 
> 0.2 would significantly reduce the protein expression level during the 
exponential phase (500 mL culture).
LBA (1 L) was used as the expression media but was later switched to TBA, 
a richer medium that gives greater cell mass and higher recombinant protein 
expression levels [38, 39]. Cells were also initially grown at 30°C. 
Expressing proteins at higher temperatures can sometimes result in 
production of non-refoldable, inactive aggregates or inclusion bodies [40, 
41]. However, this did not dramatically decrease the solubility of GpdQ 
proteins. Expressing GpdQ at 37°C saved a lot of time as this is the optimal 
temperature for cell growth. Moreover, the use of TB medium helps to 
prevent cell death [37].
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An SDS-PAGE gel comparing GpdQ expression levels in TBA and LBA 
media is given in Figure 2.16.
Low range 
molecular 
weight marker
97.4 kDa 
66.2 kDa
45.0 kDa
31.0 kDa
21.5 kDa 
14.4 kDa
1 2 3  4 5 6 7 8 9
Figure 2.16: A comparison of GpdQ proteins expressed in TBA and LBA 
media.
Lane 1 is low range molecular weight marker, with the sizes (in kDa) of the protein 
standards given on the left. The GpdQ monomer (-30.8 kDa) is aligned with the 31.0 
kDa carbonic anhydrase band in the marker. Lanes 2, 4, 6, 8: wild-type GpdQ, 
N53D, C269S and C269A expressed in TBA. Lanes 3, 5, 7, 9: The same proteins 
expressed in LBA.
2.5.2 Protein purification
ProtParam (http://au.expasv.org/tools/protparam.htmn is a tool that allows 
the computation of various physical and chemical properties of a protein 
from its sequence. Prior to purification, the theoretical values of molecular 
weight (monomer), pi and extinction coefficient of every GpdQ protein were 
calculated based on DNA sequencing of each mutant.
All purification steps were carried out at 4°C to minimise loss due to 
denaturation. Three protocols were used to purify GpdQ in this study. All 
buffers and mQH20  used in purification were filtered with vacuum driven 
0.45 pm nitrocellulose membrane filters. An AKTA™ FPLC system was 
used to automatically control elutions.
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2.5.2.1 Protocol A -  McLoughlin et al. (modified)
Cell pellets were resuspended with 50 mM HEPES, pH 8.0 and lysed with a 
French" pressure cell press operated at 14,000 lb/in2. The lysate was then 
centrifuged at 40,000 x g with an SS-34 rotor. The supernatant was loaded 
onto a DEAE anion exchange column that was eluted with a 0-0.6 M NaCl 
gradient applied over 6 column volumes (The column volume was 80 mL) at 
a flow rate of 1.5 mL/min. GpdQ enzymes eluted between 0.3M and 0.4 M 
NaCl, depending on the mutation(s) that had been made. It was noted that 
many mutations changed the pi and the elution point of the proteins.
The eluted fractions (8 mL each) were assayed for phosphodiesterase 
activity with bpNPP as the substrate (Figure 2.17). Fractions that displayed 
the highest activity were analysed by SDS-PAGE. 10 pL of each fraction 
was mixed with 10 pL Tris-HCl buffer pH 6.8 that also contained 
bromophenol blue (BPB), sodium dodecyl sulfate (SDS), glycerol and 5% 
ß-mercaptoethanol. The samples were heated at 100°C for 5 minutes for a 
complete denaturation before they were loaded into the polyacrylamide gels. 
10 pL of Low Range Molecular Weight marker was normally injected into 
the left most well of the gel. Electrophoresis was run in the Tris-HCl-glycine 
buffer system using a Hoefer Mighty Small II gel tank at 300 V and 30 mA 
with tap water cooling for about 40 minutes or until the BPB had migrated 
to the end of the gel. Recipes for ‘cracking’ buffer, stacking and resolving 
polyacrylamide gels, as well as the Tris-HCl-glycine buffer are given in 
detail in Appendix B. The gel was then detached from the tank, destained 
with 1T1QH2O for 30 minutes to remove SDS and later stained with 
GelCode " blue stain reagent to visualise the protein bands.
Up to 3 fractions with the highest amounts of GpdQ protein were chosen for 
the next purification step. 3 M ammonium sulphate (AmS) solution was 
added to equilibrate the fractions up to a final concentration of 1 M. The 
protein solution was then centrifuged at 30,000 x g for 40 minutes. The
97
CHAPTER TWO
supernatant was loaded onto a Phenyl Sepharose hydrophobic interaction 
column. A linear AmS gradient (0.6 to 0 M) was applied over 6 column 
volumes to elute bound proteins at 1.5 mL/min. Each column volume was 
80 mL. GpdQ enzymes typically eluted between 0.3 and 0.2 M.
The main disadvantage of this protocol was that the high AmS concentration 
caused GpdQ to precipitate, leading to a significant loss of the protein 
during the purification process.
2.5.2.2 Protocol B -  Ghanem et al. (modified)
Due to the inefficiency of the DEAE-Phenyl Sepharose step, a method based 
on the one devised by Ghanem and colleagues was used [42]. In brief: cells 
were resuspended in 50 mM Tris-HCl buffer, pH 8.0. The soluble fraction, 
obtained after cell disruption and centrifugation, was treated with AmS at 
60% saturation. The saturation point of AmS is 3.93 M at 4°C. The protein- 
AmS mixture was equilibrated at 4°C for an hour before it was centrifuged 
at 10,000 x g for 30 minutes. The pellet was resuspended with 1 mL elution 
buffer (50 mM Tris-HCl, pH 8.0) and loaded slowly onto a Superdex 200 
gel filtration column with a peristaltic pump. The sizing column had a 
column volume of 120 mL. The proteins were eluted at 0.5 mL/min to 
ensure good resolution. Once again, the eluted fractions were assayed for 
hydrolysis of 5.0 mM bpNPP. The existence of the protein of the required 
molecular weight in fractions with the highest activity was confirmed via 
SDS-PAGE. Confirmed fractions were pooled and loaded onto a Q 
Sepharose anion exchange column. Elution was run at 2 mL/min with a 0- 
0.6 M NaCl gradient applied over four column volumes (Column volume 
was 80 mL). The ~70% purity of GpdQ derived from this purification 
method was unsatisfactory.
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2.5.2.3 Protocol C -  Ghanem’s method, ‘reversed’
Cells were resuspended with 20 mL 50 mM Tris-HCl buffer (pH 8.0), 
disrupted and centrifuged as before. The soluble fraction was loaded onto 
the Q Sepharose column where a 0-0.6 M NaCl gradient was applied over 
three column volumes. During optimisation of the Q Sepharose elution, it 
was found that a steeper NaCl gradient gave a better resolution and 
separation of proteins. GpdQ enzymes could elute anywhere between 0.32 
M and 0.50 M NaCl, depending on how radically the mutations change the 
pi of the proteins. The native protein eluted at about 0.4 M NaCl (Figure 
2.18).
The two fractions with the highest GpdQ concentration and least impurities 
were selected for the next purification step. 6.61 g of ammonium sulfate salt 
was added to the two protein fractions (16 mL) and topped up to 20 mL with 
mQH20  so that the final AmS concentration was 2.5 M. The proteins were 
equilibrated for an hour at 4°C, then centrifuged as described before. The 
pellet was resuspended with 1 mL elution buffer and loaded onto the 
Superdex 200 gel filtration column. The chromatography was run at 0.5 
mL/min for the first column volume (elution of proteins) and 1.0 mL/min 
subsequently (re-equilibration of column). GpdQ eluted at ~60 mL 
(hexamer), ~72 mL (dimer) and ~78 mL (monomer) of the elution volume. 
The Superdex 200 column had been calibrated with protein standards 
(details in section 2.7). A Superdex 200 elution profile of wild-type GpdQ is 
given in Figure 2.19.
SDS-PAGE indicated that the proteins were at least 95% pure, based on the 
estimation of the intensity of the protein bands using Adobe Photoshop 
(Figure 2.20). The purest fractions were dialysed against storage buffer 50 
mM Tris, pH 7.5 overnight or for at least four hours. Purified GpdQ proteins 
were stored at 4°C.
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Figure 2.17: Drop assay of fractions eluted from Q Sepharose column. Grids 
C6-C12 correspond to fractions 8-14 of the elution profile in Figure 2.17.
Figure 2.18: An elution profile of the soluble fraction of crude lysate eluted 
from the Q Sepharose column.
Elution of proteins was detected at 280 nm (blue line). The green line represents the 
NaCI gradient while the brown line represents the ionic conductivity. Wild-type GpdQ 
eluted at about 0.42 M (fractions 8-14). Fractions 11 and 12 were selected for further 
purification with the Superdex 200 column (Figure 2.19).
Figure 2.19: A profile of wild-type GpdQ eluted from the Superdex 200 column.
Peak A: Unresolved protein aggregates were the first to elute. Peak B: The -180 
kDa hexamer eluted in fractions 4-6. Peak C: Salts eluted towards the end of the first 
column volume (120 mL).
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Figure 2.20: Purified GpdQ visualised in a 17.5% SDS-PAGE gel.
The low-range molecular weight protein marker from Bio-Rad was used and 
visualised on the left most lane of the gel.
Proteolytic activation o f GpdQ
GpdQ had been previously reported to undergo proteolytic activation [4, 
43]. Purified GpdQ proteins, when visualised in an SDS-PAGE gel (Figure 
2.17) were associated with the 31.0 kDa band of the marker. There were 
other visible faint bands of sizes smaller than the 30.8 kDa GpdQ monomer 
that could not be removed through any further purification step. These may 
be GpdQ proteolytic fragments.
The two proteolytic cleavages were predicted to occur between D168-P169 
and R227-P228 [44]. Mutagenesis experiments, based on the predictions, 
were conducted in this study to investigate this proteolysis phenomenon 
further. Results and discussions are found in Appendix E.
2.6 KINETIC ANALYSIS OF GpdQ PROTEINS
Purified and dialysed GpdQ proteins were assayed for phosphodiesterase 
activity with bpNPP as the substrate. Mutants N80D and N80A were also
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assayed for their phosphomonoesterase activity with /?-nitrophenol 
phosphate (pNPP) that was a product from the hydrolysis of b/?NPP. Figure 
2.21 shows the degradation of bpNPP and pNPP.
Both bpNPP and pNPP were obtained from Sigma. bpNPP (FW = 362.16) 
in the form of a sodium salt was >99% pure. pNPP disodium salt 
hexahydrate (FW = 371.14) was in the form of 20 mg tablets.
The production rate of p-nitrophenolate by wild-type GpdQ and mutants 
was monitored spectrophotometrically at 405 nm ( £ 4 0 5  = 17,000 M ’em'1) 
using various concentrations of bpNPP or pNPP. bpNPP concentrations 
ranged from 50 pM-20 mM while pNPP concentrations ranged from 0.5-20
mM.
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Figure 2.21: Hydrolysis of bpNPP and pNPP.
Diagram A shows the hydrolysis of bpNPP into p-nitrophenyl phosphate and p- 
nitrophenol. Diagram B shows the production of phosphate and p-nitrophenol from 
the hydrolysis of pNPP.
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The most commonly used assay conditions were 50 mM CHES (FW = 
207.29) pH 9.0, 0.5 mM MnCb , 0.1 mg/mL bovine serum albumin (BSA) 
and 20°C. The MnC^ was used as an exogenous supply of enzyme co-
factors. BSA was used to help stabilise the enzyme. All buffers, substrate 
and metal solutions were filtered with syringe driven 0.20 pm filter units to 
reduce the noise due to background during kinetic measurements.
The assays with b/?NPP were set at an alkaline pH so that the measurements 
would not be contaminated with phosphomonoesterase activity. It had been 
shown that GpdQ’s monoesterase activity is higher at lower pH values [4, 
44, 45]. In some other assays, Mn2+ concentrations were varied to 
investigate the effect on enzymatic activity. To study the role of residue 
H81, assays were also carried out at pH 6.0 using 50 mM MES (FW = 
213.2) as the buffer.
Non-cooperative GpdQ enzymes
For GpdQ enzymes that showed no cooperativity, the kinetic parameters kcat 
and Km were determined by fitting the initial velocity (v) data collected at 
different subtrate concentrations to the classic Michaelis-Menten equation:
v = Vm^rSl (Equation 2.3)
+ [S]
Where v is initial velocity, KM is the Michaelis constant and [S] is the 
substrate concentration. The value of kcat is derived from the following 
equation:
kca{ = Vmax/[E] (Equation 2.4)
And [E] is the enzyme concentration.
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The software KaleidaGraph was used for Michaelis-Menten curve fitting 
purposes.
Negatively cooperative GpdQ enzymes
For GpdQ enzymes that showed negative cooperativity, the Eadie-Hofstee 
derivative of the Michaelis-Menten was plotted:
V = - KM (v/[S]) + Vmax (Equation 2.5)
How apparent values of Vmax and KM were obtained from the Eadie-Hofstee 
plots are detailed in Chapter 3. Microsoft Excel was used for Eadie-Hofstee 
curve fitting.
Determining cooperativity in GpdQ enzymes
To ascertain cooperativity in GpdQ enzymes, the value of n in Equation 2.5 
was determined by using values of Vmax and Km as obtained from Equations 
2.2 or 2.4. Equation 2.6 is a simplified, linearised version of the Hill 
equation:
log [v/(Vmax -  v)] = n log [S] + log Kd (Equation 2.6)
where v is initial velocity; Vmax, maximum velocity; n, Hill coefficient; [S], 
substrate concentration and Kd, dissociation constant.
2.7 DETERMINATION OF PROTEIN MOLECULAR WEIGHT
All size exclusion columns used in this study were pre-calibrated with a set 
of six protein standards whose molecular weights were known (Figure
2.22) . The linear graph of logarithm of protein sizes in Dalton (Da) versus 
their elution volumes was plotted and fitted using linear regression (Figure
2.23) . GpdQ protein sizes were subsequently calculated based on the 
equation.
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1. Aggregated proteins
2. Thyroglobulm,670 kDa
3. y-globulin, 158 kDa
4. Ovalbumin, 44 kDa
5. Myoglobin, 17 kDa
6. Vitamin B12, 1.35 kDa
Figure 2.22: Elution profile of molecular weight markers from Superdex 200 
size exclusion column.
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Elution volume
Figure 2.23: Calibration curve obtained with molecular weight markers eluted 
from Superdex 200 size exclusion column.
The linear equation derived from the curve fit is given in the box at the right hand 
corner. Vitamin B12 has been excluded in order to give a good fit.
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2.8 PROTEIN CRYSTALLOGRAPHY 
2.8.1 Vapour diffusion of hanging drops
GpdQ proteins that were to be crystallised were subject to a second gel 
filtration elution to enhance their purity. The proteins were then 
concentrated with Amicon Ultra-15 centrifugal filter units (30 or 10 kDa 
MWCO) that were spun at 3,000 x g in the 11133 rotor. The proteins were 
adjusted to a final concentration of 10-20 mg/mL with mQH20  and filtered 
with a syringe driven Millex' -GV 0.22 pm filter unit.
For wild-type GpdQ and other mutants whose hexameric structures were 
intact, crystallisation conditions were 60% (v/v) Tacsimate, 0.1 M Bis-Tris 
propane, pH 7.5, with or without 1 mM MnCl2 or CoCl2, and 18°C. GpdQ 
was crystallised via vapour deposition of hanging drops. 1 mL of the 60% 
Tacsimate solution was laid into the reservoirs of a 24-well crystallisation 
tray. The sides of the wells were greased with petroleum jelly before use. 1 
pL of the reservoir solution was mixed with 2 pL of protein on a plastic 
coverslip. If metals ware used, 1 pL of 4 mM MnCl2 or CoCl2 was also 
added into the mixture. The coverslip was then overturned to cover the 
wells.
Crystals grew within three days but were left to grow for at least a further 
four weeks before they were mounted, with the assistance of Drs Paul Carr 
and Jee-Loon Foo. Crystals were scooped up with a nylon loop, soaked in a 
cryoprotectant solution (80% Tacsimate) and flash-frozen in liquid nitrogen. 
The mounted crystals were then irradiated with monochromatic X-rays to 
test their ability to diffract well. Irradiation experiments, data collection and 
analyses were all done by Dr Paul Carr.
A crystal of wild-type GpdQ that diffracted to a resolution of 1.9 Ä was 
obtained in this study [44]. This structure (PDB ID 3D03) was in a different
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space group (P2]2|2i) from those previously solved by Jackson et al. (P2i3) 
[46]. The 3D03 crystal was orthorhombic in shape while those reported by 
Jackson et al had cubic morphology.
2.8.2 Crystallisation screens
New crystallisation conditions were sought for GpdQ dimer proteins like the 
F21K mutant using Hampton Research (Index, Crystal HT, PEG, PEG/Ion) 
and Jena Bioscience HT screens. A Cartesian dispensing robot was used to 
set up all the screening trays. 100 pL of each screening solution was 
dispensed into the reservoir wells while 0.2 pL of it was taken out to mix 
with the ~20 mg/mL F21K purified protein. These crystallisation screens 
were set up by Miss Tracy Murray.
2.8.3 Computer software programs
Analyses of crystal structures of GpdQ and other structurally and/or 
functionally proteins were performed using the software Coot Auto Opener 
with files downloaded from Protein Data Bank (http://www.rscb.org/pdb/). 
Structural diagrams presented in this thesis were generated using the 
MacPymol program.
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CHAPTER THREE: MUTATIONAL ANALYSIS OF ACTIVE SITE 
RESIDUES AND MECHANISTIC STUDIES OF GpdQ
3.1 INTRODUCTION
This chapter chronicles experiments that were carried out with the purpose 
of investigating the following:
■ The roles and functions of active site residues, in particular the 
ligands coordinating the metal ions.
■ The catalytic mechanism of GpdQ .
Site-directed mutagenesis was the main technique employed to produce 
active site mutants. These mutants are listed in Table 3.1 below.
Residue Substitutions Significance of residue
D8 N, A A ligand of a-metal.
H10 A A ligand of a-metal.
D50 N, A The bridging ligand of a- and ß-metal.
N80 D, A A ligand of ß-metal. Mutant 3-25-N80A 
was also made to study cooperativity 
between the two metal binding sites.
H81 Q, A Conserved active site residue with 
putative catalytic roles.
H156 Q, A A ligand of ß-metal.
HI 95 Q, N, A A ligand of ß-metal.
Table 3.1: List of active site mutants made, characterised and discussed in 
this study.
Jackson et al. first detected the possible difference in the metal-binding 
affinities at the GpdQ binuclear active site [1]. Using the anomalous data 
collected at the Zn K-edge, Jackson et al. generated a Bijvoet-difference
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Fourier map of the active site of the ZrT -GpdQ holoenzyme. The map 
demonstrated the respective nearly full (96%) and partial (80%) occupancies 
of the a- and ß-sites with Zn2 ions, which indicated the difference in metal 
binding affinities between these two sites. This observation agreed well with 
the ligand coordination geometries at the GpdQ active site: both a -  and ß- 
metal ions are coordinated by two histidine ligands each and jointly, the 
bridging D50 ligand, but the a-metal has another strong acidic ligand in 
asparatate (D8) whereas the ß-metal is additionally coordinated by an 
asparagine residue (N80) (Figures 1.13 and 3.1).
One of the key research objectives of this thesis was to characterise the 
binding affinities of the binuclear active site. To this end, mutants D8N/A, 
D50N/A, N80D/A were constructed. D —> N mutations neutralise the 
negative charge of the acid residue and are expected to reduce but not 
abolish the ability of the residue to bind metal ions altogether, since 
asparagine is capable of forming hydrogen bonds. N —> D mutations have 
the opposite effects and increase the metal binding affinity of a residue. D 
—> A mutations abolish the ability of the residue to coordinate metals 
completely.
Histidine residues commonly act as ligands in metalloenzymes, especially 
zinc enzymes. The zinc ions can be substituted by other metal ions like 
Mn2f, Co2f, Ni2\  Cd2 and others. Site-directed mutagenesis is a common 
tool employed to identify metal ligands and such mutations often lead to a 
huge loss in the catalytic activity of the enzyme [2-5]. Mutants H10A, 
H156Q/A and H156Q/N/A were made to investigate the importance of these 
histidine residues as metal ion ligands. With these ligands, the rationale 
behind making the H —> Q/N mutations was to deprive the residue of the 
imidazole ring that coordinates metal ions. The chemical structures of 
glutamine and asparagine are the closest to histidine among the 20 amino 
acids as each of them carries a nitrogen atom in the side chain. Therefore, H 
—> Q/N mutations were expected to cause the least disruption to the
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conformation of the enzyme, especially the active site. Once again, no metal 
ion coordination and hydrogen bond formation would be possible when a 
histidine was substituted by an alanine (H —> A).
H81 does not coordinate any metal ions directly but is an active site ligand 
that is highly conserved in several structurally related phosphodiesterase and 
phosphatases. Therefore H81Q/A mutants were made to study the role(s) of 
this residue in catalysis/substrate binding. Such mutations also eliminated 
the ability of the residue to donate and accept protons. Residues 
homologous to H81 in other related enzymes have been postulated to 
participate in general acid/base catalysis.
Figure 3.1 shows a diagram of the active site of GpdQ and all the active site 
mutants made in this study.
H195Q
H195N
H195A
Figure 3.1: The active site of GpdQ and active site mutants made in 
this study.
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3.2 A SUMMARY OF MUTAGENESIS STUDIES OF GpdQ ACTIVE 
SITE RESIDUES
All active site mutants discussed in this chapter were made, expressed and 
purified using methods described in Chapter 2. Mutants N80D/A, D8N/A, 
D50N/A and H81Q/A were made in years 2006-2007. At that time, Protocol 
B as described in section 2.5.2 of Chapter 2 was used to purify these 
proteins. The purified proteins were then preliminarily assayed for their bis 
(p-nitrophenyl) phosphate (bpNPP) activity at pH 9.0, 20°C and in the 
presence of 0.5 mM MnCh and 0.1 mg/mL BSA. In 2009, mutagenesis 
studies of GpdQ active residues resumed with the production of new 
mutants H10A, H156Q/A and H195Q/N/A. These proteins were purified 
using Protocol C (section 2.5.2, Chapter 2). The mutants made in 2006-2007 
were also expressed again and purified using Protocol C. Kinetic analyses of 
the old mutants was repeated with bpNPP at the same assay conditions and 
indicated no major differences from the kinetic data obtained two years ago. 
The biphasic behaviour of N80A kinetics was studied further in 2009 by 
varying assay conditions and the H81 mutants were also assayed at pH 6.0.
Table 3.2 is a summary of results from kinetic assays of GpdQ active site 
mutants with substrate b/?NPP under the default assay conditions of 50 mM 
CHES pH 9.0, 0.5 mM MnC^. 0.1 mg/mL bovine serum albumin (BSA) at 
20°C. Discussions of these results will be presented systematically 
throughout this chapter. Kinetic data of assays performed under different 
conditions are not included in Table 3.2.
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M u t a n t
^cat
( s 1)
K m
(mM)
*cat/KM
(m V )
Wild type 7 .5 0  ± 0 . 1 2 .1 0  ± 0 . 0 8 3 .5 7  x 10J
N 80D 0.0 3  ± 0 . 0 0 2 1 .59  ± 0 . 2 0 1 .84  x 1 0 1
N 80A 2.28 3 8 .6 2 5 .9 0  x 1 0 1
0 .17 0 .39 4 .2 6  x 102
H 156Q 0.5 7  ± 0 . 0 1 5 .0 3  ± 0 . 3 4 1 .14  x 10 2
H 156A 1.51 3 4 .2 8 4.41 x 1 0 1
0 .19 1.62 1 .16  x 102
H 195Q 0.9 9  ± 0 . 0 4 4 .0 3  ± 0 . 6 1 2 .4 5  x 102
H 195N 3 .5 7  ±  0 .0 0 8 3 .0 4  ±  0 .2 6 1 .18  x 103
H195A 1.72 ± 0 . 0 5 6 .7 5  ± 0 . 5 3 2 .5 5  x 102
D8N 0.01 ± 0 . 0 0 0 4 1 .85  ± 0 . 3 7 7 .7 3  x 10u
D8A 0 .0 0 2  ±  0 .0 0 0 0 5 1 .78  ± 0 . 2 2 1 .13  x 10U
H10A 5 .3 5  ± 0 . 0 3 2 .5 8  ± 0 . 6 0 2 .0 8  x 103
D 50N 5 2 .4 5  ± 1 . 3 6 .7 0  ± 0 . 4 5 7 .6 0  x 103
D 50A 4 .8 3  ± 0 . 1 4 10 .0 3  ± 0 . 6 8 4.81 x 102
H81Q 0.9 2  ± 0 . 0 1 0 .9 6  ± 0 . 0 6 9 .6 0  x 102
H81A 4 .8 3  ± 0 . 1 4 3 .3 9  ± 0 . 4 4 2 .1 7  x 102
Table 3.2: Kinetic parameters of GpdQ active site mutants.
The enzymes were assayed under the conditions of 50 mM CHES pH 9.0, 0.5 mM 
MnCl2. 0.1 mg/mL bovine serum albumin (BSA) at 20QC.
The kinetic data on Table 3.2 shows in addition to the N80D mutant, the 
two D8 mutants and the D50N mutant, most mutagenesis of the active site 
residues reduced the activity of the GpdQ enzyme but did not completely 
abolish it. D50N was the only active site mutant whose kcat was enhanced by 
mutagenesis by more than three-fold. As for the Km values, some mutations 
improved substrate affinity while others reduced it.
Two mutants, namely N80A and H156A, exhibited activities that deviated 
from Michaelis-Menten kinetics. The kinetic data of these two mutants was 
treated differently to derive two sets of apparent values for kCM and Km. 
Results and discussions on N80A and H156A are also presented separately 
from the other ß-metal ligand mutants in section 3.3.4.
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3.3 MUTATIONAL ANALYSIS OF ß-METAL LIGANDS 
3.3.1 N80D
As pointed out in Chapter 1, the loose metal binding affinity of the ß-site 
could be somewhat predicted through the ligand coordination geometries at 
the active site of GpdQ. The a-metal is coordinated by two histidines and an 
aspartate. Its ß-counterpart also has two histidines but the third ligand is a 
polar but uncharged asparagine, which is N80. Therefore, N80D and N80A 
were the first active site mutants constructed in this project.
N80 was mutated to an aspartate with the objective of increasing the metal 
binding affinity at the ß-site. This mutation caused GpdQ to lose its 
phosphodiesterase activity, with a 250-fold drop in the catalytic turnover 
(Table 3.2). Another research group working on the structurally related 
mammalian protein phosphatase 1 (PP-1) made a similar mutation (N124D) 
and that resulted in a 12.5-fold loss in catalytic activity (£cat) [6]. Although 
N80D increased the substrate affinity (by reducing K^) in GpdQ, an 
increase in KM was observed in N124D of PP-1. The slight improvement in 
Km in N80D could be explained by the notion that the ß-metal is associated 
with the substrate molecule. If the product also leaves together with ß-metal, 
this would justify the need for the metal binding at this site to be flexible.
N80A was catalytically active but deviated from Michaelis-Menten kinetics. 
This behaviour was different to the equivalent N97A mutant of the Rv0805 
3’,5’-cyclic nucleotide phosphodiesterase from Mycobacterium tuberculosis 
that was found to retain ~1% of the wild-type activity with b/?NPP [2].
The biphasic kinetics of N80A is discussed in section 3.3.4.
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3.3.2 H156Q, H195Q, H195N and H195A
3.3.2.1 H156Q
HI 56 is one of the two histidine residues that coordinate the ß-metal. When 
H I56 was mutated to a glutamine, the catalytic turnover was more than 10 
times lower than that of the wild type, while the Km suffered from a 2.4-fold 
increase (Table 3.2). As glutamine is a polar residue it should still be able to 
coordinate the ß-metal. However, glutamine is a neutral residue as opposed 
to histidine, a basic residue. Such a difference might have resulted in 
detrimental changes to the active site conformation.
H I56 was also mutated to an alanine. As H156A displayed biphasic 
kinetics, it will be discussed together with N80A in section 3.3.4.
3.3.2.2 H195 -  H195Q, H195N and H195A
HI95 is the second of the two histidine residues coordinating the ß-metal. 
HI95 was mutated to a glutamine (H195Q), asparagine (H195N) and 
alanine (HI95A). Results of kinetic assays performed under conditions 
previously described for H I56 mutants are given below in Table 3.2.
The kinetic results of H156Q, H195Q, H195N and H I95A mutants can be 
explained if we assume that they decreased in the metal binding affinity at 
ß-site in the mutants that led to a decrease in the catalytic rate (kcat) and an 
increase in /Cm relative to the wild type.
Shenoy et al. produced a H207A mutant of the Rv0805 protein that is 
homologous and has a similar effect to GpdQ’s H I95A. H207A also 
suffered from drastic reductions in both the catalytic rate and the substrate 
affinity [2].
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3.3.3 Magnetic circular dichroism (MCD) studies on N80 mutants
Magnetic circular dichroism (MCD) experiments were performed on the 
wild-type GpdQ and two N80 mutants (N80D and N80A) by collaborators 
at the University of Queensland. These experiments were carried out with 
the purpose of characterising the a- and ß-metal binding sites of GpdQ. 
With the wild-type GpdQ, the addition of two equivalents of Co2' to the 
apoenzyme gave rise to a fully occupied a-site while to populate the ß-site, 
an additional 48 equivalents of Co2' were added.
Up to 100 equivalents of Co were added gradually to N80A apoenzyme. 
The a-site was fully occupied with the metal ions but not the ß-site. 
However, it was interesting to find that after the addition of 10 equivalents 
of inorganic phosphate Pi, the formation of a binuclear active site was 
observed. This observation was in agreement with the kinetic data in Table 
3.6, where the presence of Pj appeared to promote metal binding at the ß- 
site.
In contrast, a fully occupied binuclear metal center was formed in N80D 
after the addition of only two equivalents of Co2' to the apoenzyme, in the 
absence of phosphate. This indicated an increased binding affinity for this 
mutant, particularly for the metal ion in the ß-site [7].
3.3.4 N80A and H156A -  Biphasic kinetics and negative cooperativity
It was found that N80A and H156A displayed biphasic, non-Michaelis- 
Menten kinetics, which is characterised by continuously increasing velocity 
(v) at high substrate concentrations [S], as shown in Figure 3.2 below.
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Figure 3.2: Michaelis-Menten plots of wild-type GpdQ, N80A and H156A.
The enzymes were assayed with bpNPP in 50 mM CHES (pH 9.0), 0.5 mM MnCh, 
0.1 mg/mL BSA at209C.
3.3.4.1 Obtaining apparent values of kinetic parameters ( K y i  and Vmax) 
using the Eadie-Hofstee curve
Biphasic kinetics can be indicative of allostery (negative cooperativity) 
and/or a low-affinity second substrate site [8]. A more conventional way to 
depict biphasic kinetics is through the Eadie-Holstee derivative of the 
Michaelis-Menten equation:
v = - K M (v/[S]) + Vmax (Equation 3.1)
The Eadie-Hofstee plot is a way of plotting kinetic data in order to yield a 
straight line for enzymatic reactions that obey Michaelis-Menten kinetics 
(eg. wild-type GpdQ in Figure 3.3). This is achieved by plotting velocity (v)
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on the y-axis versus velocity/substrate concentration (v/[S]) on the x-axis. 
The slope of the line is -  KM while the y-intercept is Vmax.
All three linear derivative plots of the Michaelis-Menten equation, ie. 
Lineweaver-Burk, Eadie-Hofstee and Hanes-Woolf, have their respective 
advantages and disadvantages. The Eadie-Hofstee plot is ideal in 
highlighting even slight deviations from the Michaelis-Menten kinetics [9, 
10].
Using the same sets of data to create the Michaelis-Menten plots in Figure 
3.2, the Eadie-Hofstee plots of bpNPP activities of the wild-type GpdQ, 
N80A and H156A are as shown below.
W titype
naoo,
▲ M136A
w tt type Eadb- 
Mctaoepbl
Figure 3.3: Eadie-Hofstee plots of wild-type GpdQ, N80A and H156A.
Apparent values of kinetic parameters of N80A and H I56A were 
extrapolated from the two straight segments of the Eadie-Hofstee plots in 
Figure 3.3 (straight lines fit to four or five points from both segments, as 
indicated by dotted lines on the N80A curve). This method to parameterise 
kcal and in biphasic enzymes was adopted from literature [11, 12].
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Two sets of values for kca{ and were derived as shown in Table 3.3 for 
N80A and H156A, respectively (also previously shown in Table 3.2). 
Assay conditions were 50 mM CHES pH 9.0, 0.5 mM MnCl2, 0.1 mg/mL 
BSA at 20°C. As these values were obtained using Microsoft Excel instead 
of KaleidaGraph, errors were not calculated.
E n z y m e A c t i v i t y A p p . *  kcat
(s-1)
A p p .  K m 
( m M )
A p p .  kc a t  /K m
(M'V)
N 8 0 A
H ig h  a c t iv i ty , lo w  a f f in ity
(A t h ig h  s u b s t r a t e  c o n c e n t r a t i o n s )
2 .2 8 3 8 .6 2 5 .9 0  x  1 0 1
L o w  a c tiv i ty ,  h ig h  a f f in ity
(A t lo w  s u b s t r a t e  c o n c e n t r a t i o n s )
0 .1 7 0 .3 9 4 .2 6 x  1 0 2
H 1 5 6 A
H ig h  a c t iv i ty ,  lo w  a ff in ity
(A t h ig h  s u b s t r a t e  c o n c e n t r a t i o n s )
1 .5 1 3 4 .2 8 4 .4 1  x  1 0 1
L o w  a c tiv i ty ,  h ig h  a f f in ity
(A t lo w  s u b s t r a t e  c o n c e n t r a t i o n s )
0 .1 9 1 .6 2 1 .1 6  x  1 0 2
App. -  apparent
Table 3.3: Apparent values of Acat, Am and W /C m of N80A and 
H156A.
There have been many other kinetic models that analyse biphasic kinetics 
that rely on computer simulations to parameterise several other kinetic 
constants apart from the basic A:cat and Km [8, 11, 13].
3.3.4.2 Assessing negative cooperativity in N80A and H156A using the 
Hill equation
Biphasic kinetics quite often is diagnostic of negative cooperativity, that is, 
in the case of homotropic allostery, the binding of the first ligand molecule 
makes it more difficult for the second one to bind [14].
The Michaelis-Menten equation describes the kinetics of a simple enzyme 
system that shows no cooperativity. However in reality many enzymes 
exhibit cooperativity and deviate from Michaelis-Menten kinetics. 
Cooperativity in proteins and enzymes can be defined as interactions 
between subunits or subsites where the binding of the first ligand molecule
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increases (positive cooperativity) or decreases (negative cooperativity) the 
binding affinity of the other(s) [8]. An equation describing cooperative 
binding of ligands to macromolecules was proposed by Hill in 1910, based 
on his observation of the oxygen binding nature of haemoglobin [9, 15]:
y =  v ^ r s r
Kd + [S f (Equation 3.2)
where v is initial velocity; Vmax, maximum velocity; n, Hill coefficient; [S], 
substrate concentration and KA, dissociation constant. When n = 1, Equation 
3.2 is exactly the same as the Michaelis-Menten equation and Kd = KM-
A simplified, linearised Hill equation is given below:
log [v/(Vmax -  v)] = n log [S] + log KA (Equation 3.3)
Determining the Hill coefficient, n, is the easiest and most straightforward 
method of assessing the cooperativity of an enzyme. If n = 1, there is no 
cooperativity in the enzyme activity, n < 1 indicates negative cooperativity 
while n > 1 indicates positive cooperativity [9]. However, in practice, the 
Hill equation is more useful in showing positive cooperativity in enzymes. 
Proving negative cooperativity using the Hill equation can be a rather 
ambiguous process [16]. The Hill equation is more easily applied to ligand 
binding studies in receptors and cytochrome P450, where the binding 
capacity, which is equivalent to Vmax, is known [17-19]. In the case of N80A 
biphasic kinetic studies, the Hill constants were calculated from the region 
of the maximum slope, by using the apparent Vmax values in the high 
activity, low affinity component (Figure 3.4). This method in determining 
the Hill constant in negatively cooperative enzyme systems was proposed 
by Tipton [20, 21].
Figure 3.4 shows the Hill plots of wild-type GpdQ, N80A and H156A 
assayed with b/?NPP in 50 mM CHES pH 9.0, 0.5 mM MnCE, 0.1 mg/mL
126
CHAPTER THREE
BSA at 20°C. Table 3.4 shows the values of the Hill coefficient (n) from 
plots in Figure 3.4.
—e— Wild type + 0.5 mM Mn 
—a  - N80A + 0.5 mM Mn 
-  -H156A + 0.5 mM Mn
-oso
l&pNPP]
Figure 3.4: Hill plots of wild-type GpdQ N80A and H156A.
The enzymes were assayed with bpNPP in 50 mM CHES (pH 9.0), 0.5 mM MnCfe, 
0.1 mg/ml BSA at 20QC.
E n zy m e n R 1
W ild -ty p e  G p d Q 1.0 1.00
N 8 0 A 0 .6 0 .9 9
H 1 5 6 A 0 .6 1 .0 0
Table 3.4: Values of the Hill constant (n) of wild-type GpdQ, N80A and H156A 
as derived from the plots in Figure 3.4 and their corresponding correlation 
coefficient (R2) values.
The Hill constant values of N80A and H156A (both 0.6, ie. < 1.0) suggest 
that these two GpdQ enzymes are negatively cooperative.
A series of experiments was conducted to investigate the factors that might 
influence the negative cooperativity in N80A kinetics. The results and 
discussions of these experiments are found in Appendix F.
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3.4 MUTATIONAL ANALYSIS OF a-METAL LIGANDS
3.4.1 D 8-D 8N  and D8A
D8 is a primary ligand to the a-metal ion and is responsible for the high 
metal binding affinity at the a-site. Mutants D8N and D8A were made to 
explore how the reduced metal binding affinities at the a-site would affect 
the enzyme activity. Results of kinetic assays conducted at conditions as 
described before are presented in Table 3.2.
By weakening the metal binding affinity at the a-site, both D8N and D8A 
mutations inactivated the enzyme. The kcat values of D8N and D8A were 
1000 and more 3000-times lower than that of the wild type, respectively, as 
the interaction of the residues with the a-metal became increasingly weak.
The D8 mutations did not have an adverse effect on the substrate affinity 
thus strongly suggesting that the a-metal is involved in catalysis but 
not substrate binding or orientation. Another inference that could be made 
from the kinetic results in Table 3.11 is that a strong metal binding affinity 
at the a-site is essential for enzyme activity. The observed effects of D8A 
on GpdQ were similar to those of its equivalent mutant, D21A in Rv0805 
[29].
3.4.2 H10-H10A
H10 is one of the two histidine ligands to the a-metal; the other one being 
H I97. H10 was replaced by an alanine and the effects of the mutation were 
investigated through bpNPP assays (Table 3.2).
The H10A mutation did not cause any great reduction in GpdQ activity, 
which is surprising because it seems unlikely that an alanine would be 
capable of coordinating the a-metal. H10A was an intrinsically active
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enzyme. The slight decrease in kcat and the minor increase in KM are 
consistent with the observations found on H23A of Rv0805. Unlike the 
drastic effects the H156Q and H159Q/N/A mutations had on the ß-metal 
site, H10A probably reduced the binding affinity at the a-metal site, but 
only slightly as it was compensated for by the assay conditions that 
contained an excess of Mn~ \
3.5 MUTATIONAL ANALYSIS OF THE BRIDGING LIGAND, D50
The GpdQ active site has a p-bridging ligand, D50, where one oxygen atom 
from the carboxylic group coordinates both the a- and ß-metal. Together 
with the two metal ions, a water molecule that is coordinated equatorially, 
D50 is responsible for the octahedral coordination geometry of the binuclear 
metal center of GpdQ (Figures 1.13 and 3.1).
During purification, D50A was found to be mostly insoluble (Figure 3.5).
---------► ◄---------
■•- I l l i
Lane 1 2 3 4 5
Figure 3.5: SDS-PAGE gel showing D50A after lysis using the French press.
Lane 1 shows the marker; Lanes 2 and 3 show duplicates of the insoluble fraction of 
D50A; Lanes 4 and 5 are duplicates of the soluble fraction. The arrows indicate the 
position of the D50A protein bands.
Kinetic assays of D50N and D50A were performed with b/?NPP at a range 
of different concentrations at in 50 mM CHES pH 9.0, 0.5 mM MnCb, 0.1 
mg/mL bovine serum albumin (BSA) at 20°C. Kinetic results are 
summarised in Table 3.2.
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Weakened metal binding affinities in D50N and D50A mutants resulted in a 
progressive increase in Km values. This again supports the hypothesis that 
the ß-metal is associated with the substrate. With N50 and A50 having 
weaker binding affinities to the ß-metal, the substrate affinities were also 
subsequently reduced.
With regard to the catalytic turnover, kcat, D50N exhibited a 7-fold increase 
whereas D50A suffered from a dramatic decrease. If the substrate molecule 
is associated with the ß-metal, the improved kcat in D50N was likely due to 
the fact that the asparagine substitution facilitated the easy departure of ß- 
metal and hydrolysis products from the active site. However, the polarity of 
the residue at this site had to be maintained for the enzyme to be 
catalytically active, as proven by the D50N mutant.
3.6 MUTAGENESIS OF H81, THE CONSERVED HISTIDINE
3.6.1 Introduction and background
The large and functionally diverse superfamily of calcineurin-like dimetallo- 
phosphoesterases contains a conserved histidine within the GNHD/E 
sequence motif. In GpdQ, this histidine is H81 [22].
The conserved histidine is always within 5 Ä of the binuclear metal center 
although it does not directly coordinate either of the metal ions [23]. The 
backbone of this residue is stabilised via an extensive hydrogen-bonding 
network, including a hydrogen bond to the backbone carbonyl of the 
adjacent asparagine residue (N80A in GpdQ), which is a ß-metal ligand [24] 
(Figure 3.6).
The nitrogen atoms of the imidazole group of H81 are hydrogen bonded to 
the backbone carboxyl of N53 and the amide group of N80 respectively. 
N53, on the other hand, interacts with H10, an a-metal ligand as well as
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S268 of another chain (not shown in Figure 3.10). Additionally, the 
backbone carboxyl of H81 is hydrogen bonded to G55.
Figure 3.6: The extensive hydrogen-bonding network of H81.
The carbon chains of non-metal ligand residues are coloured in green while those 
belonging to metal ligand residues are in white.
Research groups working on different enzymes that contain the conserved 
histidine have extensively studied the residue. Proposed roles for this 
conserved histidine include the following:
i. Substrate binding and orientation.
ii. Activation of nucleophile that attacks the phosphodiester bond 
of substrates.
iii. General acid catalysis involving the protonation of the leaving 
group. The protonation of the leaving group of poor substrates 
in the transition state is vital for physiologically relevant 
substrates that typically have high pKa values [23].
iv. General base catalysis by deprotonation of an iron-coordinated 
solvent molecule [24].
Results from mutagenesis studies of the conserved histidine have not been 
consistent and conclusive enough to conclusively distinguish the correct 
hypothesis. Table 3.5 summarises the kinetic findings on the conserved
T !
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histidine residues o f related metallophosphatases over the last two decades 
by four research groups.
Research Enzyme and ^cat K m Conclusions
Group mutants
Zhuo X p ro te in H76 con tribu tes  to
e t al. [25] phospha tase 105 low er N ot a ffected  in the m eta l b ind ing and
H76N a b sence  o f M n2* cata lysis.
bu t 40 tim es h igher
w hen  the  m etal
w as  added
Funho ff P urp le  acid H92 is invo lved in
e t al. [24] phospha tase position ing  e ithe r
H92N 3 tim es h igher 5 tim es h igher the  nucleoph ile  o r
at the  op tim a l pH the substra te ,
va lue ra the r than d irec tly
in acid  or base
H 92A 10 tim e s low er at 9 tim es h igher ca ta lysis.
the  op tim a l pH
va lue
M ertz C a lc ineurin H151 and H76 are
e t al. [23] H 151Q no t required fo r
pN P P  hydro lys is 460-fo ld  low er 10 tim es low er p ro tonation  o f the
[P]-Rn hydro lysis 1300-fo ld  low er S im ila r leav ing  group. Loss 
o f activ ity  is
X p ro te in a ttribu ted  to  the
ph ospha tase pertu rba tion  o f the
H76N ligand env ironm ent,
p N P P  hydro lys is 590-fo ld  low er S im ila r poss ib ly  by
P henyl phospha te 530-fo ld  low er S im ila r d is rup tion  o f a
hydro lys is hydrogen bond
betw een the
his tid ine  and a
m e ta l-coo rd ina ted
solvent.
H off X p ro te in S ubstra te  b ind ing
e t al. [26] ph ospha tase is ass is ted w hen
H76N Lower, d iffe rence H ighe r at low  pH H 76 is p ro tonated.
is m ore s ign ifica n t va lue s  bu t not
in h igher pH affected  at h igh pH
va lues. va lues.
Table 3.5: Kinetic findings from mutagenesis studies of the conserved 
histidine residues in various structurally related dimetallophosphatases.
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3.6.2 Results
H81Q and H81A mutants of GpdQ were made. The purified enzymes were 
assayed at pH 9.0 and pH 6.0. Assay results are summarised in Tables 3.6 
and 3.7.
E n zy m e / f e a t
( s ’1)
R e la tiv e
/ f e a t
K m
(mM)
R e la tiv e
Km
f c c a t /  K m
(M V )
R e la tiv e
/ f e a t  /
Wild type 7.50  ± 0 .1 1.00 2 .10  ± 0 .0 8 1.00 3 .57  x 10J 1.00
H 81Q 0.92 ± 0 .0 1 0.12 0 .96  ± 0 .0 6 0 .46 9 .60  x 102 0 .27
H81A 4 .83  ± 0 .1 4 0 .64 3 .39  ± 0 .4 4 1.61 2 .17  x 10z 0 .06
Table 3.6: Results of kinetic assays of H81 mutants at pH 9.0.
E n zy m e f r e a t
( s 1)
R e la tiv e
* c a t
K m
(mM)
R e la tiv e
Km
* c a , / K M
(m V )
R e la tiv e  
f r e a t  / K m
Wild type 0 .08  ± 0 .003 1.00 0.51 ± 0 .1 1 1.00 1 .5 3 x 10" 1.00
H 81Q 0 .03  ± 0 .0004 0 .38 0 .64  ± 0 .0 7 1.25 4 .8 4 x 1 0 1 0 .32
H81A 0 .03  ± 0 .0 1 0.38 2.31 ± 0 .4 1 4 .53 1.45  x 101 0 .09
Table 3.7: Results of kinetic assays of H81 mutants at pH 6.0.
3.6.3 Discussion
The uniform reduction in catalytic activity ( k ca{)  in both H81Q and H81A 
mutants, at both pH 9.0 and pH 6.0, strongly demonstrated that this histidine 
residue might play a role in the catalytic mechanism of GpdQ.
At high pH values (pH 9.0), H81 was unprotonated, hence making 
protonation of any leaving group impossible. H81 was therefore not 
involved in general acid catalysis at alkaline pH.
However, at pH 9.0, an unprotonated H81 could possibly participate in 
general basic catalysis and activate the nucleophile. This proposition
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generates support from the poor catalytic activities of both H81Q and 
H81 A.
H81 mutations had a similar effect on GpdQ’s phosphodiesterase activity at 
pH 6.0, although, like X protein phosphatase, the decrease was more 
profound at higher pH values. At pH 6.0, H81 was protonated and so its role 
in protonating the leaving group was possible. As the pKa of the p- 
nitrophenolate leaving group is 9.6, it seems unlikely that the hydrolysis of 
bpNPP would require protonation.
An alternative explanation for the loss of activities in the mutants was that 
in the absence of H81, the active site environment had been disrupted. This 
is a reasonable argument considering how H81 is involved in an extensive 
hydrogen bonding network, including an interaction with N80.
At pH 9.0, H81Q exhibited an enhanced affinity for bpnpp while H81A 
experienced otherwise. At pH 6.0, the KM of H81Q was similar to the wild- 
type while H81A’s increased more significantly than at pH 9.0. Comparing 
the two values of the wild-type enzyme at pH 9.0 and pH 6.0, it could be 
inferred that substrate binding was assisted when H81 was protonated (low 
Km at pH 6.0). This may explain why the Km value of H81Q was not 
affected at pH 6.0, as a glutamine was capable of interacting with the 
substrate due to the polarity of its side chain.
The improved Km of H81Q has parallels. A H151Q mutant of calcineurin 
experienced a 10-fold drop in Km when assayed with pnpp. Mutation of 
histidine to a glutamine resulted in an increase in the magnitude of the 
negative charge. This may present a more conducive environment at the 
active site for the formation of a complete binuclear metal center [23].
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3.6.4 Conclusions on H81
Extensive mutational analysis has been perfonned on the conserved 
histidine in the GNHD/E sequence motif of the ct/ß sandwich superfamily of 
dimetallo-phosphohydrolases. Experimental results from these mutagenesis 
studies are conflicting (Table 3.5). Therefore though this histidine residue is 
conserved across all the members of this family of enzymes, it may play 
different roles in different enzymes.
Based on the kinetic assays done in this study, the following conclusions are 
made on GpdQ’s H81:
i. H81 has a catalytic role in GpdQ:
■ Whether or not the protonated H81 is involved in general 
acid catalysis cannot be ascertained with substrate b/?npp as it 
has a good leaving group.
■ The unprotonated H81 could possibly act as a general base to 
activate the nucleophile.
■ Loss of activity in both H81Q and H81A is attributed to the 
perturbation of the binuclear metal center environment, 
possibly by disruption of a hydrogen bond between H81 with 
the carbonyl oxygen of N80 backbone. Thus, H81 also has a 
structural function in stabilising the folded structure of the 
active site.
ii. H81 contributes to substrate binding, especially when it is 
protonated at low pH values.
iii. H81 may also assist in metal binding.
3.7 CONCLUSIONS
The catalytic mechanism of GpdQ remains unclear. The catalytic 
mechanisms of other structurally related enzymes such as purple acid 
phosphatases, Ser/Thr protein phosphatases, 3’,5’-exonucleases and 5’-
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nucleotidases have been more or less established [27]. The metal ligands of 
all these enzymes, including GpdQ, are conserved with only slight 
variations of one or two residues. However, though structurally similar, 
these enzymes catalyse the hydrolysis of different substrates that are mainly 
diesters and monoesters of phosphoric acid, including ribo- and 
deoxyribonucleoside 5’-monophosphates [28].
At the end of this study, two questions surrounding the catalytic mechanism 
of GpdQ remain unaddressed: how the catalytic water molecule or the 
nucleophile is activated and whether the substrate is bound in a monodentate 
or bidentate mode. The biggest success to have come out from the 
mechanistic studies in this research project is the characterisation of the 
binuclear metal center with primary focus on the two non-identical metal 
binding sites.
Non-identical binuclear active site and implications on the catalytic 
mechanism
Anomalous scattering analysis [1] and magnetic circular dichroism (MCD) 
experiments [7] have both unequivocally confirmed the difference in metal 
binding affinities between the two a- and ß-sites.
The high metal binding affinity at the a-site is largely attributed to the acid 
ligand, D8. Decreasing and abolishing altogether the ability of this residue 
to coordinate the a-metal via mutants D8N and D8A respectively caused 
significant drops in kcat. The mutations did not affect the Km adversely. The 
inference drawn from these kinetic results is that the a-metal plays a pivotal 
role in catalysis.
The ligand responsible for the low metal binding affinity at the ß-site is 
N80. Enhancing the binding affinity by converting the asparagine to its acid 
resulted in an inactive GpdQ mutant enzyme. N80A, on the other hand was
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catalytically active. This demonstrated the importance of flexibility in metal 
binding at the ß-site.
Results from the kinetic assays of N80D and N80A mutants suggested that 
the ß-metal is associated with the substrate molecule. Initially, especially 
with the improved Km in N80D, it was tempting to believe that the ß-metal 
was responsible for substrate binding. However, EPR and stopped-flow 
fluorescence experiments later showed otherwise, that the binding of the ß- 
metal was promoted by the substrate [29].
Biphasic kinetics and negative cooperativity
The dual phenomena of biphasic kinetics and negative cooperativity were 
observed in mutants N80A and H156A. Negative cooperativity makes a 
protein or enzyme less sensitive in response to the changes in ligand or 
substrate concentrations but enables the protein to work at a broader range 
of concentrations [14]. The nature of the biphasic kinetics/negative 
cooperativity in N80A was investigated further in Appendix F to establish 
factors that influenced the kinetic behaviour.
The non-Michaelis-Menten kinetics was prevalent only when then enzyme 
was assayed with b/?NPP. It also appeared to be a function of metal binding, 
as the biphasic behaviour was not observed when N80A was assayed in the 
absence of exogenously added metal ions. The concentration and the type of 
metal ions as well as the oligomeric state of the enzyme did not affect 
greatly the extent of negative cooperativity in N80A, as indicated by the 
values of the Hill constant in Tables F.l and F.3 in Appendix F.
Mutational analysis o f histidine ligands
Mutating the histidine residues that coordinate the a- and ß-metals, namely 
H10, H I56 and HI95, all led to reductions in enzyme activity, thus 
underlining the importance of histidines as ligands in metalloenzymes.
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Activation o f the nucleophile
As two forms of phosphodiesterase activity have been characterised with pH 
activity analyses [9, 33], it is highly possible for GpdQ to employ two 
different catalytic mechanisms at alkali and acidic pH values. The role of ß- 
metal in substrate binding probably remains the same, but the nucleophilic 
activation, catalysis and substrate coordination roles played by the oc-metal 
and H81 are flexible, subject to factors like pH and the pKa of the leaving 
group of hydrolysis products.
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CHAPTER FOUR: DIRECTED EVOLUTION OF GpdQ -
SCREENING METHODS AND PART ONE
4.1 INTRODUCTION
Organophosphate triesters that are commonly used as pesticides and 
chemical warfare agents pose serious risks upon the environment and 
human health. Much research has been dedicated to the development of 
efficient and safe strategies to detoxify organophosphate triesters that have 
been dispersed into the ecosystem.
One of the objectives of this project, initially, was to further develop Dr Yu- 
McLoughlin’s growth-based assay as a preliminary screening method for 
the directed evolution of GpdQ with methyl paraoxon, ethyl paraoxon, 
dimethyl phosphate and diethyl phosphate. Improved activity with any of 
these substrates would potentially lead to bioremediation applications [1-3].
The growth assay and top agar overlay agar plate-based methods of in vivo 
screening of GpdQ mutant libraries were pursued for 2-3 months with little 
success. Details of how and why these experiments failed are reported in 
section 4.2. The objective was then changed to evolving GpdQ's bis (p- 
nitrophenyl) phosphate (bpNPP) hydrolytic activity. An in vitro method was 
employed to screen the libraries for improved variants. At the end of this 
project, eight full rounds of directed evolution of GpdQ with bpNPP were 
completed.
4.2 IN VIVO AGAR PLATE-BASED SCREENING OF GpdQ 
MUTANT LIBRARIES
One very interesting feature of GpdQ is the unusually broad substrate 
specificity of the enzyme. The hydrolase has primarily diesterase activity, 
but since its first discovery, purification and characterisation more than
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three decades ago, there have been reports of weak activities with 
monoesters of phosphoric acid [4-6]. Since the revival of research interest in 
the enzyme in recent years, GpdQ has been characterised more thoroughly. 
It was found that this highly promiscuous phosphohydrolase extends its 
specificity spectrum wide enough to even include organophosphate triesters 
[7, 8]. Table 4.1 shows the kinetic parameters for the hydrolysis of 
organophosphate triesters, diesters and monoester used in this study, as 
published by Ghanem and colleagues [8]. The last column is the values of 
c^at/Km relative to that of the best substrate, bpNPP.
S u b s tr a te kcat
( s ' )
K m
(m M )
k cafJ K m
(m V )
R e la t iv e
^caJ K \\
(m V )
D
I
E
b is  (p -n itro p h e n y l)  
p h o sp h a te
6 .0  ± 0 . 2 0 .9  ± 0 .1 (6 .7  ± 0 .5 )  
x 103
l
s
T
D im e th y l p h o sp h a te (5 .0  ±  
0 .1 )  x 1 0 3
0 .0 6  ±  
0.01
82 ±  14 1.2 x 10 '2
R D ie th y l p h o sp h a te (7 .4  ±  
0 .5 )  x  10 '3
0 .5  ±  
0 .0 6
15 ±  1 2 .2  x 10 '3
T
R
I
M e th y l p a ra o x o n nd nd 13 ±  1 1.9 x 10 'J
E
S
T
E
R
E th y l p a ra o x o n nd nd <  1 N d
M
0
N
O
E
S
T
E
R
p -n i tro p h e n o l  p h o sp h a te nd nd 5 ±  1 7.5  x 10‘4
nd -  not determined
Table 4.1: Kinetic parameters of GpdQ-catalysed hydrolysis of various 
organophosphate compounds used in this project, as published by Ghanem et
at. [8].
4.2.1 McLoughlin’s growth assay method [7]
Using this method, GpdQ mutant libraries were screened for heightened 
DMP or DEP hydrolysis activity. Experimental procedures are described in 
Chapter 2 (2.4.2.1). The idea behind this strategy was that, the more
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efficiently a GpdQ mutant degraded the alkyl diester compounds, the bigger 
the size of its E. coli DH5a host colony, as it had a more abundant supply of 
inorganic phosphate (Figure 1.7) to stimulate growth. Other E. coli colonies 
bearing inferior GpdQ mutants would either grow very slowly or they might 
not survive at all due to the lack of a direct phosphorus source. In other 
words, the substrate for GpdQ was a source of nutrient for bacterial growth.
After two days of incubation at 37°C, no cell growth was observed on the 
modified MOPS minimal medium that was plated with GpdQ mutants. A set 
of control experiments was designed to investigate reasons behind this 
negative observation. The E. coli DHlOß cells carrying the recombinant E. 
aerogenes ugp operon were prepared by Dr Sean Yu-McLoughlin in 2003 
and stored at -80°C.
Strain
P h o sp h o r u s  s o u r c e  (all at th e  co n cen tra tio n  o f  1 mM)
N o n e  DM P D E P  K2H P 0 4
D H 5 a
(G pdQ *)
- " “ + +
D H 10ß
(ugp*)
+ + + +
- denotes no growth, + colonies of < 1 mM in diametet after 2 days, ++ colonies of > 1 mM after 2 days
Table 4.2: Results of the growth assays of E. coli strains phosphate-free 
MOPS minimal medium each supplemented with a different source of 
inorganic phosphate.
Discussion
Ghanem and colleagues successfully grew E. coli expressing GpdQ in liquid 
MOPS phosphate-free medium supplemented various organophosphate 
diesters and methyl phosphonate monoesters as an only source of inorganic 
phosphate. Based on their experiments, the agar-plate based growth assays 
in this study were expected to work.
There are three main reasons which may explain why in this study, DH5a 
E. coli that expressed recombinant GpdQ failed to grow on DMP or DEP as 
their sole phosphorus source:
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1. The complete putative ugp operon was vital for cell survival and 
growth
The results summarised in Table 4.2 illustrate the inability of DH5a E. 
coli to utilise simple alkyl diesters like DMP and DEP as the sole source 
of phosphorus. On the other hand, these diesters supported the growth of 
DHlOß cells, thus highlighting the importance of having the complete, 
functional putative E. aerogenes ugp operon for the survival of cells. As 
reported in section 1.3.2 in Chapter 1, the operon contains four other 
open reading frames that would presumably express permeases and 
transporter proteins, thus facilitating the uptake of diesters into the 
cytoplasm. McLoughlin et al. had previously shown that native DHlOß 
cells were unable to survive on DMP plates, which suggests that E. coli 
does not express a phosphodiesterase capable of hydrolysing DMP 
under phosphate-limiting conditions [7]. Finally, transformed DH5a and 
DHlOß cells grew equally well on plates fortified with a phosphate salt 
as a direct source of phosphate. This implied there was no apparent 
difference in growth rate between the two E. coli strains.
2. Difference in media used (solid/liquid forms)
Lower recoveries of stress-induced cells in agar media compared to 
liquid media have been reported in literature [9]. Reasons for poor 
recoveries include impurities found in the agar, cell density effect and 
limited diffusion of nutrients into the cells [10-13]. This might explain 
why in this study, E. coli cells expressing GpdQ could not survive on 
solid minimal media supplied with DMP or DEP as the sole phosphorus 
source. Ghanem et al., using liquid media, obtained bacterial growth 
with similar experiments [8].
3. Different properties o f E. coli strains (protein expression level and 
growth rate)
The BL21 (DE3) cells used by Ghanem et al. had a recombinant protein 
expression system that was superior to their DH5a counterpart, due to
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the presence of the T7 promoter. BL21 (DE3) cells also exhibit a higher 
growth rate.
McLoughlin’s growth assay is a high-throughput method for screening 
GpdQ mutant libraries. Especially for the first round of screening, a quick 
and least laborious process that enables a library of 106 variants to be 
screened is ideal. This elegant screening method associates GpdQ’s 
phosphodiesterase activity with a phenotype that is easily recognisable - the 
size of the E. coli host colony. It is also extremely useful when the enzyme 
is evolved for higher catalytic activity with non-chromogenic substrates like 
DMP and DEP.
However, the workability of this method was complicated by the fact that 
GpdQ was originally part of an operon functioning unit that encodes other 
proteins to regulate the system. Discovery of improved mutants may be 
compromised when the recombinant gpdQ gene has been segregated from 
its sister genes in the putative E. aerogenes ugp operon, and the support of 
their encoded proteins.
The cells were not grown on the screening minimal medium for more than 
48 hours as long incubation periods (at 37°C) might deplete the ampicillin 
selectivity of the medium and cause an increased background of satellite 
colonies.
4.2.2 Cho’s top agar method
This screening technique, applicable only to chromogenic substrates, was 
tried with paraoxon only [14]. In our experiment, MPO was used as GpdQ 
reportedly displayed a preference for methyl-substituted triesters [8]. A 
mutant’s potency in degrading MPO was associated with the intensity the 
yellow halo (formation rate of /?-nitrophenol hydrolysis product) 
surrounding its colony. There was no apparent formation of yellow colour
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around the cell colonies after they had been subject to 5 hours of incubation 
at 37°C with the MPO-containing agarose top solid layer.
Another positive control experiment was set up where DH5a cells were 
transformed with recombinant opdA (courtesy of Dr Jee-Loon Foo) which 
expresses the eponymous phosphotriesterase. Cells that grew overnight on 
M9 minimal medium with ampicillin selection were then layered with the 
agarose solution containing 1 mM MPO. Faint yellow halos formed around 
the cell colonies after 1 hour of 37°C incubation.
The positive control experiments suggested that GpdQ’s poor 
phosphotriesterase activity was the reason behind the failure of the MPO 
screen. The success of the screen was further inhibited by the cell membrane 
barrier which limited the diffusion of organophosphate esters into the 
cytoplasm.
Discussion
The top agar overlay facilitated screening faced a major dilemma: When 
GpdQ was evolved with a slow substrate, it was preferable to have the 
enzyme expressed on the surface of E. coli, like Cho and co-workers did 
while evolving the activity of organophosphate hydrolase with methyl 
parathion [14]. Otherwise, the poor catalytic activity of the enzyme and 
limited accessibility of the subtrate into the cell would both hinder the 
success of the screen. A longer waiting time, for example overnight, was not 
recommended due to the high level of toxicity of organophosphate triesters.
Conclusions on in vivo agar plate-based screening
The biggest challenge faced by most directed evolution projects is the 
availability of a suitable, high-throughput screening/selection system for the 
enzyme of interest.
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Once established and optimised successfully, agar plate-based screens are 
cost and time effective. They also require minimal and simple equipment to 
operate. Above all, they enable huge libraries to be evaluated in each round 
of evolution [15]. However, both the methods tried in this study inflict 
cellular stress (phosphate starvation, incubation with toxic compounds) that 
might have sabotaged E. coli survival.
4.3 IN VITRO RANDOM SCREENING OF GpdQ MUTANT 
LIBRARIES
bis (p-nitrophenyl) phosphate (bpNPP) is a model phosphodiester substrate 
extensively used for the characterisation of phosphodiesterase activities in 
enzymes like nucleases, cyclic nucleotide phosphodiesterases (PDEs) and 
glycerophosphodiesterases (GPDs) as well as micelles [16-18]. The 
popularity of the substrate is attributed to its relatively convenient assay 
where the release of p-nitrophenol from catalysis can be monitored directly 
via spectrophotometry. The phosphodiester bond in bpNPP can also be 
broken down easily as the p-nitrophenol leaving group has a low pKa value.
b/?NPP is the fastest among the characterised non-physiological substrates 
of GpdQ [8], During the earlier rounds (rounds 1-4), GpdQ was evolved 
towards two different directions, simultaneously but separately with b/?NPP: 
higher substrate affinity (low Km) and higher catalytic activity (high kcat). 
Results and discussion will be presented in 4.5. Directed evolution from 
round 5 onwards, where different strategies had been applied will be 
discussed in section 4.6.
All techniques used in the in vitro random screening of GpdQ genetic 
libraries are explained in Chapter 2 (section 2.4.2.2).
In random screening, each variant of the library is subject to examination for 
a particular desired characteristic, which in the case of this project, is
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enhanced activity with b/?NPP. Individual clones are picked from an agar 
plate, either manually or robotically, to inoculate growth medium in a 96- 
well culture plate. Clearly, inoculation is a tedious process that drastically 
reduces the size of the libraries to be screened [15]. Therefore, the library to 
be screened was diluted with the growth medium instead before it was 
dispensed into the wells at a mean nascent concentration of ~2 cells per 
well. The size of the screened libraries in each round was maintained at 
approximately 10,000.
This ‘diluted library’ random preliminary screening method offered a direct 
and less ambiguous phenotype observation. The in vivo agar plate-based 
assay screening techniques described in 4.3 depend solely on visual 
judgements of colony size or formation of yellow colour around a colony to 
determine the catalytic rate of a variant, whereas in the random screening 
described hereby, catalytic activities were measured directly using UV 
spectrophotometry.
However, just like the in vivo screenings, there were several confounding 
factors including: cell density, protein expression level and solubility. A 
very good mutant’s improvement might be hidden by its low cell density or 
poor protein expression.
4.4 DIRECTED EVOLUTION OF GpdQ (ROUNDS 1-4)
4.4.1 High affinity evolution
Under the assay conditions of 50 mM CHES pH 9.0, 0.1 mM MnCb, the 
native GpdQ was reported to have a Km of 0.9 mM [19]. In this study, under 
the similar assay conditions, except where the concentration of MnCl2 was 5 
times higher at 0.5 mM, the Km value was about 2.0 mM. To evolve GpdQ 
towards higher substrate affinity, the libraries were subject to kinetic assay 
screenings with decreasing amounts of bpNPP (1.0, 0.5 and 0.25 mM) each
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successive round in the first three rounds, respectively to increase selection 
pressure. After each round of screening, the 10 mutants displaying the 
highest bpNPP activities (at substrate concentrations that were below Km) 
were selected for StEP recombination to generate the library for the next 
round of evolution. After the third round of evolution, selected mutants were 
sequenced. Table 4.3 summarises the 20 best mutants obtained after three 
rounds of high affinity evolution and their genotypes.
G enotype N um ber o f m utants  
w ith  sam e g eno typ e
P ercen tag e  o f m utants  
w ith  sam e g eno typ e  (% )
C54G 3 15
C54G, H217R 1 5
C54G, Y221H 2 10
C54G, G259R 4 20
C54G, H217R, G259R 3 15
C54G, Y221H, G259R 7 35
Table 4.3: The 20 fittest mutants showing highest activities when assayed with 
0.25 mM bpNPP during the third round of directed evolution.
Based on the sequencing results of the 20 best mutants listed in Table 4.3, 
the high affinity evolution of GpdQ appeared to have reached convergence 
with four repetitive mutations (C54G, H217R, Y221H and G259R) after 
only three rounds of genetic recombination. Convergence could be due to: 
(i) pressure from natural selection; (ii) fixation by random genetic or allele 
drift, (iii) It could be simply due to limitations of the PCR protocols (epPCR 
and StEP-A) used to generate the libraries, or (iv) a combination of these 
events. It was noteworthy that two of the iterative mutations, H217R and 
Y221H, did not occur together in any of the 20 selected variants. These 
mutations are close in sequence and their exclusiveness may arise from 
limitations of the StEP-A protocol.
Six GpdQ enzymes, representing each of the six different genotypes in 
Table 4.4, were expressed, purified to near homogeneity and characterised 
for bpNPP hydrolysis activity. The purification method used for these six
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enzymes and all other enzymes characterised in this chapter was Protocol B, 
as described in section 2.6.2 o f Chapter 2. Assay conditions were 50 mM 
CHES pH 9.0, 0.5 mM MnCE, 0.1 mg/mL bovine serum albumin (BSA) 
and at 20°C (section 2.7, Chapter 2).
E nzym e /feat
( s ' 1)
R elative
/feat
K m
(m M )
R ela tive
K m
/fe a t/K m
( m V )
R ela tive
/ f c a . /K M
W ild  type 7.50 ± 0 .1 1.00 2.10 ± 0 .0 8 1.00 3.57 x 10" 1.00
3-4
(C 54G )
13.74 ± 0 .2 1.83 0.43 ± 0.04 0.20 3.21 x 10" 8 .99
3-3
(C 54G ,
H 217R )
15.70 ± 1.8 2.09 0 .23  ± 0 .0 2 0.11 6 .78  x 10" 18.99
3-16
(C 54G , Y 221 H )
7.01 ± 0 .1 0.93 0 .29  ± 0 .0 2 0.14 2 .42  x 10" 6 .78
3-5
(C 54G ,
G 259R )
11.82 ± 1.9 1.58 0 .29  ± 0 .0 3 0.14 4 .06  x 10" 11.37
3-10
(C 54G , H 217R , 
G 259R )
9.46 ± 0.2 1.26 0.37 ± 0 .0 4 0.18 2.52 x 10" 7.06
3-25*
(C 54G , Y 221H , 
G 259R )
91 .45 ± 1 .1 12.19 0.21 ± 0 .0 2 0.10 4 .2 6  x 105 119.33
* Hcxamcr-dimcr equilibrium
Table 4.4: Kinetic parameters of the best variants acquired after the first three 
rounds of high affinity evolution of GpdQ with substrate bpNPP.
These six variants were essentially different combinations of the four repetitive 
mutations -  C54G, H217R, Y221H and G259R.
E nzym e /feat
(s’1)
R elative
/feat
K m
(m M )
R elative
K m
/ fe a t/K m
( M * V )
R ela tive
/fe a t/ K m
W ild  type 7.50 ± 0 .1 1.00 2.10 ± 0 .0 8 1.00 3.57 x 10J 1.00
C 54G 13.74 ± 0 .2 1.83 0.43 ± 0.04 0.20 3.21 x 10" 8.99
H 217R 9.68 ± 0.2 1.29 0.71 ± 0 .0 7 0.34 1.36 x 10" 3.81
Y 221H 8.20 ± 0 .1 1.09 0.43 ± 0.04 0.20 1.89 x 10" 5.29
G 259R 11.25 ± 0 .2 1.50 0.66 ± 0.07 0.31 1.70 x 10" 4 .76
Table 4.5: Kinetic parameters of single site mutants C54G, H217R, Y221H and 
G259R.
These mutants were generated via site-directed mutagenesis to examine the effects 
of the individual mutations on GpdQ phosphodiesterase activity.
The kinetic data in Table 4.5 emphasises the synergistic effects o f the 
mutations or the importance o f recombination as the individual mutations 
did not change the catalytic activity (kcat) significantly. The Km values saw a
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3- to 5-fold improvement with the single mutations functioning by 
themselves.
Triple mutant 3-25 emerged as the fittest variant after three rounds of 
evolution. The dominance of this genotype as depicted in Table 4.6 
(constituting 7 out of the 20 best variants) and again in Table 4.7 (8 out of 
20 fourth round variants) was already a sign of its superiority. It was found 
that the catalytic turnover of 3-25 was about 12 times higher than the wild- 
type GpdQ, although it had been evolved towards higher substrate affinity, 
not higher catalytic activity. The Km of mutant 3-25 was 10 times lower than 
that of the wild type.
Due to the early convergence of the mutations, high affinity evolution of 
GpdQ was not continued for a subsequent fourth round.
4.4.2 High activity evolution
For the initial four rounds of high activity evolution, GpdQ libraries were 
screened with 5.0 mM b/?NPP in 50 mM CHES pH 9.0, 0.5 mM MnCh, 0.1 
mg/mL bovine serum albumin (BSA) and at 20°C. For these experiments, 
mutants chosen from each round of evolution were sequenced. Up to 10 
variants were selected for StEP recombination in the next round of 
evolution. The list of the sequenced mutants from the first four rounds of 
high activity evolution is summarised in Tables 4.6 and 4.7.
Evolution of GpdQ towards enhanced b/?NPP catalytic activity also 
assumed a convergent nature. The number of mutations that led to amino 
acid changes decreased progressively from 36 to 17 (first round —> second 
round) to 11 (second round —» third round) and finally to 4 (third round —> 
fourth round). Single-site mutants were reproduced via site-directed 
mutagenesis to explore to what extent the individual mutations improved the 
catalytic activity of GpdQ (Tables 4.8 and 4.11). Kinetic analyses of these
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mutants revealed that many of mutations might in fact be artefactual as a 
result of spurious observations during the screening process. Most of these 
single-site mutants had either minimal activity improvement or none at all. 
However, all these mutations did nonetheless contribute towards lowering 
the Km. The reason for this false positive scenario was that the 5.0 mM 
concentration of bpNPP was too high for an accurate screening for 
improved catalysis.
Convergence drove the number of beneficial mutations to narrow down 
further to just 4 at the end of the fourth round of evolution. These four 
mutations, interestingly, were the very same mutations generated after three 
rounds of high affinity evolution. Once again, with high affinity evolution 
as the precedence, the dominance of triple mutant C54G-Y221-G259R 
(from now on referred to as 3-25) was manifest, with 8 out of the 20 best 
fourth round mutants bearing this genotype (mutant 4-5 in Table 4.7).
It should also be mentioned that among the selected third round and fourth 
round mutants lay a recurring silent mutation of residue Y250 (TAC —> 
TAT).
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1 1 1 1 1 1 1 1 1 1 - 1 - 1 - 1 - 1 - 1 - 1 -  
-1 - 2 - 3 -4 - 5 - 6 - 7 - 8 - 9 10 11 12 13 14 15 16
R12C >/
R12L V
R 12P V
F21L V
A26P V
D 30G V
C 54G V  V
C54Y V  V
N 53D V
R 64P V
V 62G V
I77V V
G 79L V
P96L V  V
A 113T V
S 114T V
R115L V
D 120Y V
S122C V
S 126T V  V
S 127L V
A 141T V
N 164D V
Q 166H V
Q 206P V
H 217R V
Y221H V
Y221N V
Y 229stop V  V
S 233A <
S 253L V
G 259R V
Y 263C V
N 266T V
I267T V
S268G V
Table 4.6: The genotypes of the 16 mutants selected from the first round of 
high activity evolution.
157
C
H
A
P
T
E
R
 F
O
U
R
l i c ? ? c c c ? ? ?  W Tf (N CO 00
oc
>  >  >  >  >
si
>  >  >
£
5 >  > >  >
>  >  >
o
o
- o
c
1 Ta
b
le
 4
.7
: 
Li
st
 o
f 
be
st
 m
ut
an
ts
 f
ro
m
 s
ec
on
d 
to
 f
o
ur
th
 r
ou
nd
s 
of
 h
ig
h 
ac
ti
vi
ty
 e
vo
lu
tk
T
he
 g
re
y 
sh
ad
in
g 
hi
gh
lig
ht
s 
th
e 
re
te
nt
io
n 
of
 m
ut
an
ts
 a
nd
 th
e 
co
nv
er
ge
nt
 n
at
ur
e 
of
 th
e 
ev
ol
CHAPTER FOUR
E n z y m e frcat
( s '1)
R e la tiv e
/CCat
K m
(mM)
R e la t iv e
K m
^cat/Km
(m V )
R e la tiv e
fcca t/K M
Wild type 7 .50  ± 0 .1 1.00 2 .10  ± 0 .0 8 1.00 3 .57  x 10J 1.00
S 122C 7 .60  ± 0 .1 1.01 1.50 ± 0 .10 0.71 5 .08  x 103 1.42
N 164D 5.41 ± 0 .1 0.72 1.08 ± 0 .0 8 0.51 5 .03  x 103 1.41
Y221N 4 .32  ± 0 .1 0 .58 0 .95  ± 0 .1 2 0 .45 4 .5 2  x 103 1.27
S233A 2 .14  ± 0 .0 0 .60 0.67  ± 0 .0 4 0 .32 3 .20  x 103 0 .90
S253L 3.92 ± 0 .1 0 .52 1.34 ± 0 .0 8 0 .64 2 .9 3  x 103 0 .82
Y 263C 1.87 ± 0 .0 0 .25 0.57  ± 0 .05 0 .27 3 .27  x 103 0.92
I267T 4 .42  ± 0 .1 0.59 1.39 ± 0 .2 1 0 .66 3 .17  x 103 0 .89
Table 4.8: Exploration of point mutations derived from the third round of high 
catalytic evolution of GpdQ.
4.5 DISSOCIATION OF OLIGOMERIC STRUCTURE IN MUTANT 
3-25
4.5.1 Initial detection
Protocol B (section 2.6.2, Chapter 2) was used to purify all the GpdQ 
mutant enzymes listed in Tables 4.4, 4.5 and 4.8. As size exclusion 
chromatography was used as the first purification step in this protocol, the 
soluble fraction from the crude lysate was loaded onto the Superdex 200 
column as sample. The proteins eluted with poor resolutions (Figure 4.1).
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Figure 4.1: Size exclusion chromatography of GpdQ mutant 3-5.
A Superdex 200 elution profile of the soluble fraction of the crude lysate during the 
purification of mutant 3-5 of high affinity evolution using Protocol B.
Protocol B did not give proteins of sufficient purity for future studies. It was 
therefore replaced by Protocol C where the purification procedure was 
reversed, thus making the size exclusion chromatography the second and 
last purification step. Mutant 3-25 was purified again, this time using 
Protocol C (section 2.6.2, Chapter 2) so that the characterisation of this best 
mutant could be repeated and verified.
The Superdex 200 elution profile of mutant 3-25 revealed disruption to the 
quatenary structure of GpdQ, where the hexameric enzyme had dissociated 
into dimers (Figure 4.2).
Figure 4.2: Oligomeric dissociation of GpdQ mutant 3-25.
In the 24-mL Superdex 200 column, wt-GpdQ (red) eluted in one single peak (A); 
mutant 3-25 (blue) eluted in two distinct peaks (B and C).
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4.5.2 Determination of protein molecular weight in mutant 3-25
The Superdex 200 size exclusion column (120 mL) used to estimate the size 
of wt-GpdQ and mutant 3-25 proteins weas pre-calibrated with six protein 
standards purchased from Sigma (Figures 2.19 and 2.20, Chapter 2).
The size of the wild-type GpdQ hexamer was estimated at 171 kDa. The 
two forms of mutant 3-25 protein are estimated at 167 kDa and 56 kDa, 
which probably represented the hexamer and the dimer.
4.5.3 Discovery of two forms of activities in mutant 3-25
The finding of oligomeric dissociation in variant 3-25 suggested that the 
hexamer and dimer should be characterised separately. Two sets of activities 
corresponding to the two different forms of the enzyme were observed.
E n z y m e / f e a t
(s’1)
R e la tiv e
/ f e a t
k m
(m M )
R e la tiv e
K „
/ f c a t / K m
(M  V)
R e la tiv e  
kc.  ,/K „
Wild type 7 .50  ± 0 .1 1.00 2 10 ± 0  08 1 00 3 57 x 1 0 J 1.00
3-25 d im er 76 .0 6  ± 1.0 10.14 0 .13  ± 0 .0 1 0 .06 5 .76  x 105 161.34
3-25 h ex am er 5 .29  ± 0 .1 0.71 0 .96  ± 0 .09 0.31 5 .54  x 103 1.55
Table 4.9: Characterisation of 3-25 hexamer and dimer with bpNPP.
The kinetic data revealed that the 3-25 dimer was a more active form of the 
enzyme. The structural dissociation had a greater impact upon the catalytic 
activity than it did on substrate affinity, with a 10-fold kcat increase 
compared to the wild-type value; while the kcat of 3-25 hexamer was slightly 
lower than the wild-type’s.
Several other GpdQ mutants also experienced a disruption to their 
oligomeric structures. The enhancement of activity by this phenomenon will 
be discussed further in Chapter 5.
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4.6 STRUCTURE-FUNCTION STUDIES OF MUTATIONS C54G, 
H217R, Y221H AND G259R
GpdQ structural studies in this project were all performed using a solved 
structure of the wild-type protein, which can be found in Protein Data Bank 
(http://www.rcsb.org/pdb/) using the PDB ID of 3D03 [19]. The 3D03 
structure (GpdQ-Co2f, 1.9 Ä) was crystallised in 60% v/v Tacsimate, 0.1 M 
Bis-Tris, pH 7.5 at 18°C using methods previously described in Chapter 2. 
All structural modelling and diagrams presented in this thesis were 
generated using or based on the same PDB file.
4.6.1 C54G
Figure 4.3: The inter-molecular disulfide bond in GpdQ.
A ribbon diagram showing the disulfide bond interaction (red stick) between residue 
C54 of one GpdQ subunit (chain A, blue) and residue C269 of another subunit 
(chain B, yellow).
One of the key features of the GpdQ structure is the presence of an inter-
chain disulfide bond between residues C54 and C269. A description of the 
bond was provided in section 1.4.5 in Chapter 1.
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A mutation of C54 into a glycine naturally abolished the disulfide bridge, 
which could result in three major consequences:
i. Reduced stability of the GpdQ dimer. However, since the GpdQ 
dimer is also held together firmly by the dimerisation domain, it is 
unlikely that the loss of the inter-chain disulfide bond would result 
in the dissociation of a dimer molecule into two monomers.
ii. A change in the orientation of the cap domain that ‘flips open’ and 
possibly disrupts the interface between two dimer units, thus the 
stability of the hexamer would also be compromised (Figure 4.4).
iii. Widened substrate entry into the active site that would enhance the 
activity of the enzyme, especially for non-physiological substrates. 
This was proven by the increment of the kcat/Km ratio by almost one 
magnitude of order. The 5-fold Km improvement by a single C54G 
mutation was considerably significant (Table 4.4).
Figure 4.4: Locations of the cap domains at the interface between the dimeric 
units of GpdQ.
A diagram showing how the cap domains of chains A and F are located at the 
interface between A-B dimer with E-F dimer. In the absence of the A-B and E-F 
disulfide bonds (in blue) through the C54G, the interface and the stability of the 
GpdQ hexamer would be disrupted. In a similar manner, the cap domains of chains 
B and E would be located at the third C-D dimer (not shown here).
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4.6.2 G259R
Glycine and proline residues have unusual conformational abilities and are 
commonly found in turns or bends in protein secondary and tertiary 
structures [20-22].
G259, together with its adjacent residue, P260, forms a bend in the cap 
domain of GpdQ (Figure 4.5A). A mutation at this point would almost 
certainly alter the orientation of the domain, especially when the side chain 
of the substitution, R259, would point towards W261 (Figure 4.5B). The 
effects of this mutation are likely to include destabilisation of the dimer and 
also the interface between dimeric units, as well as enhanced substrate 
binding through the changed conformation of the cap domain.
Figure 4.5: Structure-function studies of G259R.
An illustration of the G259-P260 bend on the cap domain of GpdQ in (A) and R259 
as modelled using MacPyMOL in (B).
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4.6.3 Y221H
Y221 is located in the outermost among the anti-parallel ß-sheets of the 
dimerisation domain. It interacts directly with another tyrosine residue, 
Y250 of the other chain (Figure 4.6). The Y221H mutation directly affected 
the stability of the dimer, but since a full domain comprising about 60 
residues (residues 196-255) has been dedicated to strengthen the dimeric 
structure, it would be unlikely for a single mutation to result in dissociation 
of a GpdQ dimer into monomers. Y221H possibly caused a change in the 
pH dependence of the protein or the conformation of the GpdQ dimer that 
was less conducive for the formation of a hexamer.
Figure 4.6: The Y221-Y250 interaction in GpdQ.
Y221 of chain A and Y250 of chain B are coloured in green to highlight their 
locations in the dimerisation domain (pink).
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4.6.4 H217R
H217 is located close to the active site (within 5 Ä) between H10 and HI97 
that both coordinate the oc-metal at the binuclear metal center of GpdQ. Due 
to the orientation of the residue, it is unlikely for H217 to have aromatic 
interactions with the imidazole rings of the two histidine ligands. There are 
no obvious interactions formed by H217 except for a hydrogen bond that is 
2.97 Ä in length between its backbone carboxyl and H I97, as shown in 
Figure 4.7(A). It remains uncertain if through the H217R mutation, the 
strong basic guanidino group of the arginine could act as a cation-7t to H10 
and H I97. Figure 4.7(B) shows a possible conformation of the arginine 
where the residue is orientated away from the active site. This modelling 
was generated using the MacPyMOL software. The effects of H217R on 
GpdQ enzyme activity can only be determined by a crystal structure of the 
mutant.
Hadler et al. suggested that H217 is involved in an extensive hydrogen 
network within the vicinity of the active site [19]. To investigate the 
involvement of H217 in catalysis, they made a H217A mutant of GpdQ and 
discovered that the catalytic turnover was 3 times higher than the wild type 
while the substrate affinity was not much affected [23]. This result was 
rather different from the H217R mutation, which appeared to have a greater 
positive effect on the Km than it did on kcat (Table 4.5). Furthermore, Hadler 
et al. proposed that H217 is also involved in the binding of the ß-metal, 
despite its distance from the ß-site and lack of any important interaction 
with other residues related to the site.
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Figure 4.7: Structure-function studies of H217R.
Diagram A shows how H217 is located just outside the active site of GpdQ. Diagram 
B is H217R modelled using the MacPyMOL software.
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4.7 CONCLUSIONS ON DIRECTED EVOLUTION OF GpdQ (PART 
ONE)
An overview
After experimenting with three screening methods (two in vivo agar plate 
based and in vitro random screening) and several phosphotriester (methyl 
paraoxon) and phosphodiester (dimethyl phosphate, diethyl phosphate and 
bis (p-nitrophenyl) phosphate) substrates, directed evolution of GpdQ was 
successfully carried out by evolving the enzyme’s bis (p-nitrophenyl) 
phosphate (b/?NPP) hydrolytic activity. The in vitro random screening 
method used for both the preliminary and secondary screenings of GpdQ 
genetic libraries was adapted from the original protocol devised by Dr 
Bradley Stevenson.
GpdQ was evolved towards high substrate affinity (low /fM) and high 
catalytic activity (high kcat) separately. With the high affinity evolution, 
three rounds of evolution were completed and mutants of Km values as low 
as 0.21 mM (mutant 3-25, Table 4.4), which produced a nearly 10-fold 
improvement. The best mutants derived at the end of the three rounds of 
high affinity evolution also exhibited improved catalytic activity, as 
indicated by their high kcat values.
Four rounds of high activity evolution were successfully completed. 
Interestingly, the variants obtained after the four rounds of evolution carried 
the same genotypes as those acquired at the end of the third round of high 
affinity evolution. The best mutant from the two directed evolution projects 
was triple mutant C54G-Y221H-G259R, commonly referred to throughout 
this chapter as mutant 3-25.
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Mutations and their implications
Both high affinity evolution (Rounds 1-3) and high activity evolution 
(Rounds 1-4) projects identified four major mutations: C54G, H217R, 
Y221H and G259R. Three of these four mutations had likely effects on the 
hexameric quaternary structure of GpdQ
Structure-function studies showed that both C54G and G259R mutations 
would alter the orientation of the cap domain, which would subsequently 
disrupt the interface between dimers and the stability of the GpdQ hexamer. 
The stability of the dimer was likely to be affected too since the cap domain 
is involved in domain swapping. However, the GpdQ dimer is also formed 
through the intertwining ß-sheets of the dimerisation domain.
Y221H was a mutation in the dimerisation domain that would also have an 
effect upon the quaternary structure of GpdQ.
H217R was the only mutation whose location was near to the active site. 
The mutation was believed to have a stabilising effect on the active site, 
thus enhancing catalysis.
It is interesting to note that mutations of conserved residues, including 
active residues, were never observed.
Dissociation o f the GpdQ hexamer -  Dimer was significantly more reactive 
Gel filtration analysis of mutant 3-25 showed that the enzyme had 
dissociated into a mixture of hexamers and dimers. This was not unexpected 
especially after learning the implications of the mutations through structure- 
function studies. The hexameric and the dimeric 3-25 enzymes were assayed 
separately and the high activity was found to be associated with the latter. 
The 3-25 dimer had an overall improvement of greater than 150
times compared to the wild type (Table 4.9).
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Therefore, directed evolution unintentionally steered the GpdQ enzyme 
towards an additional direction apart from catalytic activity and substrate 
affinity improvements: dissociation of the hexameric structure. To 
paraphrase this more effectively, directed evolution of GpdQ led to a 
simultaneous optimisation of its b/?NPP activity and quaternary structure. 
Such outcomes from directed evolution projects are not unprecedented [24].
Premature convergence
Premature convergence occurs through the loss of genetic variation within a 
population, which causes the inability of the population to produce offspring 
that are superior to their parents [25]. Premature convergence is a persistent 
problem in genetic and evolutionary algorithms, as well as in directed 
evolution studies [25-28].
At the end of the four rounds of high activity evolution and three rounds of 
high affinity evolution, only four mutations remained in the population of 
the screened mutants, suggesting convergence had been reached. Directed 
evolution experiments were then temporarily shelved while attempts were 
made to revise and optimise error-prone PCR (epPCR), staggered extension 
process (StEP) and random screening techniques. The GpdQ structure was 
also studied further in search of mutations that would form a stable GpdQ 
dimer.
Evolvability o f Km and kca,
The GpdQ affinity for substrate bpNPP (ATm) appeared to have a higher 
evolvability than its catalytic activity (£cat). Single mutations could result in 
significant improvements (Tables 4.5 and 4.8) whereas great kcat 
enhancements required synergy from at least three mutations, with 3-25 as a 
fine example.
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CHAPTER FIVE: OPTIMISATION OF GpdQ OLIGOMERIC 
STRUCTURE WITH RATIONAL DESIGN FOR BIS (P- 
NITROPHENYL) PHOSPHATE ACTIVITY
5.1 INTRODUCTION
One of the key objectives of this research project was to evolve GpdQ’s 
weak and promiscuous activities. After experimenting with several 
screening methods and substrates, GpdQ was eventually evolved towards 
high activity with a non-physiological phosphodiester substrate, bis (p- 
nitrophenyl) phosphate (bpNPP).
The first part of the directed evolution studies in this project was made up of 
the rounds 1-4. Results and discussions of work from these four rounds 
were presented in Chapter 4. At the end of the four rounds, directed 
evolution experiments were discontinued for two reasons. Firstly, premature 
convergence significantly reduced the diversity of the population of 
mutations. Experiments and techniques, especially those related to 
generating diversity in the libraries, had to be redesigned.
Secondly, two of the four mutations in the best mutants screened from the 
first part of directed evolution had direct implications on the cap domain of 
GpdQ. It appeared that these mutations also broke down the oligomeric 
structure of the protein. These two mutations in question are C54G and 
G259R. The C54G mutation abolished the disulfide bond between the cap 
domain of one chain and the catalytic domain of a second chain (Figures 
1.16, 4.3 and 4.4). G259R, on the other hand, was a mutation on the cap 
domain, which was likely to change the conformation of the domain. At first 
glance, these two mutations appeared to have a more direct effect on the 
stability of the GpdQ dimer, since the cap domain is involved in domain 
swapping, a known mechanism in the dimerisation of protein chains. 
However, GpdQ has an additional secondary domain, the dimerisation
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domain, consisting of two pairs of anti-parallel ß-sheets that increase the 
stability of the GpdQ dimer.
Instead, both C54G and G259R mutations likely affect the stability of the 
GpdQ hexamer. This hypothesis was made based on the location of the cap 
domain at the interface between the GpdQ dimers and strengthened by the 
results of the gel filtration analysis on mutant enzyme 3-25 (C54G, Y221H, 
G259R), which confirmed the hexamer —> dimer dissociation (Figure 4.2). 
Assay studies also revealed that the activity of the dimeric 3-25 enzyme was 
remarkably higher than that of the 3-25 hexamer (Table 4.9).
The dissociation resulted in the disruption of the £>3 dihedral symmetry of 
the hexamer. The Cj  cyclic symmetry of the dimer remained intact.
The first part of directed evolution studies of GpdQ and structural analysis 
delivered an important message which would serve as the pointer for the 
rest of the experiments conducted in this project: The GpdQ dimer was 
optimal for the hydrolysis of b/?NPP.
To this end, the structure of GpdQ was analysed again to identify mutations 
that could promote the dissociation of the hexamer. In other words, this 
chapter is a record of site-specific mutants and their studies that were all 
dedicated to the goal of producing a stable GpdQ dimer.
5.2 FACTORS AFFECTING THE DISSOCIATION EQUILIBRIUM
Dissociating GpdQ mutants did not migrate in two or more distinct peaks 
during size exclusion chromatography with the 120 mL Superdex 200 
column, even when the sample volume and flow rate were reduced to less 
than 1% of the column volume (1% = 1.2 mL) and 0.25 mL per minute, 
respectively. The column was repacked at one point and re-equilibrated with 
the eluting buffer (50 mM Tris-HCl, pH 8.0) that had been filtered and
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degassed (both with an air vacuum system) thoroughly to enhance its 
resolution. The column was also subject to regular maintenance cleaning 
with 0.5 M NaOH and mQH20. Notwithstanding the efforts made to 
minimise the contribution of column resolution as a factor in poor 
separation, dissociating GpdQ mutant proteins still eluted in overlapping 
peaks.
Dissociating mutant enzymes were initially characterised as hexamer-dimer 
mixtures. These two oligomeric forms of GpdQ were assayed separately. 
This was achieved by selecting elution fractions with pure hexamers 
(fraction 4, Figure 5.1) or dimers (fractions 6 and 7) to be assayed, while 
fractions containing a mixture like fraction 5 are eliminated. The vast 
difference in enzymatic activities implied that diluting the enzymes did not 
cause the hexamer to dissociate into dimers.
1!
1 J  2 A 4 5 6 J
50 100
Figure 5.1: An excerpt of Superdex 200 migration profile of GpdQ triple mutant 
enzyme 3-25.
A series of gel filtration experiments were run to study the effects of 
enzyme concentration and presence of exogenous metal ions on the 
hexamer-dimer equilibrium.
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Enzyme concentration
At high concentrations, hexamers were the dominant species of dissociating 
GpdQ enzymes. (Figure 5.2).
Hexamer Dimer
Figure 5.2: The effects of enzyme concentration on oligomeric dissociation in 
GpdQ.
Elutions of 9.35 mg/mL (blue) and 1.77 mg/mL (red) of mutant Y257stop 
respectively, from Superdex 200 column. The Y257stop mutant will be discussed in 
detail in section 5.5.1.
Metals
The presence of cofactor metals had minimal effect upon the re-
association/dissociation of the enzyme (Figure 5.3).
Dimer
Hexamer
Figure 5.3: The effects of metal ions on oligomeric dissociation in GpdQ.
Elutions of mutant 3-25-C269A with 1 mM Mn2+ (blue) and without Mn2+ (violet).
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5.3 C269 MUTANTS
Perhaps the most conspicuous mutation, detected since the first round of 
directed evolution and conserved all throughout the 20 fittest mutants after 
three rounds of high b/?NPP affinity evolution and also the 20 best mutants 
after four rounds of high bpNPP activity evolution (Tables 4.3 and 4.7, 
Chapter 4), was C54G. Based on the information on the structure of GpdQ, 
it can be inferred, quite directly, that a mutation at position C54 would 
destroy the inter-chain disulfide bridge between the residue and C269. 
Consequently, C269S and C269A were the first rationally designed GpdQ 
mutants in this study. Site-directed mutagenesis was used to make C269 as 
well as all other mutants discussed in this chapter. Experimental procedures 
are described in section 2.3 of Chapter 2.
5.3.1 C269S and C269A
Both C269S and C269A single mutations caused GpdQ to dissociate into an 
equilibrium of hexamer-dimer, with majority of the enzyme remaining in 
assembly (Figure 5.4).
Hcxamcr
Dimer
100
Figure 5.4: Gel filtration analysis of C269A.
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C269S and C269A GpdQ enzymes as well as the rest of the enzymes 
discussed in this chapter were expressed and purified using Protocol C as 
described in Chapter 2 (section 2.6.2).
The kinetic properties of these two mutants are given in Table 5.1. The 
hexamer-dimer equilibrium enzyme mixtures were used for the 
characterisation. All assays reported in this chapter were performed in 50 
mM CHES buffer pH 9.0, 0.5 mM Mn2+, 0.1 mg/mL BSA at 20°C.
E n z y m e ^ca t
( s ’1)
R e la t iv e
frcat
K m
(m M )
R e la t iv e
K m
k c a J  Km
(m V )
R e la t iv e
k c a ll  K m
Wild ty p e 7 . 5 0  ± 0 . 1 1 .0 0 2 . 1 0 ± 0 . 0 8 1 .0 0 3 . 5 7  x 1 0 J 1 .0 0
C 5 4 G 1 3 . 7 4 1 0 . 2 1 .8 3 0 . 4 3  1  0 . 0 4 0 . 2 0 3.21  X 1 0 4 8 . 9 9
C 2 6 9 S 4 7 . 6 8 1 1 . 3 6 . 3 6 1.21 ± 0 . 1 7 0 . 5 8 3 . 9 3  x 1 0 4 11.01
C 2 6 9 A 3 6 . 0 2  ±  1.4 4 . 8 0 1 . 4 8 1 0 . 2 7 0 . 7 0 2 . 4 3  x 1 0 4 6.81
Table 5.1: Characterisation of C269S and C269A.
Kinetic parameters of C54G are shown here again for comparison.
Kinetic data tabulated above show significant enhancements upon both the 
catalytic activity and substrate affinity of GpdQ, resulting in an overall ~7- 
fold and 11-fold increment in kcJKw  in C269A and C269S, respectively. 
All the three mutations of C54G, C269S and C269A underscored the 
importance of the absence of the inter-chain disulfide bond for enzyme 
activity. However, while C54G improved the KM more remarkably than it 
did the kcat, C269 mutations had a more profound effect on the activity.
Although these kinetic parameters indicated C269S as a superior mutant 
compared to C269A, it was the latter that was retained until the eighth and 
final round of directed evolution. During the sixth round of evolution, both 
C269S and C269A single site mutants were added into the DNA template 
mixture for the StEP PCR. C269A was the only genotype that was retained 
among the best mutants after screening (Tables 6.1 and 6.2). This retention 
highlights the importance of combining rational design into directed
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evolution studies, as a mutation from a cysteine to an alanine (TGT —> 
GCT), involving two nucleotide changes, could not have been achieved 
through the random mutagenesis approach used.
5.3.2 3-25-C269S and 3-25-C269A
Triple mutant 3-25 (C54G, Y221H, G259R) was the most catalytically 
efficient mutant obtained after four rounds of directed evolution. Mutants 3-
25-C269S and 3-25-C269A were constructed via site-directed mutagenesis 
(SDM), using 3-25 as the template DNA for SDM PCR. Kinetic parameters 
of these two new mutants are summarised in Table 5.2. The hexameric and
E n z y m e ^ c a t
( s 1)
R e la t iv e
^ c a t
Km
(mM)
R e la t iv e
Km
^ c a t /K m
( m V )
R e la tiv e
fC cat/K m
Wild type 7.50 ±0.1 1.00 2.10 ±0.08 1.00 3.57 x 10J 1.00
3-25 5.29 ±0.1 0.71 0.96 ±0.09 0.31 5.54 x 103 1.55
Hexamer
3-25 76.06 ± 1.0 10.14 0.13 ±0.01 0.06 5.76 x 105 161.34
Dimer
3-25-C269S 6.79 ±0.1 0.91 0.59 ±0.02 0.28 1.16 x 104 3.25
Hexamer
3-25-C269S 161.30 ±1.4 21.51 0.26 ±0.04 0.12 6.15 x 105 172.27
Dimer
3-25-C269A 14.13 ± 0.3 18.84 0.59 ±0.07 0.28 2.38 x 104 6.67
Hexamer
3-25-C269A 151.05 ±1.4 20.14 0.27 ±0.02 0.13 5.68 x 104 159.10
Dimer
Table 5.2: Assay results of hexamers and dimers of mutants 3-25-C269S and 3- 
25-C269A.
The kinetic parameters of mutant 3-25 are shown here again for easy reference and 
comparison.
Table 5.2 shows vividly how an additional C269S/A mutation doubled the 
&cat value of 3-25 dimer. However, the improvement in kcal was 
compromised by a commensurate increase in Km- This further substantiates 
the proposition that C269 mutations improved the catalytic activity of GpdQ 
considerably more than substrate affinity. The kcat/Km ratio of the 3-25- 
C269S dimer was also slightly higher than that of its C269A counterpart, 
which once again confirmed serine as a better substitution for C269. Thus, it 
is unclear why directed evolution was preferential towards the C269A 
mutation instead.
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Most importantly, Table 5.2 presents three instances of the GpdQ dimer as a 
more potent form of the enzyme, with approximately 20 and 10-fold 
enhancements on the kcat and Km, respectively compared to the native 
enzyme.
5.3.3 Hysteretic kinetics of C269 mutants
Figure 5.5 shows a typical example of a non-linear progress curve derived 
from kinetic assays of mutants C269S and C269A. Each assay reaction was 
run and measured over a period of 10 minutes to sufficiently allow the 
reaction to approach equilibrium or steady state. The values of initial 
velocity, v, were derived from the steady-state kinetics.
0 2 4 6 8 10
Time (min)
Graph 1 - Front Sample X:, Y:
Figure 5.5: Hysteretic kinetics of GpdQ mutant C269S.
The red curve show the kinetic progress of 20 mM bpNPP hydrolysed with 0.625 nM 
of C269S for 10 minutes. The green dashed line was drawn to show the deviation of 
the curve from linearity. The blue arrow indicates the area of the curve (steady-state 
kinetics) from where the value of the initial velocity, v, was calculated.
Carl Frieden was responsible for introducing the term hysteresis to describe 
one form of non-linear kinetics, where the initial velocity displays a 
sigmoidal dependence on substrate concentration [1]. The term hysteresis 
was used because the behaviour of such enzymes was likened to the time lag 
taken by a body in reacting to exterior forces. Therefore, enzymes exhibiting
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hysteresis undergo a time lag or a slow transition in response to a change in 
ligand concentration which in most cases, is represented by the addition of 
substrate to initiate a catalytic reaction. In other words, the pre-incubated 
enzyme is intrinsically inactive but goes through conformational changes 
upon substrate induction and becomes fully active when the kinetic progress 
curve becomes linear. Hysteric kinetics may also be indicative of quaternary 
structural fluctuations in oligomeric enzymes, where the lag time is the time 
taken for the enzyme to fully transform through association or dissociation 
into its active form [1-3].
However, as sigmoidal kinetic progress curves are diagnostic of both 
positive cooperativity and substrate-induced hysteretic kinetics, it is 
important to distinguish these two enzyme mechanisms. Not all hysteretic 
enzymes are cooperative, and vice versa. Neet and Ainslie proposed a 
system to divide hysteretic enzymes into four classes [4]. Enzymes that fall 
into Classes III and IV are hysteretic and cooperative simultaneously.
Class III that describes cooperativity in monomeric enzymes can be 
discounted immediately for C269S/A mutants as the enzymes did not 
dissociate into monomers.
The three progress curves presented in Figure 5.6 below would help to 
eliminate the possibility of cooperativity being prevalent in C269S/A 
mutants.
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Figure 5.6: The kinetic progress curves of GpdQ C269 mutants.
10-minute hydrolysis of 20 mM bpNPP by (A) hexamer-dimer enzyme mixture of 
mutant 3-25-C269A; (B) 3-25 hexamer and (C) 3-25 dimer.
In Figure 5.6, hysteresis was detected only when 20 mM bpNPP was 
hydrolysed with the pure 3-25 hexamer (Experiment B). When the substrate 
was reacted with the pure 3-25 dimer and the 3-25 hexamer-dimer mixture, 
the classic hyperbolic progress curves were obtained (Experiments A and
C).
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In Experiment B, the hysteresis that was shown implies the partial inactivity 
of the pre-incubated 3-25-C269A hexamer which, upon the addition of 
b/?NPP the substrate, underwent a ~2-minute transition time to convert into 
its active form. It is very tempting to assume that by ‘active form’ the 
dimeric state of the enzyme is meant, but the disparity between the catalytic 
reactivity of these two forms of enzyme, as shown in Table 5.2, does not 
reconcile with this notion. Since values of initial velocity were derived from 
the post-transitional part of the progress curves (indicated by the blue arrow 
in Figure 5.5), and if the lag is the time taken for hexamers to dissociate into 
dimers, the enzyme activity in Experiment B should be similar to both those 
attained from Experiments A and C. Hence, it is more reasonable to 
conclude that the exhibited lag period was the time required for the hexamer 
to undergo conformational changes to its tertiary fold, especially the active 
site to perfectly fit or envelope the structure of substrate molecules in order 
to catalyse the hydrolysis of the phosphodiester bond efficiently. Due to its 
low activity, it is unlikely that the dissociation of hexamers occurred at all.
A probable explanation for the lack of hysteresis in Experiment A is that the 
four mutations had caused most of the enzyme molecules to dissociate into 
dimers before any further induction by the substrate (Figure 5.3).
Determining positive cooperativity in C269 mutants
Two methods of analysis were used to determine the presence of positive 
cooperativity in C269 mutant enzymes: The Eadie-Hofstee plot and the Hill 
equation.
The Eadie-Hofstee plot
The Eadie-Hofstee plot is, as previously described in Chapter 3 (Equation 
3.1), one of the several ways of linearising the Michaelis-Menten equation 
by plotting the reaction initial velocity v, as a function of initial 
velocity/substrate concentration ratio (v/[S]). Eadie-Hofstee plots of
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standard Michaelis-Menten kinetic data would yield a straight line with a 
negative gradient (Figure 3.3).
An Eadie-Hofstee plot that is shaped like a curve convex to the right is 
diagnostic of positive cooperativity. An example of this kinetic pattern is 
shown in Figure 5.7.
Figure 5.7: Positive cooperativity presented in an Eadie-Hofstee plot.
The Eadie-Hofstee plots of C269S/A and 3-25-C269S/A enzyme reactions, 
as shown in Figure 5.8, were not indicative of positive cooperativity.
188
CHAPTER FIVE
0.002 0 . 0 0 b 0 . 00 &
C269S nwaine'-a mer 
■  CS»iSA ■vexine'-a -ner 
A.3-2&-C269S ne-xame' 
x 3-2&-C26SS »ne*
* 3-2&-C269A Texine ' 
3-2S-C26SA ö fTief
Figure 5.8: Eadie-Hofstee plots of C269 mutants.
The Hill equation
The Hill equation (Equation 3.2), its use, linearised version (Equation 3.3) 
and how the values of the Hill co-efficient, n, have been previously 
described in Chapter 3. The Hill plots of C269S/A, 3-25-C269S/A enzyme 
reactions with b/?NPP are drawn using KaleidaGraph (Figure 5.9) and 
values of n are calculated (Table 5.3).
—*— C269S hexamer-dimer 
—e  - C269A hexamer-dimer
-  -3-25-C269S hexamer
- -x -  - 3-25-C269S dimer
- - 3-25-C269A hexamer
Figure 5.9: Hill plots of GpdQ C269 mutants.
Hill plots of C269S/A, 3-25-C269S/C269A catalytic hydrolysis of substrate bpNPP.
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E n zy m e n i f
C 2 6 9 S 1.0 0 .9 6
h cx a m cr-d im c r  eq u ilib r iu m  
C 2 6 9 A 1.2 0 .8 6
h cx a m cr-d im c r  eq u ilib r iu m  
3 -2 5 -C 2 6 9 S  h ex a m er 1.0 1 .00
3 -2 5 -C 2 6 9 S  d im er 0 .9 0 .9 8
3 -2 5 -C 2 6 9 A  h ex a m er 0 .9 0 .9 7
3 -2 5 -C 2 6 9 A  d im er 0 .9 0 .9 9
Table 5.3: Hill coefficient (/^ and correlation coefficient (R2) values of the 
catalytic reactions in Figure 5.9.
The calculated values of n in Table 5.4 are not very accurate as many of the 
corresponding R2 values were low. But they nevertheless demonstrate the 
absolute (n = 1) and almost non-cooperativity {n < 1) of all the enzymes 
examined. An n value of 1.2 as portrayed by C269A hexamer-dimer cannot 
be considered as an indication of positive cooperativity as the Hill equation 
fits the kinetic data of this enzyme very poorly with an R2 value of 0.86.
As previously discussed in Chapter, the Hill equation has many limitations 
despite its simplicity that appeals to many researchers. The true definition of 
the Hill coefficient (n) and what it signifies remains ambiguously 
interpreted and understood. For example, the Hill coefficient has been 
misused for a physical application to estimate the number of ligand binding 
sites [5]. Another fallacy commonly practised by some scientists is to draw 
unequivocal conclusions about the cooperativity of a protein based on 
kinetic data that are poorly fit to the Hill equation. Among the broad range 
of points plotted, only those in the middle would fit the equation exactly and 
they fall within the useful range of data for an accurate measurement of the 
Hill coefficient. Data points outside this range are often non-linear and will 
definitely affect the measurement accuracy when they are considered [6, 7]. 
One fine example from this study is the C269A hexamer-dimer (Figure 5.9)
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where the Hill plot of the enzyme equilibrium clearly progressed into a non-
linear curve as the substrate increased in concentration. If only data points < 
4 along the x-axis were used for the curve fit instead, the generated plot 
would be closely parallel to the other plots, which would then yield a lower 
n value.
Conclusions on the hysteretic kinetics o f C269 mutants 
All four C269 mutants, namely C269S, C269A, 3-25-C269S and 3-25- 
C269A exhibited a 2-minute lag in their kinetic progress curves 
(Absorbance vs time). This lag was found to be associated only with the 
hexamer (3-25-C269S and 3-25-C269A hexamers) and hexamer-dimer 
enzyme mixtures (C269S and C269A) but not the dimeric enzymes (3-25- 
C269S and 3-25-C269A dimers).
The best explanation for the hysteresis was that the C269 hexameric 
enzymes were initially inactive but went through conformational changes 
upon the addition of the substrate bpNPP into the reaction mixture.
Both Eadie-Hofstee plots and the calculation of the Hill coefficients (n) 
confirmed that all of the C269 mutants were non-cooperative enzymes.
5.4 N53 MUTANTS
N53 in GpdQ forms inter-chain hydrogen bond with S268 with the nitrogen 
in its amide group [7] (Figure 5.10). This interaction, together with two 
others (C54-C269 and R56-P270), is believed to help stabilise the 
hexameric and dimeric quaternary organisations of the protein.
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5268*
•. 3.12 A Cap domain, cham 8
Chain A
Figure 5.10: The three inter-chain bonds at the cap domain of GpdQ.
Furthermore, N53 is located at the periphery of the active site of GpdQ. The 
oxygen from the amide functional group of N53 is hydrogen bonded to H10, 
an oc-metal ligand. The main chain carboxyl group of N53 is 2.80 Ä away 
from H81, the conserved histidine in the GNHD motif of 
dimetallophosphatases, which is always within 5 Ä from the active site [9]. 
N53 is homologous to D66 in the Rv0805 3’,5’-cyclic nucleotide 
phosphodiesterase from Mycobacterium tuberculosis (Figure 5.11).
)
Figure 5.11: Structural alignment of the active sites of Rv0805 and GpdQ.
The backbones of Rv0805 and GpdQ residues are coloured in pink and white 
respectively.
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5.4.1 N53D and N53A
Mutational analysis of N53 was carried out by making two mutants, where 
the residue was replaced by an aspartate and an alanine respectively. The 
dissociation phenomenon was also seen in both N53D and N53A, where the 
purified enzymes contained a mixture of hexamer and dimer. Kinetic results 
of the mixtures assayed with b/?NPP are tabulated below (Table 5.4).
E n z y m e ^ ca t
( s '1)
R e la t iv e
k c a i
K m
(m M )
R e la t iv e
K m
fCcat/Km
( M 'V )
R e la t iv e
k c a t l  K m
Wild ty p e 7 . 5 0 * 0 . 1 1 .00 2 . 1 0 * 0 . 0 8 1 .0 0 3 . 5 7  x 1 0 J 1 .0 0
N 5 3 D 1 3 . 2 9 * 0 . 3 1 .77 1 . 3 9 * 0 . 0 1 0 . 6 6 9 . 5 5  x 1 0 3 2 .6 8
N 5 3 A 4 1 . 5 3 * 2 . 3 5 .5 4 2 . 2 8  *  0 . 0 5 1 .0 9 1 .8 2  x 1 0 4 5 . 1 0
Table 5.4: Kinetic parameters of mutants N53D and N53A.
In N53D, the interaction with S268 was made impossible as the two 
carboxyl groups from S268 and D53 would repel each other. This means the 
stability of the quaternary organisation of GpdQ would be compromised, 
resulting in dissociation that was beneficial for the catalytic activity and 
substrate affinity of the enzyme.
An alanine substitution for N53, on the other hand, would annul all the 
hydrogen bond interactions with S268, and H10. Interaction with H81 
would not be affected by any mutation as the hydrogen bond was 
established between H81 and the backbone carboxyl of any amino acid at 
position 53. The kcat improvement for N53A was more remarkable than 
N53D’s. However, the mutation caused N53A to lose its substrate affinity. 
The most likely explanation for the poor Km was the loss of interactions 
with H10 and H81.
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5.4.2 Comparison of GpdQ N53 mutants with Rv0805 D66A
As stated in section 1.5 in Chapter 1, the Rv0805 3’,5’-cyclic nucleotide 
phosphodiesterase from Mycobacterium tuberculosis is the enzyme with the 
closest in sequence (Figure 1.20) and structure (Figures 1.21 and 5.12) to 
GpdQ.
Shenoy et al. constructed the Rv0805 D66A mutant when the aspartic acid 
was shown to align with a tyrosine, Y167 in the kidney bean purple acid 
phosphatase (KBPAP) [10]. However, in the KBPAP, this tyrosine residue 
is a ligand to the Fe3 ion and is responsible for imparting the purple colour 
to the protein. D66 does not coordinate any metal ion directly but interacts 
with H23, a metal ligand. The crystal structure of D66A revealed the loss of 
this hydrogen bond that consequently affected the positioning of H23 and 
the Fe31 ultimately ion at the active site [11].
In Figure 5.12, it is shown that the backbone carboxyl of N53 is hydrogen 
bonded to the imidazole group of the conserved histidine in the GNHD 
motif, H81. In the same manner, the backbone carboxyl of D66 interacts 
with H98 in Rv0805. Mutagenesis of D66 or N53 to alanine should not 
affect the interaction due to the location of the carboxyl group in the main 
chain. This was confirmed by kinetic studies of Rv0805 D66A and GpdQ 
N53A enzymes, where no drop in activity was observed in both mutants. 
However, in other ot/ß sandwich metallophosphatases, the side chains of 
these two residues have been shown to interact, eg. D52 and H76 
(homologous to N53 and H81 in GpdQ respectively) in bacteriophage X 
Ser/Thr phosphatase (A.-PP) [11] (Figure 5.12). Mutagenesis of D52 in A,-PP 
led to a dramatic decrease in the enzyme activity [12].
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Figure 5.12: The active site of bacteriophage A Ser/Thr protein phosphatase 
and the hydrogen network of H76 and D52.
The side chains of H76 and D52 are hydrogen bonded to each other; this interaction 
does not exist between the homologous residues in Rv0805 and GpdQ. This 
diagram was generated from the PDB structure 1G5B.
D66A displayed a mild increase in Vmax but a significant increase in K™ 
when assayed with varying concentrations of Mn2t. The sigmoidal kinetics 
observed indicated the role of D66 in the binding of metal ions at the active 
site of Rv0805 [11].
The activity improvements in both N53D and N53A mutants of GpdQ are 
likely due to the abolition of the interaction with S268, which promotes 
oligomeric dissociation. This N53-S268 inter-chain hydrogen bond does not 
exist in the Rv0805 protein.
5.5 TRUNCATION AT THE CAP DOMAIN OF GpdQ
Two of the mutations derived from directed evolution, namely C54G and 
G259R presumably resulted in a change in the orientation of the cap domain 
of GpdQ. We concluded that increasing the flexibility of this domain would
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enhance both the catalytic activity and substrate affinity of the enzyme. The 
improvement would be manifested especially when working with non-
natural substrates such as b/?NPP, whose chemical structure is very different 
from glycerophosphodiesters, the putative physiological substrates.
5.5.1 Y257stop
To this end, the Y257stop mutant was designed by converting the tyrosine 
residue into a stop codon. This would produce a truncated GpdQ mutant 
without an expressed cap domain, with a calculated molecular weight of 
28.7 kDa per monomer and an extinction coefficient of 31400 M 'em '1. 
However, the difference in molecular weight could not be shown clearly in 
the SDS-PAGE gel below, probably due to the limitations of the resolving 
gel (Figure 5.13).
97.4 kDa
66.2 kDa
45.0 kDa
31.0 kDa
21.5 kDa 
14.4 kDa
Marker N53A Y257stop
Figure 5.13: SDS-PAGE gel showing the expressed Y257stop compared to 
N53A.
A gel filtration analysis of Y257stop showed that the enzyme had 
dissociated into a mixture of hexamer and dimer (Figure 5.2). The assay 
results of the hexamer-dimer mixture are presented in Table 5.4.
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E n z y m e /CCat
( s 1)
R e la tiv e
frca t
K m
(m M )
R e la t iv e
k m
^cat/K m
(M  V )
R e la tiv e  
kcaJ Km
Wild typ e 7 . 5 0  ± 0 . 1 1 .0 0 2 . 1 0  ± 0 . 0 8 1 .0 0 3 . 5 7  x 1 0 J 1 .0 0
C 5 4 G 1 3 . 7 4  ± 0 . 2 1 .83 0 . 4 3  ± 0 . 0 4 0 . 2 0 3 .2 1  X 1 0 4 8 . 9 9
G 2 5 9 R 1 1 . 2 5  ± 0 . 2 1 .5 0 0 . 6 6  ± 0 .0 7 0.31 1 .7 0  x 1 0 4 4 . 7 6
C 2 6 9 S 4 7 . 6 8  ±  1.3 6 . 3 6 1.21 ± 0 . 1 7 0 . 5 8 3 . 9 3  x 1 0 4 11.0 1
C 2 6 9 A 3 6 . 0 2  ±  1.4 4 . 8 0 1 .4 8  ± 0 . 2 7 0 . 7 0 2 . 4 3  x 1 0 4 6.81
Y 2 5 7 s t o p 7 2 . 4 2  ±  1.8 9 .6 6 1 .4 5  ± 0 . 1 1 0 . 6 9 5 . 0 0  x 1 0 4 14.01
Table 5.5: Kinetic parameters of Y257stop.
Kinetic parameters of the wild type and four other single site mutants that sustained 
changes to the changes to the cap domain are also given for comparison.
Without the cap domain, GpdQ was not only still functional but the kca{ was 
almost 10-times higher. It is most likely that this remarkable activity 
improvement was attributed to the high level of dissociation of the enzyme 
(as shown in Figure 5.2) caused by the complete removal of the cap domain. 
Surprisingly though, the Y257stop mutation did not improve the substrate 
affinity greatly.
5.5.2 C54G-Y221H-Y257stop
A GpdQ variant with mutations C54G, Y221H and Y257stop was 
constructed via site-directed mutagenesis. This was achieved with designed 
Y257stop forward, reverse primers and the plasmid DNA of mutant 3-25 
(C54G, Y221H and G259R) as template during SDM-PCR. The two 
mutations, Y257stop and G259R are mutually exclusive: the presence of 
Y257stop will not allow G259R to be expressed due to a premature end of 
translation; an expressed G259R would indicate the absence of Y257stop.
During the purification process, it was found that the combination of the 
three mutations had extended the dissociation of GpdQ further to a mixture 
of hexamers, dimers and monomers, as shown in Figure 5.14.
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Figure 5.14: Dissociation of GpdQ into dimers and monomers.
Superdex 200 migration profiles of mutants C54G-Y221H-Y257stop (blue) and 3-25 
(magenta).
Kinetic results of C54G-Y221H-Y257stop assayed with bpNPP are given in 
the table below.
E n z y m e k Ca i
( s 1)
R e la t iv e
/ f e a t
k m
(m M)
R e la t iv e
K m
/ f e a t / K m
( m V )
R e la t iv e
W K m
Wild ty p e 7 . 5 0  ± 0 . 1 1 .0 0 2 . 1 0  ± 0 . 0 8 1 .0 0 3 . 5 7  x 1 0 J 1 .0 0
H e x a m e r 1.31 ± 0 . 1 0 . 1 8 0.31 ± 0 . 0 3 0 . 1 5 4 . 1 9  x 1 0 3 1 .1 7
Dim er 6 5 . 6 2  ±  0 .9 8 . 7 5 0 . 2 5  ± 0 . 0 2 0 . 1 2 2 . 6 6  x 1 0 6 74 .5 1
M o n o m e r 2 0 2 . 4 5  ± 3 . 8 2 6 . 9 9 0 . 2 9  ± 0 . 0 3 0 .1 4 6 . 9 8  x 1 0 s 1 9 5 . 5 2
Table 5.6: Kinetic results of hexameric, dimeric and monomeric forms of 
C54G-Y221 H-Y257stop.
As the C54G-Y221H-Y257stop enzyme dissociated from hexamer into 
dimer then monomer, the catalytic activity also increased accordingly. 
However, the different oligomeric forms did not appear to affect the Km. 
The low K M  values of these three forms of the enzyme are also probably 
attributed to the other two mutations, C54G and Y221H as Table 5.5 
showed that Y257stop alone did not improve the affinity much.
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The kcJKy\ ration of 3-25 dimer was about 160 (Table 5.3), which was more 
than twice higher than that of C54G-Y221H-Y257stop dimer. This would 
imply that the Y257stop mutation was not compatible with C54G and 
Y221H.
Surprisingly, the monomeric enzyme was the most catalytic reactive form of 
the enzyme. Based on the structure of the wild-type enzyme, where two 
domains contribute to dimerisation, one would expect the GpdQ dimer to be 
extremely stable and most catalytically efficient.
5.5.3 Conclusions on the cap domain of GpdQ
Exploring the role of the cap domain in GpdQ through Y257stop mutants 
led to several conclusions. Firstly, this short peptide serves as a mechanism 
for enhancing the substrate specificity of GpdQ by minimising the entrance 
space into the active site. In the absence of the cap domain in Y257stop, the 
active site was made more accessible, GpdQ was not only still functional 
but was significantly more active.
Secondly, the cap domain is also responsible for stabilising the oligomeric 
structure of GpdQ. Its role in holding two monomers together as a single 
dimeric unit can be seen and understood more directly. However, as the 
hexamer is very much less than the dimer, the single Y257stop mutation 
resulted in the hexamer —> dimer dissociation but not dimer —> monomer 
dissociation. The residues in the cap domain must have weak interactions 
with another dimer to stabilise the hexamer.
With the synergy of the three mutations in C54G-Y221H-Y257stop, the 
monomeric GpdQ was acquired. It cannot be ascertained though, whether a 
hexamer breaks down into monomers directly, or via dimer intermediates, 
or via both mechanisms.
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5.6 TRUNCATION AT THE DIMERISATION DOMAIN OF GpdQ
Y204 was changed to a stop codon to truncate the protein prior to the 
dimerisation domain. This was done to investigate if GpdQ could function 
with only the catalytic domain.
Y204stop had a calculated molecular weight of 22.7 kDa. Y204stop had a 
very high level of expression and the expressed protein band was estimated 
to be ~22 kDa. However, the protein was insoluble and was challenging to 
purify. Most purification protocols of insoluble proteins involve the use of 
denaturing detergents like sodium dodecyl sulfate (SDS) [13]. The poor 
presentation of the Y204stop protein in the SDS-PAGE gel below (Figure 
5.15) was due to the overloading of the samples.
97.4 kDa 
66.2 kDa
45.0 kDa
31.0 kDa
21.5 kDa 
14.4 kDa
I
Lane 1 2  3 4 5 6 7
Figure 5.15: The insolubility of GpdQ mutant Y204stop.
Lane 1 shows the marker while lanes 2-7 show duplicates of Y204stop crude lysate 
(Lanes 2 and 3), insoluble fraction (Lanes 4 and 5) and soluble fraction (Lanes 6 and 
7) respectively.
At the start of the purification, a drop assay with b/?NPP was performed on 
the crude lysate, soluble and insoluble fractions of Y204stop and no activity 
was detected (Figure 5.16). Two attempts were made to purify the very little 
amount of Y204stop in the soluble fraction. However, due to the extremely 
low concentration, the exact fractions containing the eluted protein could 
not be determined. The inactivity and the insolubility of Y204stop indicate 
that the protein did not fold properly and therefore was catalytically inert.
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Wild type Y204stop Y204stop Y204stop Blank (bpNPP only)
crude lysate soluble fraction insoluble fraction
Figure 5.16: Drop assay of GpdQ mutant Y204stop.
Drop assay of Y204stop crude lysate, soluble and insoluble fractions with bpNPP, 
flanked by positive (wild-type GpdQ) and negative control experiments (bpNPP 
only).
5.7 F21 
5.7.1 F21K
Directed evolution of GpdQ towards higher catalytic activity and substrate 
affinity simultaneously showed that dissociation of the enzyme was a key 
factor in reaching such a target, through mutations such as C54G, Y221H 
and G259R. However, the hexamer-dimer equilibrium made purification 
and kinetic assays more complicated and challenging. Wang proposed a 
method for determining kinetic parameters of dissociating enzyme systems 
that involved too many complex equations that are based on theoretical 
examples [14]. The very few citations of the publication would reflect the 
lack of user friendliness and the unpopularity of the mathematical equations. 
Moreover, the rapidly equilibrating system of GpdQ dissociating enzymes 
would make them nearly impossible to crystallise.
To this end, the GpdQ structure was analysed again by Dr Paul Carr to 
search for mutation(s) that would directly destabilise the hexameric 
interface so that a pure GpdQ dimer mutant enzyme could be acquired. As a 
result, two mutations, namely F21K and W261R were recommended.
F21 (of chain A) and W261 (of chain B) of the same dimer unit form 
hydrophobic contacts with the aliphatic parts of the side chains of H256 and 
D30 (of chain D that belongs to another dimer unit) that form a salt link 
with each other (Figures 5.17 and 5.18). In the absence of F21 and W261,
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the side chains o f H256 and D30 would be comfortable in a hydrophilic 
environment and this would favour the formation o f a stable dimer.
Figure 5.17: The inter-chain hydrophobic patch in GpdQ.
The hydrophobic patch, indicated by the black arrow is formed by interactions 
among F21, D30, H256 and W261 from different chains.
Figure 5.18: Detailed view of the inter-chain hydrophobic patch in GpdQ.
An up close view of the interactions among F21 (chain A, blue), W261 (chain B, 
yellow), H256 and D30 (chain D, red). Chains C and E have been omitted from this 
diagram for clarity reason.
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The Superdex 200 elution profile of F21K in Figure 5.19 below shows that 
this mutant enzyme is about 90% dimeric.
' F21K dimer
l|
100
Figure 5.19: The F21K GpdQ dimer.
Superdex 200 migration profile showing the elution of dimeric F21K.
Table 5.7 presents the kinetic parameters of F21K.
E n zy m e k Cat R e la tiv e k m R e la tiv e /Ccat/Km R e la tiv e
(S '1) k c a \ (mM) K„ (m V ) k c a J  K m
Wild ty p e 7 .50  ± 0 .1 1.00 2 .10  ± 0 .0 8 1.00 3 .57  x 10J 1.00
F21K 4 5 .7 5  ± 0 .1 6 .10 0 .33  ± 0 .04 0 .16 1.40  x 105 39 .22
Table 5.7: Kinetic properties of F21K relative to the wild type GpdQ.
F21K emerged as the best of all the single mutants that had been 
characterised in this study. This once again underlined the importance of 
rational design to complement directed evolution in protein engineering, as 
a mutation from F21 to a lysine (TTT —> AAG) involved three nucleotide 
changes that would not occur through random mutagenesis. It should be 
mentioned that an F12L mutation (involving one nucleotide change) was 
detected in one of the mutants after the second round of screening in 
directed evolution (Tables 4.6 and 4.7).
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5.7.2 F21K-C54G-Y221 H-Y257stop
The quadruple mutant was made via site-directed mutagenesis using F21K 
forward and reverse primers to introduce the mutation to the C54G-Y221H- 
Y257stop plasmid DNA template described in section 5.4.2.
The quadruple mutant dissociated into a mixture o f hexamer, dimer and 
monomer. The hexamer, based on previous examples o f dissociating GpdQ 
enzymes, was presumed to be inactive and was therefore not assayed. We 
focused on characterising the dimer and monomer separately to determine 
which form o f the enzyme was more catalytically active. Assay results are 
given in Table 5.8.
E nzym e c^at
(s’1)
R elative
k c a t
Km
(m M )
R ela tive
Km
c^at^ Km
(M  V )
R ela tive
k c J K m
Wild type 7.50 ±0.1 1.00 2.10 ± 0 .08 1.00 3.57 x 10J 1.00
Dimer 13.29 ± 0 .3 1.77 1.39 ±0.01 0.66 9.55 x 103 2.68
Monomer 56.65 ± 1.0 7.55 0.18 ± 0 .02 0.09 3.22 x 105 90.19
Table 5.8: Kinetic properties of the dimeric and monomeric forms of quadruple 
mutant F21K-C54G-Y221 H-Y257stop.
Comparing the assay results presented in Tables 5.6 and 5.9, it can be 
inferred that F21K was not compatible with the other three mutations, as the 
k c J K u  ratio o f the triple mutant, in both dimeric and monomeric forms, is 
significantly higher than that o f the quadruple mutant with an additional 
F21K mutation. However, the two sets o f kinetic results consistently 
showed that the monomeric enzymes displayed higher bpNPP activity than 
the dimers.
5.7.3 The preliminary crystallisation of F21K
Attempts were made to crystallise F21K. As the novel structure o f the GpdQ 
dimer is different from the native hexamer, previous crystallisation
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conditions as reported in section 5.3 of this chapter were no longer suitable. 
New crystallisation conditions were sought for the GpdQ dimer, as 
described in section 2.9.2 in Chapter 2.
Of a total of 576 conditions screened (96 from each of the six different 
screens named in Chapter 2), crystals were formed only under one 
condition: 0.5 M ammonium sulfate (salt), 0.1 M sodium citrate tribasic 
dihydrate pH 5.6 (buffer), 1.0 M lithium sulfate monohydrate (precipitant), 
which was reagent F3 of the Hampton Research Crystal Screen HT. Crystals 
are shown in Figure 5.20.
Figure 5.20: GpdQ F21K crystals.
Attempts to reproduce the crystals by using the hanging drop vapour 
diffusion method were unsuccessful. The crystallisation conditions were 
optimised by varying the pH values (5.0 to 6.5), and the lithium sulfate 
concentration (0.5 to 1.5 M).
5.8 W 261R
The mutant W261R was constructed as another effort to acquire a pure 
GpdQ dimer. Interestingly, this mutant enzyme remained associated as a 
hexamer. The kinetic results of this mutant are given below.
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E n z y m e feat R e l a t i v e K m R e l a t i v e k c a J  Km R e l a t i v e
( s 1) kca t (m M ) K „ (m V ) k c a J
Wild ty p e 7 . 5 0  ± 0 . 1 1 .0 0 2 . 1 0  ± 0 . 0 8 1 .0 0 3 . 5 7  x 1 0 J 1 .0 0
W 2 6 1 R 12.41  ± 0 . 2 1 .65 0.71  ± 0 . 0 6 0 . 3 4 1 .7 4  x 1 0 4 4 . 8 7
Table 5.9: Kinetic results of W261R.
The W261R mutation improved both the kcat and Km slightly but it did not 
cause GpdQ to dissociate as expected.
5.9 CONCLUSIONS
Rationally-designed GpdQ mutants with improved activity 
A total of six single site mutants (C269S, C269A, N53D, N53A, F21K, 
W261R) and two truncation mutants (Y257stop and Y204stop) were 
designed in this chapter. Y204stop was an insoluble and completely inactive 
enzyme. Apart from Y204stop, the other mutants showed improved activity 
with substrate bis (p-nitrophenyl) phosphate (bpNPP). F21K was the best 
single site mutant to be produced in this thesis, with an almost 40-fold 
improvement in the overall kcat/K.m ratio. Apart from W261R, all other 
mutations resulted in oligomeric dissociation in GpdQ.
The DNA samples of C269S, C269A, N53D, N53A, F21K and Y257stop 
were included as templates for in vitro gene recombination via staggered 
extension process (StEP) in the second part of directed evolution of GpdQ 
(Chapter 6).
High activity associated with simpler oligomeric forms o f GpdQ 
Four multiple site mutants of GpdQ were also designed in this chapter:
1. C54G-Y221H-G259R-C269S (3-25-C269S)
2. C54G-Y221H-G259R-C269A (3-25-C269A)
3. C54G-Y221H-Y257stop
4. F21K-C54G-Y221 H-Y257stop
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Mutants 3-25-C269S and 3-25-C269A had dissociated into mixtures of 
hexamers and dimers. When assayed separately, it was found that high 
activity was associated with the dimers of both enzymes.
Mutants C54G-Y221H-Y257stop and F21K-C54G-Y221H-Y257stop had 
dissociated further into hexamers (very small amounts), dimers and 
monomers. For both mutants, the monomers were the most catalytically 
active fonn of the enzymes. Therefore, these four multiple site enzymes 
showed a consistent pattern, where simpler oligomeric fonns of GpdQ were 
favourable towards enzyme activity.
Rational design of proteins - fast and precise
Another highlight of this chapter is the ease and the precision of rational 
design in engineering very active and/or dissociating GpdQ enzymes. Many 
of the mutations made in this chapter involved two or three nucleotide 
changes within a codon, which were made possible only through site- 
directed mutagenesis.
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CHAPTER SIX: DIRECTED EVOLUTION OF GpdQ (PART TWO) 
6.1 INTRODUCTION
This chapter is a chronicle of experiments conducted as a continuation of 
the directed evolution studies presented and discussed in Chapter 4.
One of the two most important outcomes from the first four rounds of 
directed evolution in Chapter 4 was the emergence of 3-25 (C54G, Y221H, 
C259R) as the best mutant. The overall kcat/Km ratio of mutant 3-25 was two 
orders of magnitude higher than that of the wild-type GpdQ. The other 
major outcome was the discovery of oligomeric dissociation in mutant 3-25. 
However, due to the premature convergence encountered, directed evolution 
experiments were stopped temporarily after four rounds to review and revise 
the techniques that were being used. Several rationally designed GpdQ 
mutants were made with the aim of improving catalytic activity through the 
dissociation of the GpdQ hexamer (Chapter 5). Directed evolution now 
proceeded with the following strategies:
1. Random mutagenesis
To give the evolutionary work a fresh start, GpdQ was subject to random 
mutagenic amplification using the previously described epPCR method to 
generate a new 5th round library of mutants.
2. Changed StEP protocol
The StEP-A protocol was replaced by StEP-B (used for rounds 6-7) and 
later StEP-D (used for round 8) programs that were able to shuffle the 
homologous template genes better. Both StEP-B and StEP-D protocols 
were two-step PCR cycles that lacked the 72°C extension step.
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3. The use o f rational design to complement directed evolution
As discussed in Chapter 4, directed evolution of GpdQ led to the discovery 
of oligomeric dissociation in mutant 3-25. This phenomenon was unlikely to 
be artefactual as structure-function studies of C54G, Y221H and G259R 
supported the notion that these mutations would disrupt the interface 
between dimers within the GpdQ hexamer. Although the other improved 
mutants from the fourth round of evolution were not subject to gel filtration 
analysis to confinn dissociation, they were presumed to have also 
dissociated as their genotypes were made up of the same mutations as 
mutant 3-25, with the exception of H217R which was not present in 3-25. 
The structure of GpdQ was studied again to identify mutations that would 
stabilise the GpdQ dimer or at least, shift the hexamer-dimer equilibrium 
towards dissociation. As a result, several rationally designed GpdQ mutants 
were produced and they were included as DNA templates for the StEP PCR 
reactions. These mutants were F21K, N53D, N53A, Y257stop, C269S and 
C269A. The production of these site-specific mutants and their mutagenesis 
studies were presented in Chapter 5.
4. Changed substrate concentration during screening
The 5 mM substrate concentration used to screen the first four generations 
of mutants during high activity evolution proved to be too high, which 
ultimately led to the selection of many false-positive mutants, as shown in 
Table 4.8. On the other hand, while trying to improve bpNPP substrate 
affinity, concentrations ranging from 0.25-1 mM were used to screen the 
mutants. The effects of the four mutations responsible for enhancing the 
affinity, namely C54G, H217R, Y221H and G259R, were reproducible 
(Tables 4.4 and 4.5) and not artefactual when the proteins were expressed, 
purified and characterised individually.
Based on all the mutations obtained from both the high affinity and the high 
activity evolutions, it appeared that any improvement in activity would also 
automatically increase the affinity (Tables 4.4 and 4.5) but not vice versa
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(Table 4.8). This would mean that screening with low concentrations of 
b/?NPP is no longer necessary. Hence, the screening b/?NPP concentration 
was fixed at 1 mM from round 5 onwards.
6.2 DIRECTED EVOLUTION OF GpdQ (ROUNDS 5-8)
6.2.1 Screening results
The selected, best mutants from rounds 5-8 and other templates included in 
StEP PCRs are listed in the Table 4.11. Table 4.12, shows detailed 
information about the genotypes of the 14 best mutants selected, and their 
activity improvements.
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k c a t
( s 1)
R e la t iv e
/ f e a t
k m
(m M )
R e la t iv e
K m (M V)
R e la t iv e
/ f e a t / K m
Wild typ e 7 . 5 0  ± 0 . 1 1 .0 0 2 . 1 0  ± 0 . 0 8 1 .0 0 3 . 5 7  x 1 0 J 1 .0 0
8-1
Dimer
7 0 . 5 6  ± 0 . 9 9.41 0 . 7 6  ± 0 . 0 1 0 . 3 6 9 . 1 9  x 1 0 “ 2 5 . 7 4
8-1
M o n o m er
1 1 1 .6 1  ± 1.3 1 4 .8 8 0 . 3 6  ± 0 . 0 9 0 . 1 7 3 . 0 8  x 1 0 5 8 6 . 2 7
8-2
Dimer
1 4 1 . 5 2  ± 0 . 5 1 8 .8 7 0 . 2 4  ± 0 . 0 1 0.11 5 . 8 5  x 10° 1 6 3 . 8 6
8 -2
M o n o m e r
7 0 . 0 9  ± 0 . 1 9 . 3 5 0 . 0 7  ± 0 . 0 0 1 0 . 0 3 1 .0 2  x 10° 2 8 5 .7 1
8 -3
Dimer
1 3 8 . 2 2  ± 0 . 7 1 8 .4 3 0 . 0 7  ± 0 . 0 0 2 0 . 0 3 1 .9 8  x 10° 5 5 1 . 8 2
8 -5
Dimer
1 6 2 . 6 0  ± 0 . 8 2 1 . 6 8 0 .11  ± 0 . 0 0 5 0 . 0 5 1 .4 7  x 1 0 b 4 1 1 . 7 6
8 -7
Dimer
1 8 9 . 5 9  ± 2 . 1 2 5 . 2 8 0 .11  ± 0 . 0 0 8 0 . 0 5 1 .7 8  x 1 0 b 4 9 5 . 6 0
Table 6.3: Kinetic parameters of the five characterised eighth round mutants.
All the five GpdQ mutants from the eighth round of directed evolution 
experienced dissociation, at varying levels. There was still a negligible 
amount of the hexameric form in all the five enzymes, but they were 
presumed to be significantly less active than the other dissociated forms and 
therefore not characterised. Mutants 8-1 and 8-2 had dissociated further into 
monomers; the other three, namely 8-3, 8-5 and 8-7, had not.
With mutants 8-1 and 8-2, the monomers were more catalytically active 
than their dimers. However, the 8-3 dimer displayed the greatest kcJK u  
improvement compared to the wild type. The relative values of kcJ K M of 8- 
5 and 8-7 dimers were also greater than those of 8-1 and 8-2 monomers. 
Based on the kinetic results of these five eighth round mutants, the GpdQ 
dimer appeared to be the most optimised form of the enzyme, displaying the 
highest values of both kcat and Km- The three mutant dimers, 8-3, 8-5 and 8- 
7, represent the most catalytically active GpdQ enzymes reported in this 
thesis, with kcJKM values as high as 106 M 's ', an enhancement of three 
orders of magnitude upon the wild-type GpdQ.
R12L, N103D and S127A were three novel mutations that were not found in 
the first rounds of directed evolution. These three single site mutants were
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made to assess each of the mutations individually. The kinetic results are 
given below.
Enzyme fCcat
(s'1)
Relative
c^at
Km
(mM)
Relative
Km
f(cat/Km
(M V )
Relative
k cJ K u
W ild  type 7.50 ± 0 .1 1.00 2 .10  ± 0 .0 8 1.00 3.57 x 10J 1.00
R 12L 32.21 ± 0 .5 4.29 0.32 ± 0 .0 3 0.15 1 .0 0 x 1 0 5 28.01
N 103D 5.29 ± 0 .1 0.71 1.04 ± 0 .0 9 0.50 5.10 x 103 1.43
S 127A 5.12 ± 0.1 0.68 1.22 ± 0 .0 7 0.58 4.21 x 103 1.18
Table 6.4: Kinetic results of single site mutants R12L, N103D and S127A 
compared to the wild type.
The kinetic results above show that with only the R12L mutation, the 
of GpdQ sustained a marked improvement. With N 103D and SI27A 
however, although both mutations gave slight Km improvements, their kcat 
values were lower than that of the wild type. As these two mutations 
‘survived’ not one but at least three rounds of screening (from Round 5 
onwards, table 6.2), it was unlikely that the conservation was artefactual. 
These two mutations probably had to combine with others to have a 
synergistic effect on the enzyme activity.
It is also noteworthy to mention that all the three enzymes in Table 6.4 
appeared to remain associated as hexamers, as indicated by size exclusion 
chromatography and that none of the mutations seemed to have affected the 
oligomeric structure of GpdQ.
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6.3 STRUCTURE-FUNCTION STUDIES OF MUTATIONS R12L, 
N103D AND S127A
6.3.1 R12L
R12L is a mutation that often co-existed with C269A, for example mutants 
7-4 and 8-2 in Table 6.3. Residues 54-59, containing a glycine (G55) and a 
proline (P57), form a hydrophobic pocket as illustrated in Figure 6.1 below. 
In the presence of the mutation C269A, the free thiol group of C54 would 
increase the hydrophobicity of the region. An R12L mutation would have a 
stabilising effect over the hydrophobic area, as leucine is non-polar. This 
mutation would also have but probably less significance if the disulfide 
bond was abolished through the C54G mutation instead, since the 
hydrophobicity of a glycine would not be as strong as that of a free cysteine.
Additionally, as shown in Figure 6.1, R12 forms an inter-chain salt link with 
E273 in the cap domain (2.77 Ä in distance). Jackson et al. did not report 
this salt link as the last three residues at the C-terminus (residues 271-274) 
were missing from the two crystal structures (2DXN and 2DXL) of GpdQ 
[6]. The structure 3D03 solved as part of this project had the complete 274 
residues. An R12L mutation would abolish the salt bridge that would 
ultimately, like mutations C54G, G259R and C269S/A, disrupt the stability 
of the hexameric interface. However, the hexameric structure of the R12L 
enzyme seemed to be intact. Dissociation of the hexamer, if there was any, 
was minimal (Figure 6.2).
Another interaction formed by residue R12 is a 2.80-Ä intra-chain salt link 
with E59. This interaction would be missing in the presence of the R12L 
mutation.
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Figure 6.1: The hydrophobic pocket constituted by residues C54-E59 and the 
two salt link interactions formed by R12.
Figure 6.2: An excerpt of the Superdex 200 elution profile of R12L.
There was no obvious indication of dissociation of the hexamer in R12L.
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6.3.2 N103D
N 103 is a surface residue whose acyl group (of the amide functional group) 
interacts directly with the exogenous solvent environment, as shown in 
Figure 6.3. Although the nitrogen atom of the amide group is buried within 
the protein molecule, it does not appear to have any interactions with other 
residues. This nitrogen atom is 5.33 Ä from K84 (Figure 6.4). When 
mutated to an aspartic acid, the residue could possibly form a salt link with 
K84, since the side chain of the lysine is flexible and could change its 
orientation and turn towards the acid residue (D103). Such a salt link could 
have a stabilising effect on the protein structure. The lack of activity 
improvement in the N103D mutant (Table 6.4) also supported this notion.
Figure 6.3: N103 -  a surface residue in GpdQ.
A diagram with N103 coloured in blue to highlight their locations on the surface of 
the GpdQ hexamer molecule.
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Figure 6.4: A close-up diagram of N103 and K84 on a GpdQ monomer.
6.3.3 S127A
The S127A mutation was retained after four rounds of screening (Rounds 5- 
8) (Table 6.2). At the end of the eighth round of evolution, the mutation was 
found to be present in 6 of the 14 best mutants were sequenced.
As illustrated in Figure 6.5, the side chain S127 is 3.62 Ä away from N80 in 
chain A, while in other subunits the distance varies from 3.39-3.78 Ä. N80 
is the ligand responsible for the low metal binding affinity at the ß-site. 
Despite the proximity, a hydrogen bond interaction between SI27 and N80 
was unlikely because of the conformation of SI27, whose side chain 
hydroxyl group points away from the amide group of N80. However an 
alanine substitution at this position might allow N80 to move flexibly, thus 
enhancing the ability of the residue to bind and release the ß-metal more 
easily. Kinetic assay of the S127A enzyme (Table 6.4) indicated no
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improvement upon the catalytic turnover (kcat) and a mild improvement on 
the substrate affinity (Km)-
H' 9 7
Figure 6.5: Location of S127 at the periphery of the GpdQ active site.
6.4 CONCLUSIONS ON DIRECTED EVOLUTION OF GpdQ (PART 
TWO)
With improved epPCR, StEP protocols and screening strategies, the second 
part of GpdQ evolution, which was constituted by the fifth to eighth rounds, 
successfully produced three GpdQ enzymes whose overall kcJK u  values 
had reached the realm of 106 M 'V ,  which was an improvement of three 
orders of magnitude compared to the wild type. The high activity of these 
three mutants, namely 8-3, 8-5 and 8-7, was associated with the dimeric 
form.
Mutants 8-1 and 8-2 dissociated into an equilibrium of three oligomeric 
forms: hexamer, dimer and monomer. The monomeric forms of mutants 8-1 
and 8-2 were more active than their dimeric counterparts, but their activity 
was still significantly lower than the activity of 8-3, 8-5 and 8-7 dimeric
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enzymes (Table 6.3). Therefore, it appeared that the GpdQ dimer was the 
oligomeric form that was best optimised for b/?NPP hydrolytic activity.
At the end of each round of screening, the DNA sequences of the best 15 
mutants were analysed. Once again, as stated in Chapter 4, mutations of any 
active residue or other conserved residues were never observed. Low 
mutation rates of epPCR and StEP reactions were unlikely to be responsible 
for this observation. A more probable explanation would be that any 
mutation of these conserved residues would result in drastic deleterious 
effect on the enzyme activity and so these mutants were eliminated during 
screening, through a process called ‘purifying selection’ by Hughes [7, 8], 
However, mutations of residues that have interactions with active site 
residues were observed. Examples of such mutations are N53D, S127A and 
H217R. N53D was a rationally designed GpdQ mutant that was introduced 
into the StEP reaction at the sixth round. The mutation was retained after the 
sixth round screening but not later.
Much of the success of the second part of GpdQ directed evolution was also 
attributed to the inclusion of several rationally designed mutants as 
templates for gene recombination during the process of generating libraries 
for screening. The most notable among these mutations were F21K and 
C269A as they were retained at the end of eighth round screening among the 
mutants that displayed the highest activity improvement (Table 6.2). The 
availability of GpdQ crystal structures facilitated the possibility of rational 
approaches to engineer the enzyme activity. A good understanding of the 
protein structure and function greatly expanded the capabilities of GpdQ 
enzyme engineering.
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CHAPTER SEVEN -  FINAL CONCLUSIONS AND FUTURE 
DIRECTIONS
7.1 MUTATIONAL ANALYSIS OF ACTIVE SITE RESIDUES AND 
MECHANISTIC STUDIES OF GpdQ
Perhaps the most significant outcome of the mutagenesis studies of GpdQ 
active site residues was the confirmation that the a- and ß-metal ions bind with 
varying affinities. Jackson et al. first proposed the difference in the metal-
binding affinities when the Bijvoet-difference Fourier map of the active site of 
the Zn2+-GpdQ holoenzyme exhibited nearly full and partial occupancies of the 
a- and ß-sites with Zn2+ ions [1].
In this study, the hypothesis was investigated further with the D8N/A and 
N80D/A mutants. The residues D8 and N80 were believed to be responsible for 
the non-identical binding affinities at the metal sites. The N80D mutation that 
was expected to increase the binding affinity at the ß-site produced an inactive 
GpdQ enzyme; while N80A was still catalytically active. These kinetic findings 
indicate that flexibility in metal binding at the ß-site was essential for GpdQ’s 
diesterase activity. Meanwhile, both the D8N and D8A mutants were 
completely inactive, thus highlighting the importance of having a strong metal-
binding affinity at the a-site.
Electron paramagnetic resonance (EPR) was employed by fellow collaborators 
on GpdQ at the University of Queensland to monitor the binding of Mn  ^ to the 
GpdQ apoenzyme [2]. They also performed magnetic circular dichroism 
(MCD) studies on the wild-type GpdQ, N80D and N80A enzymes [3]. All these 
experiments confirmed the non-identical binding affinities at the a- and ß-sites. 
This provided an insight into the possible catalytic mechanism of GpdQ: The a-
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metal is responsible for the activation of the nucleophile (a catalytic water 
molecule, OH ) that catalyses the cleavage of the phosphodiester bond while the 
ß-metal is associated with substrate binding.
7.2 ENGINEERING GpdQ’s BIS (/MNITROPHENYL) PHOSPHATE 
ACTIVITY WITH DIRECTED EVOLUTION AND RATIONAL DESIGN 
-  A SEMI-RATIONAL APPROACH
Combining both directed evolution and rational strategies in what is sometimes 
referred to as a ‘semi-rational’ approach in protein engineering, this study 
successfully developed GpdQ mutants that were -500 times {kcJKu)  more 
active than the wild type towards bpNPP. The kcJ K m ratios of some of the 
eighth round mutants had even entered the realm of 106 NT's’1 which are two 
orders of magnitude below diffusion-limited catalytic rates (Table 6.3, Chapter 
6) .
Rational design played a major role in the success of the engineering of GpdQ’s 
bis (p-nitrophenyl) phosphate (bpNPP) activity. At the end of the first part of 
directed evolution studies, the take-home message was that apart from the 
improvement upon the catalytic activity, the selection pressure was also driving 
GpdQ towards oligomeric dissociation. Throughout the many kinetic assays 
conducted in this project, it had been shown that the high activity was 
associated with simpler oligomeric forms (dimer and monomer). This prompted 
the structural analysis of GpdQ to identify mutations that could be made to the 
protein to design a stable dimer or monomer. These mutations were introduced 
into the second part of directed evolution studies. Two of these rationally- 
designed mutations, F21K and C269A, were retained in many of the most 
catalytically active eighth round variants (Table 6.2, Chapter 6).
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Many of the mutations (most notably R12L, C54G, G259R and C269A) had 
similar implications on the structure of GpdQ: Conformational changes to the 
cap domain that would lead to increased accessibility of the active site and also 
ultimately, oligomeric dissociation.
It is believed that oligomerisation in proteins happens as a result of the natural 
evolutionary process [4, 5]. The conservation of the catalytic domains of GpdQ 
and the other members of the oc/ß sandwich superfamily of 
dimetallophosphohydrolases lends support to the notion that these enzymes 
must have diverged from the same monomeric ancestor and each has evolved 
secondary domains to cater for the physiological needs of its host organism. In 
the case of GpdQ, the dimerisation and cap domains were likely to have 
developed as a result of divergent evolution. The formation of the GpdQ 
hexamer, with the cap located at the entrance of the active was probably crucial 
in maintaining the enzyme’s selectivity for its natural substrates -  the 
glycerophosphodiesters. A figure showing how the cap domain overhangs the 
active site is given in Figure 7.1.
bpNPP contains two large aromatic ester groups (p-nitrophenolate) and has a 
much bulkier chemical structure than glycerophosphodiesters (Figures 1.5 and 
1.8, Chapter 1). It was therefore understandable that a widened entry into the 
active site to diminish steric entrance was required for bulky substrate 
molecules.
Engineering GpdQ’s bpNPP activity may lack direct industrial and clinical 
applications but helps us to understand how enzymes evolve and novel 
functions in nature.
Here is a list of proposed follow-up experiments on the mutants with improved 
b/?NPP activity in this study:
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l i .
iii.
The activity of these mutants should be tested with 
glycerophosphodiesters and simple alkyl diesters like dimethyl 
phosphate and diethyl phosphate to examine their substrate specificity. 
Our ability to separate the hexamer, dimer and sometimes also monomer 
with a size exclusion column indicates that the rate of inter-conversion 
of the species is slow compared to the time required to run the 
experiment. The dissociate rates need to be further investigated.
The thermodynamics of association/dissociation and the molecular 
dynamics of the GpdQ hexamer, dimer and monomer should be studied.
Figure 7.1: A figure showing how the cap domain of chain B overhangs the active 
site of chain A.
Presently in the Ollis laboratory, there is an ongoing directed evolution project, 
led by Miss Tracy Murray that aims to improve GpdQ’s dimethyl phosphate 
activity. The agar plate-based growth assay method [6] is used for the 
preliminary screening of the GpdQ mutant libraries. The E. coli BL21(DE3) 
cells used are equipped with the recombinant putative ugp operon from
232
CHAPTER SEVEN
Enterobacter aerogenes. Hopefully the results from these studies would enable 
us to answer better to the question whether GpdQ has potential for 
bioremediation applications.
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APPENDIX A -  MANUFACTURERS AND SUPPLIERS OF 
EQUIPMENT, KITS, CHEMICALS AND REAGENTS
EQUIPMENT
30°C and 37°C temperature control units 
AKTA FPLC system 
All glassware
All plasticware 
Autoclave model ASB270BT 
Auto vortex mixer 
Cell density meter 
Centrifuge 5415, 5804 
Centrifuge 3K18 
Centrifuge RC5C, RC6+
Centrifuge tubes
Centrifugal filter devices
Class II Biological safety cabinet
Combination pH electrode
DEAE Sepharose™ fast flow column
Dri-Bath Type 17600
Electricity power supply
French " pressure cell press
Fume cabinet
Gene Amp PCR system 9700
Hot plate
iCycler"
Labsystem Multiskan Ascent plate reader 
Ligh scattering detector 
Micropipettes 
MicroPulser™
Microscope 
Mighty small gel tank 
MF™ 0.45 pm membrane filter 
Millex®-GV 0.22 pm filter unit 
Milli-Q reagent water system 
Minisart® 0.20 pm filter unit 
NanoDrop" ND-1000 spectrophotometer 
Orbital mixer and incubator
Orbital shaker
Orbital shaking water bath
Peristaltic pump
Phenyl Sepharose™ fast flow column 
Q Sepharose™ fast flow column 
Qik Spin microcentrifuge 
Robotic dispensing system
Qualtex Solidstat 
GE Healthcare 
Duran, E-Mil England, 
Hirschmann Germany, LMS 
Germany, Pyrex 
Greiner Bio-one, Sarstedt 
Astell Scientific 
Chiltem 
WPA Biowave 
Eppendorf
Sigma Laboratory Supplies 
Thermo Electron Corporation 
Nalgene
Amicon, Millipore 
Flow Laboratories 
Orion Pacific Pty Ltd 
GE Healthcare 
Thermolyne
Bio-Rad, Pharmacia LKB 
SLM Aminco 
Dynaflow
P. E. Applied Biosystems
IKA Laboratory Equipment
Bio-Rad
Pathtech Pty Ltd
Wyatt
Gilson
Bio-Rad
Olympus
Hoefer
Millipore
Millipore
Millipore
Sartorius
Nano Drop
New Brunswick Scientific, 
Ratek Instruments 
Bio-Line 
Paton Scientific 
Gilson
GE Healthcare 
GE Healthcare 
United Biosciences 
Cartesian
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Rotors 11133
Rotors SA-600, SLA-3000, SS-34 
Sephadex™ G-75 column 
Sonicator
SpectraMax® M2/M2C multi-detection 
microplate reader 
Superdex™ 200 column 
Syringe
UV transilluminator 312 nm with attached 
camera for photo acquisition 
UV transilluminator 365 nm
Varian Cary UV/Vis spectrophotometer 
Water bath with temperature control 
Weighing scales
Sigma Laboratory Supplies 
Sorvall
GE Healthcare 
Soniclean Pty Ltd 
Molecular Devices
GE Healthcare
Terumo
UVItec
Hanimax Statesman,
UVP Inc.
Varian
Polystat, Thermomix 
Sartorius
KITS
QIAprep® Spin Miniprep Kit
QIAquick® PCR Purification Kit
QIAquick® Gel Extraction Kit
QuikChange™ Site Directed Mutagenesis Kit
Wizard® SV Gel and PCR Clean-Up System
CHEMICALS AND REAGENTS
1 kb DNA marker
10X BugBuster
10X PCR buffer
10X PCR buffer without MgCL
2% (w/v) N,N’-methylene-bisacrylamide
40% (w/v) acrylamide solution
Acetic acid, anhydrous
Adenosine 5’-monophosphate sodium
Adenosine 5’-triphosphate
Agar technical
Agarose, for routine use
Alkaline phosphatase, calf intestinal
Ammonium chloride
Ammonium molybdate
Ammonium persulfate
Ammonium sulfate, for molecular biology
Ampicillin
BamHl
ß-mercaptoethanol
BigDye terminator v3.1
bis (p-nitrophenyl) phosphate sodium
Bis-Tris
Boric acid
Bovine serum albumin
Qiagen
Qiagen
Qiagen
Stratagene
Promega
New England Biolabs
Merck
Roche
Roche
Merck
Bio-Rad
Ajax Finechem
Sigma-Aldrich
Sigma-Aldrich
Bacto Laboratories
Sigma-Aldrich
New England Biolabs
BDH Chemicals
Chem Supply
Bio-Rad
Sigma-Aldrich
Amresco
New England Biolabs
Sigma-Aldrich
BRF, JCSMR, ANU
Sigma-Aldrich
Sigma-Aldrich
BDH Chemicals
Sigma-Aldrich
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B ro m o p h e n o l  b lu e C h e m  S u p p ly
B u f f e r  3 N e w  E n g la n d  B io la b s
B u f f e r  4 N e w  E n g la n d  B io la b s
B u f f e r  H R o c h e
C a lc iu m  c h lo r id e A ja x  F in e c h e m
C a s a m in o  a c id s D ifc o  L a b o ra to r ie s
C H E S S ig m a - A ld r ic h
C o b a l t  ( I I )  c h lo r id e  h e x a h y d r a te S ig m a - A ld r ic h
C r y s ta l l i s a t io n  s c r e e n s H a m p to n  R e s e a rc h ,
J E N A  B io s c ie n c e
C u p r ic  s u lfa te M a y  a n d  B a k e r
D -(+ ) -  G lu c o s e ,  a n h y d r o u s S ig m a - A ld r ic h
D ie th y l  p h o s p h a te C h e m  S e rv ic e
D im e th y l  p h o s p h a te A c ro s
D im e th y l  s u l fo x id e S ig m a - A ld r ic h
D ip o ta s s iu m  h y d r o g e n  o r th o p h o s p h a te A ja x  F in e c h e m
d N T P  m ix R o c h e
D p n \ N e w  E n g la n d  B io la b s
E c o R l N e w  E n g la n d  B io la b s
E th a n o l ,  a b s o lu te A ja x  F in e c h e m
E th id iu m  b r o m id e S ig m a - A ld r ic h
E th y le n e d ia m in e te t r a a c e t ic  a c id  d is o d iu m A ja x  F in e c h e m
G e lc o d e  “ b lu e  s ta in  r e a g e n t P ie rc e
G ly c e ro l A ja x  F in e c h e m
G ly c in e ,  f o r  e le c t r o p h o r e s i s S ig m a - A ld r ic h
G u a n id in e  h y d r o c h lo r id e S ig m a - A ld r ic h
H E P E S S ig m a - A ld r ic h
H y d r o c h lo r ic  a c id  3 7 % S c h a r la u
H ig h  r a n g e  m o le c u la r  w e ig h t  s ta n d a rd B io -R a d
L ith iu m  s u lfa te S ig m a - A ld r ic h
L o w  r a n g e  m o le c u la r  w e ig h t  s ta n d a rd B io - R a d
M a g n e s iu m  c h lo r id e  h e x a h y d r a te B D H  C h e m ic a ls
M a g n e s iu m  s u lf a te M a l l in c k r o d t
M a n g a n e s e  ( I I )  c h lo r id e S ig m a - A ld r ic h
M E S S ig m a - A ld r ic h
M O P S S ig m a - A ld r ic h
N jN jN ’jN V te t r a m e th y le th y le n e d ia m in e S ig m a - A ld r ic h
N a t iv e  P fu  D N A  p o ly m e r a s e S tr a ta g e n e
N d e  I N e w  E n g la n d  B io la b s
N u tr ie n t  b ro th B a c to  L a b o r a to r ie s
p - n i t r o p h e n y l  p h o s p h a te  d is o d iu m S ig m a - A ld r ic h
P a ra o x o n -e th y l R ie d e l - d e - H a e n
P a r a o x o n - m e th y l R ie d e l - d e - H a e n
P e t r o le u m  je l l y S h e ll
P h e n y lm e th a n e s u l f o n y l f lu o r id e S ig m a - A ld r ic h
P o ta s s iu m  c h lo r id e A ja x  F in e c h e m
P o ta s s iu m  d ih y d r o g e n  o r th o p h o s p h a te
P o ta s s iu m  s u lf a te S ig m a - A ld r ic h
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Protamine sulfate 
Pstl
Sigma 7-9®
Sodium acetate 
Sodium chloride 
Sodium dodecyl sulfate 
Sodium phosphate dibasic 
T4 DNA ligase and buffer 
Tacsimate 100% pH 7.0 
Taq DNA polymerase 
Tris
Tryptone
Xbal
Xho\
Yeast extract 
Zinc chloride
Sigma-Aldrich 
New England Biolabs 
Sigma-Aldrich 
ICN Biomedicals 
Chem Supply 
BDH Chemicals 
Sigma-Aldrich 
New England Biolabs 
Hampton Research 
Bio-Line, Roche 
Amresco
Bacto Laboratories 
New England Biolabs 
New England Biolabs 
Bacto Laboratories 
BDH Chemicals
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APPENDIX B -  RECIPES OF CULTURE MEDIA AND BUFFERS 
USED IN THIS STUDY
The main reference used in the preparation of the following recipes was 
Molecular Cloning: A Laboratory Manual by Sambrook and Russell [1].
B.l CULTURE MEDIA
All media were sterilised by autoclaving for 20 minutes at 15 psi (1.05 
kg/cm ) before use.
Ampicillin (not autoclaved)
Ampicillin was the only selection antibiotic used throughout this study. 
Stock solutions of ampicillin were prepared by dissolving the ampicillin 
sodium salt (stored at 4°C) in 50% v/v ethanol (diluted from 100% 
undenatured ethanol of analytical grade) to a final concentration of 100 
mg/mL, eg. 1 g in 10 mL. The prepared solutions were stored at -20°C until 
future use. Due to the presence of ethanol, the solutions did not freeze at - 
20°C storage and therefore need not be thawed at room temperature before 
use. Ampicillin was added to cooled, sterilised culture media ( < 55°C) at a 
final concentration of 100 pg/mL, ie. 1 mL of ampicillin stock solution into 
every 1 L of media.
Agar media
To prepare agar media, 15 g of technical agar powder was added into every 
1 L of media and autoclaved together with the media. When the media 
cooled to about 55°C after autoclaving, 15-20 mL was poured into each agar 
plate in a lamina hood and left to set.
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Luria-Bertani (LB) medium
To 950 mL of IT1QH2O, the following were added and dissolved well:
Tryptone 10g
Yeast extract 5 g
NaCl 10 g
The pH of the medium was adjusted with saturated NaOH solution (~10 M) 
to 7.5 and the final volume, 1 L.
Terrific Broth (TB)
To 900 mL of m Q ^O , the following were added and dissolved well: 
Tryptone 12 g
Yeast extract 24 g
100% glycerol 4 mL
The 10X salt solution was prepared separately by dissolving the following 
in 100 mL of 1T1QH2O:
KH2PO4 2.31 g
K2HPO4 12.54 g
The solutions were autoclaved separately and allowed to cool before mixing 
them together.
M9 minimal medium
To 750 mL of sterile mQH20  (cooled to 50°C), the following were added:
5X M9 salts 200 mL
1 M MgS04 2 mL
20% glucose 20 mL
1 M CaCl2 0.1 mL
Sterile mQH20 to 980 mL
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5X M9 salts were prepared by dissolving the following in mQI-hC) to a final 
volume of 1 L:
Na2HP04.7H20 64 g
KH2PO4 15 g
NaCl 2.5 g
NH4CI 5.0 g
The 5X M9 salt solution was divded into 5 200 mL aliquots and autoclaved. 
The MgSC>4 and CaCh solutions were also prepared and autoclaved 
separately.
Modified MOPS phosphate-free minimal medium
The following recipe was modified from the original one by Neidhardt et al.
[2]
MOPS minimal medium 
Per liter:
10X MOPS mixture 100 mL
mQfhO 900 mL
The pH was adjusted with saturated NaOH solution (~10 M) to 7.2 and filter 
sterilised.
1 OX MOPS mixture
To a total volume of 440 mL, the following were added:
MOPS 83.72 g
Tricine 7.17 g
The pH of the MOPS/Tricine solution was adjusted with NaOH to 7.4. Then 
0.01 M of FeS0 4  solution was prepared separately, of which 10 mL was 
added into the MOPS/Tricine solution. Then the following were added to 
the MOPS/Tricine/ FeS0 4  solution according to the order shown:
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I.9MNH4CI 
0.276 M K2SO4
50 tnL
10 mL
0.02 M CaCl2.2H20 0.25 mL
2.5 M MgCl2 
5 M NaCl 100 mL
2.1 mL
Micronutrient stock 0.2 mL
Autoclaved mQH20  to 1000 mL final volume
The 10X MOPS mixture was sterilised using vacuum filtration units, 
dispensed into 100 mL aliquots and stored at -20°C. All the solutions above 
were prepared individually. To make the micronutrient stock, the following 
salts were dissolved in mQH20 , adjusted to a final volume of 50 mL, 
autoclaved and stored at room temperature:
Ammonium molybdate [(NH4)6Mo7024.4H2OJ 0.009 g
Boric acid (H3BO3) 0.062 g
CoCl2 0.018 g
CuSC>4 0.006 g
MnCl2 0.040 g
ZnS04 0.007 g
B.2 DNA AGAROSE GEL ELECTROPHORESIS
1.0 % agarose gel with ethidium bromide
1.0 % w/v agarose gel was prepared by dissolving 1 g of agarose into 100 
mL SB or TBE buffer. The solution was brought to a brief boil in the 
microwave, shaken to dissolve all agarose and cooled at room temperature 
to about 55°C. 5 pi of ethidium bromide solution (10 mg/mL) to a final 
concentration of 0.5 pg/mL. For gel extraction in library making purposes, 
the amount of ethidium bromide was increased to 1.0 pg/mL.
20X SB (sodium hydroxide-boric acid) buffer
Per liter as dissolved in mQH20:
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0.2 M NaOH adjusted to pH 8.0 with boric acid (—48 g).
10X TBE (Tris-boric acid-EDTA) buffer
Per liter:
Tris 108 g
55 gBoric acid
0.5 M EDTA 20 mL
6X Loading dye
20 mM Tris pH 8.0, 10% w/v of bromophenol blue (BPB) and 40% v/v 
glycerol.
B.3 SDS-PAGE
Both the running and stacking gel stock solutions were stored at 4°C. 10% 
w/v APS solution was stored at -20°C. TEMED was stored at room 
temperature.
17.5% running gel
17.5% running gel stock solution 3.75 mL
TEMED
10% w/v APS 25 pi 
3 pi
17.5% running gel stock solution
40% acrylamide 
2% bis-acrylamide 
2 M Tris pH 8.8 
10% w/v SDS 
mQH20 to 50.0 mL final volume
21.9 mL
9.4 mL
0.5 mL
1.8 mL
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Stacking gel
Stacking gel stock solution 1.7 mL
10% w/v APS 25 pi
TEMED 3 pi
Stacking gel stock solution
40% acrylamide 
2% bis-acrylamide 
2 M Tris pH 6.8 
10% w/v SDS 
1T1QH2O
6.3 mL
3.3 mL 
3.1 mL 
0.5 mL
to 50.0 mL final volume
10X running buffer
Per liter in mQH20:
Glycine 144 g
Tris 30 g
SDS 10g
Cracking buffer
200 mM Tris pH 6.8, 2% w/v SDS, 0.1% w/v bromophenol blue (BPB) and 
5% v/v ß-mercaptoethanol.
B.4 PROTEIN PURIFICATION
All buffers in protein purification were filtered with syringe driven 0.20 pm 
filters before use.
DEAE anion exchange chromatography
Starting buffer (buffer A) -  50 mM HEPES (11.92 g in 1 L) pH 8.0 at 4°C 
(adjusted with NaOH).
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Eluting buffer (buffer B) -  50 mM HEPES pH 8.0 at 4°C, 1 M NaCl (58.44 
g in 1 L).
Phenyl Sepharose hydrophobic interaction chromatography
Buffer A - same as for the DEAE column above.
Buffer B -  50 mM HEPES pH 8.0 at 4°C, 1 M ammonium sulfate (132.1 g 
in 1 L).
Q Sepharose anion exchange chromatography
Buffer A -  50 mM Tris (6.07 g in 1 L) pH 8.0 at 4°C (adjusted with 
hydrochloric acid HC1).
Buffer B -  50 mM Tris pH 8.0 at 4°C, 1 M NaCl.
Superdex 200 size exclusion chromatography
One buffer, with the same formula as buffer A for the Q Sepharose column 
above.
The recipes of all other buffers and reagents have been described in good 
detail in Chapter 2.
245
APPENDICES
APPENDIX C NUCLEOTIDE SEQUENCE OF PLASMID pCY76
pCY76 GCT ACCAGCACGCCATAGTGACTGCCGATGCTGTCGGAATGGACGATAATTCC
to to 100
I I I
pCY76 ACACT AACACCCCT AACCCTCTTCAT CATACCCCTCCCTTACTCCCTCCATT A
pCY76 GCCAGTCTGAATGACCTGTCACGGCAT AATCCCAACTGGTCAGACTGGAAAAT
160 ISO 200
I I I
pCY76 CAGACGGCACCAACTGCGAACAGCAAAAAGTCAGAT ACCACCACAT ACCAGAC
220 240 260
I I I
PCY76 CCCCCAT AAAACGCCCTCAGAGCCCCTCACGGGCT TTTCTTCT ATT AT CGGT A
2S0 *00
pCY76 CTTTCCTTGCATGAATCCATAAAAGGCGCCTCTACTCCCATTTACCCCCATTC
pCY76 ACTCCCACAGCCGTCAGCCCAGCGAACTGAATCTCACGAAAAACACAGCCACT
*80 400 420
I I I
pCY76 CAGCTGCCTGATGCTCGGAGACAAAAGGAATATTCACCCATTTCCCCCAGAAT
pCY76 TATCCCGCAAGAGGCCCCGCAGTCACCTCCCACTTTTCGCGGAAATGTGCGCG
460 500 *20
I I I
pCY76 GAACCCCTATTTCTTTATTTTTCTAAATACATTCAAATATCTATCCCCTCATG
pCY76 AGACAATAACCCTGAT AAATCCTTC AAT AAT ATTCAAAAAGCAACACT AT GAG 
pCY76 TATTCAACATTTCCGTCTCCCCCTTATTCCCTTTTTTGCCGCATTTTGCCTTC
pCY76 CTCT TTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAACATGCTCAAGATCAC
OCY76 TTGGCTCCACGAGTGGCTTACATCCAACTCCATCTCAACACCGCTAAGATCCT
pCY76 TGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACT TTTAAAGTTC
pCY76 TGCTATGTGGCGCGCTATTATCCCCTATTCACGCCCGCCAAGACCAACTCGCT
660 MO 600
I I I
PCT76 CGCCGCAT ACACTAT 1 CTCAGAATCACTTGGTTGAGTACTCACCACTCACAGA
820 *40
pCY76 AAACCATCTTACGGATGGCATGACACTAAGAGAATTATGCACTCCTGCCATAA
960 «60 1.000
pCY76 CCATCAGTGATAACACTCCGGCCAACTTACTTCTGACAACGATCGCAGGACCC
1.020 1.040 1.060
I I I
pCY76 AAGGAGCTAACCGCTTTTTTGCACAACATGGCCGATCATGTAACTCGCCTTGA
1060 l.ioo
PCY76 TCGTTCGGAACCCCACCTCAATCAAGCCATACCAAACGACGAGCGTGACACCA
1.120 1.140 1.160
I I I
pCY76 CGATGCCTGTAGCAATGGCAACAACCTTGCGCAAACTATTAACTGGCGAACTA
pCY76 CTTACTCTACCTTCCCGGCAACAATTAATAGACTGCATGGAGGCCGATAAACT
1^ 20 1.240 1.260
I I I
pCY76 TGCAGGACCACTTCTGCGCTCGGCCCTTCCGCCTGGCTGGTTTATTGCTGATA
L2*0 1.K» i.»20
I I I
pCY76 AATCTGGAGCCGGTGAGCGTCCGTCTCGCGCTATCAT TGCAGCACTGGGCCCA
1.240 1.160
pCY76 GATCCTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCACGCAAC
1 *60 1.400 1.420
I I I
PLY/b I A I CCA I O A ALL. AAA I AC A LAG A I CGC I GAGA I AGG I GCC I CAL IGA I I AAGL
1440 1.460 1460
• I I
PCY76 ATTGGT AACTGTCAGACCAACTTT ACTCAT AT AT ACTTT AGATTCATTTAAAA
1 *00 1.520
pCY76 CTTCATTTTTAATTTAAAACGATCTACGTGAAGATCCTTTTTGATAATCTCAT
11« 1.560 1.560
I I I
pCY76 GACCAAAATCCCTTAACCTCACTTTTCGTTCCACTGACCGTCACACCCCCTAC
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1.600 1.620 1.640
I I I
pCY76 AAAACATCAAACCATCTTCTTCACATCCTTTTTTTCTCCCCCTAATCTCCTCC
1660 1.660
pCY76 TTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTCTTTCCCCCATCAACA
1.200 1,220 1.240
I I I
pCY76 GCTACCAACTCTTTTTCCCAACCTAACTCGCTTCACCAGACCGCACATACCAA
1.260 1.260 1.600
I I I
pCY76 ATACTGTTCTTCTAGTCTAGCCGTACTTAGGCCACCACTTCAACAACTCTCTA
1.620 i.64o
pCY76 GCACCGCCTACATACCTCCCTCTGCTAATCCTGTTACCACTGGCTGCTGCCAC
1.660 1.660 1.900
I I I
pCY76 TGGCGATAACTCGTGTCTTACCGGCTTCGACTCAACACGATACTTACCGGATA
1.920 1.940 1.900
I I I
PCY76 AGGCGCAGCGGTCGGGC TGAACGGGGGCTTCGTGCACACACCCCAGCT TGGAG
1.960 2.000
pCY76 CGAACGACCTACACCGAACTGAGATACCTACAGCCTGACCATTGAGAAAGCGC
pCY/6 ACTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTCTGATGCTC
2.160 2-200 2.220
I I I
pCY76 GTCAGGGGGGCCGAGCCTATGGAAAAACGCCACCAACGCGGCCTTTTTACGGT
pCY76 TCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCT 
2,280 2.900 2.320r I I
pCY76 GATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCG
2.340 2.360 2.360I I I
pCY76 CACCCCAACGACCCAGCGCAGCGAGTCAGTCAGCGAGGAAGCGGAAGACCGCC
pCY76 CAATACGCAAACCCCCTCTCCCCGCGCGTTGCCCGATTCATTAATGCAGCTGG
2.440 2.460 2.460I I I
pCY76 CACCACACCTTTCCCCACTCCAAAGCGCGCACTGACCCCAACCCAATTAATCT
2.900 2.920 2.940
I I I
pCY76 CACTTACCTCACTCATTAGGCACCCCACGCTTTACACTTTATGCTTCCCGCTC
2.V60 2.960
0CY76 GTATGTTCTCTGGAATTCTGAGCCGATAACAATTTCACACAGCAAACAGCTAT
»JB
ATCCGAATTAATTT T A G A AATA
2.600 2.620 e S S K IS z l
pCY76 GACCATGATTACGAATTGCCGGCGATKTCctA T C C
PCY76 ATTTTGTTT AACTTT AAGAAGGAGAT AT ACAT ATGACCj f  CGACGCGT CTGC 
pm  M  M  2 720 i Ä Ä S f l
PCY76 4vGCTTT:TACyATTCGCATGGCATGCATCGAT4> A T(JC G A i.AGGCCTCGCCAGC
2.760 2.760 2600
I I I
pCY76 TTCCCACTGGCCGTCCTTTTACAACCTCCTCACTCCCAAAACCCTGCCCTTAC
1M0 2 640 2-660
I I I
pCY76 CCAACTTAATCCCCTTGCACCACATCCCCCTTTCGCCACCTCGCCTAATAGCG
2 660 2.900
PCY76 a a g a g g c c c g c a c c c a t c g c c c t t c c c a a c a c t t g c g c a g c c t c a a t g c c g a a
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APPENDIX D -  SEQUENCES OF PRIMERS USED IN THIS RESEARCH 
PROJECT
Primer Forward (5 ’ -»  3 ’) Reverse (5 ’ —> 3 ’)
Sequencing G C C  G G C  GAT A TC  GG A TC C  G G TA AAA C G A  C G G  CCA G T
Chapter 3
D8N TG T TAG C G C  ACA TT T  C C A  ATA C CC G C T G C G  GAA ATG G G T A TT G G A  AAT
A TT TC C  G C A  GC G TG  C G C  TAA CA
D8A TTA G C G  CAC A TT TC C  G C T A CC CAT G C T G C G  GAA ATG G G T AG C G G A  AAT
TTC  C G C  AG C G TG  C G C  TAA
H10A CAC A TT TC C  G A T A CC G C T  TT C  C G C C C G  C C G  C TG  C G G  AAA G C G  G TA TC G
A G C  C G C  GG GAA A TG  TG
D50N G TG  G TG  G TG  A G C  G G C  A A T A TC  G TC C G C  A G T TG A  CGA TA T TG C  C G C  TCA
AAC TG C  G C C A  C CA C
D50A G G T G G T GAG C G G  C G C  TA T C G T CAA C G C  A G T TG A  C G A  TA G  C G C  C G C  TCA
C T G C G C C A  CC
N80D C TC  A TC  C C C  G G C  GAC CAC G A T GAT C G C  TT T  A TC  A TC  G TG  G TC G C C  G G G
AAA G C G G A T GAG
N80A C TC  ATC C C C  G G C  G C C  CAC G A T GAT C G C  TT T  ATC A TC  G TG  G G C  G C C  G G G
AAA G C G G A T GAG
H 81Q A TC  C C C  G G C  AAC CAG GAT G A T AAA C G C  T T T  ATC A TC  C TG  G T T  G C C  G G G
GCG GAT
H81A ATC C C C  G G C  AAC G C C  G A T GAT AAA C G C  TT T  A TC  ATC G G C  G T T  G C C  G G G
G C G G A T
H 156Q G CA G C G  G C G  G G T G C T G C A  TAA AGA G C A  A C G  A TC  TT T  A TG  CAG CAC CCG
TC G  TTG  C C C G  C TG  C
H 156A C G G  CAA CGA T C T  TTA TG G  C C C  ACC A G C  G G C  G G G  TG G  G C C  ATA AAG ATC
C G C  C G C  T G T T  G C C  G
H 195Q C G C  A TC  T T T  TG C  G G T CAG AAC CAT A TG  G TC  AG G  CTA TG G  TTC  TG A C C G
A G C  C TG  A C C  AT C AA AAG A TG  CG
H 195N C G C  G C A  T C T  TT T  G C G  G T A  ATA ACC G G T CAG  G C T ATG G T T  A TT A CC G CA
ATA G C C  TG A  CC AAA GAT G C G  C G
H 195A C G C  G C A  T C T  T T T  G C G  GTG  C TA  ACC TG G  TC A  G G C  TA T G G T  TAG CAC C G C
ATA G C C  TG A  CCA AAA AG A TG C  G C G
Chapter 4
epPCR, G G A  G A T ATA C A T ATG C TG  TTA  G C G G C C  A TG  C G A  A TT C C T  TA T TA G  C G C
StEP
C 54G G C G  ATA TC G  TC A  ACG  G C G  G C C  GTC TC C  G G A  C G G  C C G  C C G  TTG  ACG  ATA
CG G  A TC G  C
S 122C G TT TAT C G A  C TC  C TG  C C G  C G C  C G G G TG  C C G  G C G  C G G  C A G  GAG  TC G  ATA
CAC AAC
N 164D C TG  C C G  C TG  G G C  G A T G C G  CAG ATG  
G
CCA TC T G C G  C A T C G C  C CA GCG  G CA G
H 217R C C C  G G C  ACC G TC  C G T CAG G TG  C C T G TA  AG G  CAC CTG A C G  G AC G G T G C C
TAC G G G
Y 221N A C C  G TC  CAT CAG G TG  C C T  A A C  TG C TC G  TG G  CAG TTA  G G C  A C C  TG A  TG G
C AC GA A C G  G T
Y 221H A C C  G TC  CAT CAG G TG  C C T  CAC TG C TC G  TG G  CAG TG A  G G C  A CC TG A TG G
C AC GA A C G  G T
S 233A C G T A TT ACG  A TC  TC G  C G C  C G G  C TT G C A  CG A AGC C G G  C G C  GAG ATC GTA
C G T G C ATA CG
S253L G G T GAG CTA C C A  G CA C TT G C T  GG C TG G  G C C  A G C  AAG TG C  TG G  TA G  C TC
C CA A CC
G 259R C C C  A C T ACG  C C A  G G C  C G T G G C  TG CAG  CCA C G G  C C T G G C  G TA G TG  GG
Y 263C C G C  C G G  G C C  G TG  G C T  G TG  C G A  CGA TT T  TC G  TC G  CAC A G C  CAC G G C  C C G
AAA G C G
I267T G C T G TA C G A  C G A  AAA CAC CAG  TTG C TT  C C G  TTG  GAC AAC TG G  TG T  TT T
TC C  AAC G G A  AG C G T C G T ACA GC
Chapter 5
F21K G C G  AG A A G C  T G T  A C G  G C A  A G A  TC G G C G  G C G  TTG  ACG TC G  A TC  TTG  CCG
ACG TC A  ACG  C C G  C TA C  A G C  TTC  TC G  C
N 53D C G G  C G A  TA T C G T CG A C TG  C G G  CCG G G A  C G G  C C G  CAG TC G  A C G  ATA TC G
TC C CCG
N53A C G G  C G A  TA T C G T  C G C  C TG  C G G  C C G C G G  A C G  G C C  G CA G G C  GAC GAT ATC
TC C  G G C C  G
Y204stop TG A CCA TG A  C C C  A G T AG C G C C  AG G G C G  C C T G G C  G C T A C T G G G  TC A  TG G
CG C TC A
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Y 257 s top C TG  G C C  C A C  T A A  G CC G G G  C C G  TG G  
C TG  TA C  G
C G T A C A  G C C  A C G  G C C  C G G  C TT A G T 
G G G  C C A  G
W 261R G G G  C C G  A G G  C TG  TA C  G A C  G A A  A A C  
A TC  A G T  TG
G TC  G TA  C A G  C C T C G G  C C C  G G C  G TA  
G TG
C 269S C G A  C G A  A A A  C A T  C A G  TA G  TC C  A A C  
G G A  A G A  G C G
C G C  T C T  TC C  G T T  G G A  C T A  C TG  ATG  
TT T  T C G  TC G
C 269A G TG  G C T G TA  C G A  C G A  A A A  C A T  C A G  
TG C  TC C  A A C  G G A  A G A  G
C TC  TTC  C G T TG G  A G C  A C T  G A T GTT 
TTC  G TC  G TA  C A G  C C A  C
C hap te r 6 (P rim ers fo r epP C R  and S tE P  as g iven under C hap te r 4)
R 12L G A T  A C C  C A T TTC  C TC  A G C  C G C  G G C  
G AG
C TC  G C C  G C G  G C T G A G  G A A  A TG  G G T 
A TC
N 103D C G G  TA G  C G A  TG C  C G A  T A A  TA T G C G  C G C G  C A T  A T T  A TC  G G C  A TC  G C T A C C  G
S 127A C G C  C G G  C A C  TG C  A A A  A G G  C TG  G C T G C A G  C C A  G C C  TT T  TG C  A G T  G C C  G G C  G
S ite  sa tu ra tion  m u tagenes is
C 54S S M G G C  G A T  A TC  G TC A A C  NNN G G C  C G T 
C C G  G A G  G A G  TA T  C
G A T A C T  C C T C C G  G A C  G G C  C NN N G T 
T G A  C G A  TA T  C G C  C
Y 221S S M C C G  TC C  A TC  A G G  TG C  CTN N N T G C C  
A C G  A A G  A C A  C A C  TC G C
G C G  A G T  G TC TTC  G TG  G C A  NNN A G G  
C A C  C TG  A TG  G A C  GG
G 259S S M C TG  G C C  C A C  TA C  G C C  NNN C C G  TG G  
C TG  TA C  G A C  G A A  A AC
G TT TTC  G TC  G TA  C A G  C C A  C G G  NNN 
G G C  G TA  G TG  G G C  CAG
A ppend ix  E
D 168A A A T  G C G  CAG  A TG  G C C  C C G  A TT G C C G G C  A A T  C G G  G G C  C A T CTG C G C  A TT
Notes
■ The pair o f primers used for error-prone PCR (epPCR) and staggered 
extension process (StEP) is referred to as SY-F (forward primer) and SY- 
R (reverse primer) in Chapter 2. The Nde 1 and EcoR\ cloning sites in SY-F 
and SY-R respectively, are underlined in this table.
■ Primers used in PCR cycle sequencing are referred as 4pCY76 (forward 
primer) and M l3 (reverse primer) in Chapter 2.
■ The rest o f the primers listed in this table are mutagenic, with the 
nucleotide changes highlighted in bold.
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APPENDIX E -  PROTEOLYTIC ACTIVATION OF GpdQ
All purified GpdQ enzymes (native and mutant), when visualised in an 
SDS-PAGE gel, had a thick band associated with 30.8 kDa calculated 
molecular weight of the monomer. Apart from this main band, there were 
four other smaller fragments between the estimated sizes of 7 and 23 kDa. 
Dr Colin Jackson suggested that GpdQ went through proteolytic activation 
after he showed that one batch of purified GpdQ that suffered from a higher 
level of proteolysis was more active than another batch with a lower level of 
proteolysis. He went on to predict these proteolysis sites by identifying the 
N-terminal sequence of the four small fragments and reconciling the 
identified proteolysis sites with the molecular weight of the fragments [1].
One of the proposed proteolytic cleavage sites was between D168 and PI 69, 
where the proteolysis would result in two fragments of polypeptide sized 
18.6 kDa and 12.2 kDa.
Cleavage of aspartate-proline (D-P) bonds has been well documented in 
literature. Some cleavages are reported to be sensitive to acidic conditions 
[2], occur at very low efficiency [3], calcium dependent [4] and 
autocatalytic [5].
A mutant, D168A was made to confirm proteolysis at this site. The other 
suggested D-P cleavage between D227 and P228, was not explored further 
as it was likely to be erroneous. At position 227, the correct residue is an 
arginine and not aspartate.
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Lane 1 2 3 4 5 6 7
Figure E.1: SDS-PAGE visualisation of purified wild-tvpe and D168A GpdQ 
enzymes.
Lane 1 shows the purified wild-type GpdQ enzyme; Lane 2 is the marker; Lanes 3-7 
are fractions of D168A from the final purification step.
The SDS-PAGE gel above shows that there was no apparent difference 
between the level of proteolysis between D168A and the wild-type enzyme. 
D168A was assayed with bpNPP and the results are given in the following 
table. The mutation produced a deleterious effect on the activity of the 
enzyme.
E n z y m e /fe a t R e la t iv e Km R e la t iv e /fe a t / R e la t iv e
( s 1) k cat (m M ) K m ( m V ) / f e a t /Km
Wild type 7 . 5 0  ± 0 . 1 1 .0 0 2 . 1 0  ± 0 . 0 8 1 .0 0 3 . 5 7  x 1 0 J 1 .00
D 1 6 8 A 0 . 7 9  ± 0 . 1 0 .11 3.2 1  ± 0 . 4 1 1 .5 3 2 . 4 7  x 1 0 2 0 .0 7
Table E.1: Kinetic results of D168A.
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APPENDIX F -  FACTORS INFLUENCING THE NEGATIVE 
COOPERATIVITY OF GpdQ MUTANT N80A
F.l N80A PHOSPHODIESTERASE ACTIVITY WITH BIS (P- 
NITROPHENYL) PHOSPHATE
Conditions of N80A assays with bis (p-nitrophenyl) phosphate were varied 
in order to explore factors that might affect the negative cooperativity in the 
mutant enzyme. Table E.l summarises the kinetic parameters (kca{, Km, 
&cat/Km) and values of the Hill coefficient (n) and their corresponding 
correlation coefficient (R") values.
Table F.1: A summary of the kinetic parameters and the Hill constant values of 
N80A assayed in various conditions.
The kinetic data for wild-type GpdQ was also included for comparison. Reactions 
that showed negative cooperativity are shaded in yellow while the rest are shaded in 
turqoise.
For all the assay reactions in Table E.l, other conditions like 50 mM CHES 
pH 9.0, 0.1 mg/mL BSA and temperature (20°C) were kept the same. 
Kinetic parameters for normal reactions with no cooperativity (shaded in 
turqoise in Table E.l) were calculated directly from their respective 
Michaelis-Menten curves (Equation 2.3, Chapter 2) using the KaleidaGraph 
software. Apparent values of kinetic parameters for reactions that exhibited 
negative cooperativity were estimated from their Eadie-Hofstee plots using
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Microsoft Excel (section 3.3.4.1, Chapter 3). The Michaelis-Menten curves 
of the assay reactions are shown in Figure F. 1.
— e - - W i l d  ty p e  + 0 .5  m M  M n
— B - N 8 0 A  w ith o u t  a d d e d  m e ta ls
O N 8 0 A  + 0  5  m M  M n
X N 8 0 A  +  1 .0  m M  M n
4- N 8 0 A +  1 .0  m M  C o
- N 8 0 A  + 0 .5  m M  M n  + 0  5  m M  P i
1 5  10* 2 5  10*
\bpNPP}
Figure F.1: The Michaelis-Menten curves of N80A assayed with bpNPP in 
different conditions.
F.2 N80A PHOSPHOMONOESTERASE ACTIVITY WITH P- 
NITROPHENYL PHOSPHATE
GpdQ is a promiscuous enzyme, showing primarily phosphodiesterase 
activity and low activities with many other organophosphate compounds, 
including phosphomonoesters and phosphotriesters [1]. GpdQ has been 
shown to display higher phosphomonoesterase activity at lower pH values 
[2, 3]. For this reason, all assays with bpNPP in this study were performed 
at pH 9.0 in order to minimise sequential phosphomonoesterase activity 
(bpNPP -» /?NPP —> inorganic phosphate) that would affect the accuracy of 
the kinetic results.
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Wild-type GpdQ, N80D and N80A were assayed with p-nitrophenol 
phosphate (pNPP) to characterise their phosphomonoesterase activities and 
to assess if the biphasic velocity curves observed of N80A could be a 
mixture of diesterase and monoesterase activities. Kinetic results are 
summarised in Table E.3. Assay conditions were 50 mM CHES pH 9.0, 0.5 
mM MnCl2 or C0 CI2, 0.1 mg/mL BSA at 20°C.
Enzyme K a t Relative K m Relative Relative
(s1) ^ ca t (mM) K n (M V) /Ccat/Km
Wild ty p e-  
Mnf+
0 .0 8  ± 0 .0 0 0 2 1 .0 0 4 .5 1  ± 0 .3 8 1 .0 0 1 .8 2  x 10' 1 .0 0
N 80D -M n z+ 0 .0 9  ± 0 .0 0 5 1 .1 3 1 1 .7 4  ± 1 .3 2 2 .6 0 7 .5 4  x 10° 0 .41
N 80A -M n 2+ 0 .1 6  ± 0 .0 4 2 .0 0 1 7 .2 7  ± 8 .3 2 3 .8 3 9 .5 7  x 10° 0 .5 3
Wild typ e-  
C o 2
0 .0 6  ± 0 .0 0 2 1 .0 0 3 .5 4  ± 0 .3 4 1 .0 0 1 .6 2  x 1 0 1 1 .0 0
N 8 0 A -C o 2* 0 .1 9  ± 0 .0 6 3 .1 7 2 5 .2 2  ± 0 .1 6 0 .7 6 7 .4 9  x 10° 0 .4 6
Table F.2: pNPP activities of wild-type GpdQ, N80D, N80A with Mn2+ or Co2+.
Both N80D and N80A mutations resulted in a drastic drop in the affinity of 
GpdQ for pNPP. The catalytic turnover, kcat, was however improved by the 
N80A mutation in both the assays with Mn:t and Co2f, although the 
ultimate kcat/Km ratio values were still much lower than those of the wild- 
type GpdQ. The kinetic progress curves, of which an example is shown 
below in Figure E.2, were not diagnostic of any obvious sequential 
hydrolysis of bpNPP and pNPP by GpdQ.
-0 .10-
-0 .15-
Time (min)
Figure F.2: A sample of a kinetic progress curve of N80A hydrolysis of 20 mM 
bpNPP.
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F.3 INTRA/INTER-MOLECULAR NEGATIVE COOPERATIVITY 
IN N80A
Aghajanian and Engel demonstrated that negative cooperativity in the 
glutamate dehydrogenase from Clostridium symbiosum was due to 
interactions between NAD* binding sites on the six subunits of the homo- 
hexamer [4].
To investigate if biphasic kinetics/negative cooperativity existed between 
the dimeric units in the N80A hexamer, mutant 3-25-N80A was generated. 
3-25 (C54G, Y221H and G259R) is a GpdQ mutant from directed evolution 
that dissociated into a mixture of hexamer and dimer.
3-25-N80A hexamer and 3-25-N80A dimer were purified and assayed with 
b/?NPP separately. The Michaelis-Menten curves of the assays are shown in 
Figure E.3 while values of the Hill coefficient for both enzyme forms are 
given in Table E.3.
o 3-25-N80A Hexamer 
D 3-25-N80A Dimer
□
C
□
1
5“
l1
....................
o
<
......X
o
r..............
Ü
□ < 
□ o
a0
3
0  5000 1 10* 1.4 10* 2 10* 2.5  10*
iOpNPP]
Figure F.3: Michaelis-Menten plots of 3-25-N80A hexamer and 3-25-N80A dimer 
assayed with bpNPP.
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E nzym e n R 2
3 -2 5 -N 8 0 A  hexam er 0 .9 0 .9 9
3 -2 5 -N 8 0 A  dim er 0 .9 0 .9 6
Table F.3: Values of the Hill coefficient (n) and correlation coefficient (R2) for 
kinetic assay reactions of 3-25-N80A hexamer and dimer with bpNPP.
F.4 CONCLUSIONS ON THE NEGATIVE COOPERATIVITY OF 
N80A
Based on the results of all the studies on the negative cooperativity in 
sections F.1-F.3, the following conclusions are made:
i. Negative cooperativity was induced by the presence of metal ions
N80A was assayed using bpNPP as substrate without adding any 
exogenous metals. The activity of the apoenzyme was extremely low 
but was found to obey Michaelis-Menten kinetics.
ii. Negative cooperativity was not dependent on the concentration 
of metal ions
N80A was assayed for bpNPP activity again with the concentration 
of Mn2t increased to 1.0 mM. The activity of the enzyme increased 
but biphasic kinetics could still be observed.
iii. Negative cooperativity was not metal specific
The bpNPP activity of N80A was tested in the presence of 1.0 mM 
Co“ . Biphasic kinetics was observed and the enzyme was less active 
with Co2+ than it was with Mn2+.
iv. The presence of Pj eliminated negative cooperativity in N80A
It had been previously shown by Hadler et al. in their magnetic 
circular dichroism (MCD) [5] and electron paramagnetic resonance 
studies [6], how the addition of inorganic phosphate (Pj) promoted 
metal binding at the ß-site in N80A. Therefore, kinetic assays of
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N80A were repeated in the presence of 0.5 mM sodium 
monophosphate monobasic (FW = 119.98) as a supply of Pj. It was 
found that in the presence of Pj, N80A displayed standard Michaelis- 
Menten kinetics.
The addition of Pj into assay reaction mixtures resulted in an almost 
two-fold increase in Km, regardless of the presence of Mn2+. GpdQ 
has a low level of phosphomonoesterase activity, which yields Pj as a 
final product. It is possible that the relationship between the active 
site of GpdQ and Pj happened as a result of product inhibition. 
Product inhibition of enzymes has long been recognised as a 
negative feedback mechanism in the homeostatic regulation of 
enzyme activity [7]. In fact, the solved crystal structure of native 
Rv0805 3’,5’-cyclic nucleotide phosphodiesterase (PDB file 2HY1) 
had a Pj molecule bound at its active site [8].
Interestingly, in the presence of Pj and absence of exogenous Mn2+, 
the catalytic rate of N80A was higher than that of N80A assayed 
without any added Mn2 and Pj. This implied that Pj promoted 
enzyme activity in the absence of excessive metal ion co-factors.
v. Biphasic kinetics was substrate specific
N80A did not exhibit biphasic but standard Michaelis-Menten 
kinetics with pNPP. A different catalytic mechanism involved in the 
hydrolysis of monoesters would be the likely reason for this.
vi. Negative cooperativity was present between the two metal- 
binding sites of the GpdQ active site
3-25-N80A hexamer and dimer, despite their different oligomeric 
forms, displayed slight negative cooperativity, with both enzymes 
having the same n value of 0.9. This implies that the observed 
negative cooperativity behaviour in N80A was most likely intra-
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(within the binuclear active site of an N80A protein monomer) and 
not intermolecular.
Negative cooperativity in cyclic nucleotide phosphodiesterases has been 
well characterised [9-12]. Negative cooperativity has its advantages in that it 
enables the enzyme to respond to a broader range of ligand or substrate 
concentrations [13] and at these exceedingly high ligand concentrations, the 
catalytic rate accelerates greatly [14].
The negative cooperativity of N80A was most likely attributed to the 
mutation disabling the coordination of the ß-metal ion by the N80 ligand 
that subsequently weakened further the metal binding affinity at the ß-site. 
Some kinetic models conceptualise discrete and static sub-sites within a 
single, large active site [15]. This concept of discrete and static sub-sites is 
supported by mutagenesis studies done by Halpert and colleagues [16-18]. 
In the case of GpdQ, these two sub-sites referred to are the two a- and ß- 
metal binding sites. Each subsite would have its characteristic affinity for 
each ligand. In a most extreme case with N80A, metal ions and substrate 
molecules bind sequentially to the high-affinity a-subsite and then ß-subsite 
at higher substrate concentrations. If this catalytic mechanism is true, then 
this would mean that at higher substrate concentrations, the N80A active site 
would actually hydrolyse two molecules of bpnpp at a time, one at each 
metal coordinating site.
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